data_2mkj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.407 ' CD1' ' HB1' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.407 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.459 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.44 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 128' ' ' CYS . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.581 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.485 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' CG1' ' A' ' 149' ' ' VAL . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.721 0.296 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.415 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.487 ' H ' HD13 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.402 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.483 ' CZ ' ' HB1' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.41 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.546 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.493 ' H ' HG23 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.433 HE21 ' NE2' ' A' ' 238' ' ' GLN . 85.1 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.624 0.25 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 . . . . . 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 tptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HB3' ' HZ2' ' A' ' 147' ' ' LYS . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 152' ' ' ARG . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.473 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 CA-C-O 121.228 0.349 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 152' ' ' ARG . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.495 ' H ' HD22 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.456 ' H ' HD13 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.483 ' H ' HG13 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.435 ' CD1' ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.435 ' H ' ' CD1' ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.58 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.58 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 . . . . . 0 N--CA 1.457 -0.075 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.421 ' HZ1' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.661 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.513 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.564 ' HG ' ' CD1' ' A' ' 137' ' ' LEU . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HG ' ' A' ' 128' ' ' CYS . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.462 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.462 ' H ' HD13 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 N--CA 1.457 -0.123 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.46 0.041 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.658 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 207' ' ' THR . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.458 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.548 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.548 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.5 tptm . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE1' ' HB1' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 187' ' ' VAL . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' A' ' 185' ' ' ARG . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.784 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.784 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.47 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.582 ' HE2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 CA-C-O 121.375 0.431 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.429 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.588 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 160' ' ' ASP . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 158' ' ' ASP . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.698 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.698 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.486 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.53 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.53 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.409 ' OD2' ' HE2' ' A' ' 246' ' ' LYS . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 245' ' ' ASP . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' HD2' ' H ' ' A' ' 63' ' ' TYR . 31.5 tpt85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 N-CA-C 114.007 0.363 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.59 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.485 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.59 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.519 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.447 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.45 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.529 0.204 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.579 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.518 ' CD2' HD11 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.48 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.506 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.506 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.616 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.616 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.428 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ILE . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 . . . . . 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 165' ' ' GLY . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 164' ' ' ASP . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.43 ' H ' ' HG3' ' A' ' 188' ' ' GLU . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.46 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.46 ' CD2' HD11 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.504 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 p . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.697 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.487 ' H ' HD13 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.427 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 87' ' ' ARG . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' PHE . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 137' ' ' LEU . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.402 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.634 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 192' ' ' ILE . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.411 ' HG ' ' CG ' ' A' ' 213' ' ' TYR . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.402 ' H ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.411 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 155' ' ' ASN . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.529 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.529 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.539 ' CD2' HD11 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . 0.489 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . 0.459 ' HE ' HG23 ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.459 HG23 ' HE ' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.531 HD21 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.577 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.577 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 84.3 p . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.169 0.509 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 140' ' ' SER . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.508 ' H ' HD13 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.58 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.58 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.485 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.422 ' HG2' HD21 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.485 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -147.86 152.49 37.71 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.108 0.563 . . . . 0.0 110.239 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -151.84 -32.64 0.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.489 0.315 . . . . 0.0 110.77 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.47 158.06 36.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.7 13.35 2.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.36 162.7 23.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.452 0.626 . . . . 0.0 110.792 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -138.92 157.16 46.54 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.333 0.653 . . . . 0.0 109.983 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.74 141.84 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.05 14.02 5.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 111.203 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -93.37 26.22 3.06 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.183 0.993 . . . . 0.0 111.475 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.424 ' CG ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 m95 -112.76 154.49 44.79 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.61 -14.86 30.54 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.118 2.545 . . . . 0.0 110.583 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -151.85 129.48 11.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -156.2 12.19 0.29 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.883 0.473 . . . . 0.0 111.914 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.8 155.46 37.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 111.49 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.16 1.88 4.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.145 0.578 . . . . 0.0 111.654 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -75.12 -15.17 60.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.842 0.457 . . . . 0.0 111.555 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -151.11 -54.24 0.14 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 t -163.88 158.7 20.2 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.068 0.395 . . . . 0.0 111.534 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -80.54 -1.2 40.93 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.146 0.578 . . . . 0.0 111.33 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.51 155.67 75.28 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.596 0.758 . . . . 0.0 109.715 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HD3' ' CG ' ' A' ' 95' ' ' TRP . 93.3 Cg_endo -76.23 150.22 32.76 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.394 2.729 . . . . 0.0 111.896 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.18 0.1 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.358 3.372 . . . . 0.0 111.93 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.64 164.68 22.37 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.472 0.709 . . . . 0.0 110.731 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.42 -1.12 69.19 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m -54.17 109.55 0.49 Allowed 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.647 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 41.3 t -167.25 -44.88 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.251 -0.88 . . . . 0.0 113.372 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 141' ' ' SER . 84.2 Cg_endo -75.08 -145.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 0.0 110.044 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.0 p -66.11 9.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -130.1 137.59 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.941 0.896 . . . . 0.0 108.6 175.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -138.8 163.94 30.92 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 123.587 0.755 . . . . 0.0 111.957 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' CD1' ' HB1' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.407 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.459 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.44 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.455 ' H ' HG23 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -147.85 172.59 13.91 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.049 0.54 . . . . 0.0 110.516 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.75 166.48 22.85 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.222 0.609 . . . . 0.0 110.086 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -129.8 9.22 5.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.024 0.53 . . . . 0.0 110.738 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.19 27.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.37 166.31 25.02 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.504 0.722 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' A' ' 60' ' ' VAL . 51.7 ttm-85 60.56 172.18 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.493 1.117 . . . . 0.0 111.808 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 10.5 p -135.2 157.52 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 123.061 0.544 . . . . 0.0 109.959 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -136.68 52.51 1.95 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.004 0.921 . . . . 0.0 109.512 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -136.23 39.19 2.71 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.196 0.598 . . . . 0.0 111.719 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -166.02 165.23 10.8 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.1 153.78 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.736 2.957 . . . . 0.0 112.438 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -63.37 150.97 42.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.838 0.855 . . . . 0.0 111.22 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 165.16 20.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.112 0.565 . . . . 0.0 111.339 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 54.25 22.5 3.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.403 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.6 t -148.59 168.23 23.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.422 0.689 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.16 8.93 3.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.769 0.828 . . . . 0.0 110.431 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.8 p -131.76 6.1 4.32 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -90.81 142.16 28.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.938 0.335 . . . . 0.0 110.342 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -147.45 156.85 45.7 Favored Pre-proline 0 C--O 1.233 0.187 0 C-N-CA 123.841 0.856 . . . . 0.0 109.424 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.14 155.85 66.75 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.972 2.448 . . . . 0.0 110.794 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.86 134.98 66.1 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.614 2.876 . . . . 0.0 112.482 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 51.91 13.16 0.23 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.919 1.288 . . . . 0.0 114.173 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.39 13.25 81.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.389 0.54 . . . . 0.0 112.094 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 128' ' ' CYS . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -74.03 140.19 45.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -145.31 172.3 5.51 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.441 0.696 . . . . 0.0 109.259 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.437 ' HA ' ' HE3' ' A' ' 145' ' ' LYS . 65.5 Cg_exo -54.85 -5.05 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.275 3.317 . . . . 0.0 115.186 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p -92.17 -21.26 20.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.909 0.777 . . . . 0.0 112.023 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 -25.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 142' ' ' PRO . 33.6 mmtp 41.88 43.88 2.73 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.063 0.945 . . . . 0.0 111.791 -178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.581 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.501 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.485 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.12 12.22 3.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.537 0.735 . . . . 0.0 111.081 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -143.09 150.8 40.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.226 0.61 . . . . 0.0 109.926 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -139.74 8.65 2.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.266 0.626 . . . . 0.0 111.343 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 4.64 90.13 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.59 165.4 20.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 117.397 0.599 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.03 18.49 3.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.08 0.952 . . . . 0.0 113.419 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.9 t -136.46 144.95 31.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.147 0.579 . . . . 0.0 109.723 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -130.21 169.52 15.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.668 0.787 . . . . 0.0 109.781 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -134.18 146.04 49.79 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.348 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' CG1' ' A' ' 149' ' ' VAL . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -152.08 148.12 20.89 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.49 -0.43 5.88 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.672 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -76.47 -6.26 50.99 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.434 0.561 . . . . 0.0 111.3 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 7.93 6.73 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.196 0.598 . . . . 0.0 112.223 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.18 4.3 8.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.245 0.618 . . . . 0.0 112.496 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.76 164.43 27.57 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.046 0.538 . . . . 0.0 110.779 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.7 p -84.65 9.76 12.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -171.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -140.81 154.4 46.22 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 118.464 0.574 . . . . 0.0 111.481 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.8 p 56.39 165.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.177 1.791 . . . . 0.0 113.598 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -142.64 15.12 1.97 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.955 0.502 . . . . 0.0 111.301 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 143.57 84.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.735 0.414 . . . . 0.0 110.612 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 153.55 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.419 2.746 . . . . 0.0 111.982 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.95 -24.72 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.389 2.726 . . . . 0.0 112.563 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -155.29 18.54 0.42 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.66 -1.47 88.82 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p -87.0 50.57 2.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.473 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.2 t -158.02 -45.95 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.473 ' CD ' ' H ' ' A' ' 141' ' ' SER . 33.2 Cg_exo -61.65 -43.1 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.991 2.461 . . . . 0.0 114.959 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -140.06 0.49 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.819 0.448 . . . . 0.0 111.742 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.63 156.23 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 119.65 11.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.188 0.449 . . . . 0.0 110.565 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.487 ' H ' HD13 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.403 0.144 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 t60 51.87 31.29 8.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 112.354 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -78.07 -15.69 58.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.572 0.349 . . . . 0.0 111.282 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -84.04 128.88 34.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.1 6.97 4.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -89.69 17.1 6.86 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.501 0.72 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.18 163.66 26.17 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.473 0.709 . . . . 0.0 111.628 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.25 178.15 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 123.754 0.822 . . . . 0.0 109.77 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.34 17.32 7.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.336 0.654 . . . . 0.0 111.097 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.02 9.7 20.41 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.403 ' HE1' ' CG ' ' A' ' 98' ' ' LYS . 0.9 OUTLIER -165.79 157.46 12.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 -6.45 6.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 124.36 3.373 . . . . 0.0 114.807 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -100.19 7.58 44.42 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' CG ' ' HE1' ' A' ' 95' ' ' TRP . 41.7 mmtm -134.67 4.19 3.32 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.202 0.601 . . . . 0.0 111.061 175.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.48 32.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.584 0.354 . . . . 0.0 110.536 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 53.59 12.57 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.698 1.199 . . . . 0.0 113.409 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -158.73 171.02 20.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.527 0.731 . . . . 0.0 109.709 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.39 149.04 50.67 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.0 m -66.96 129.93 41.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -156.58 179.45 9.25 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.871 0.869 . . . . 0.0 109.005 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -74.26 146.22 84.04 Favored Pre-proline 0 CA--C 1.532 0.28 0 O-C-N 122.135 -0.353 . . . . 0.0 110.482 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -70.96 171.99 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.549 3.499 . . . . 0.0 111.667 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.36 155.85 28.44 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.512 2.808 . . . . 0.0 111.177 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.23 129.53 34.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.28 -4.91 23.18 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p -97.77 44.39 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.671 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 84.9 p -168.1 -31.17 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.671 ' HD2' ' H ' ' A' ' 141' ' ' SER . 62.8 Cg_endo -80.59 -23.4 5.93 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.818 1.685 . . . . 0.0 112.727 -171.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.8 m -146.91 -28.56 0.38 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.88 177.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.577 0.751 . . . . 0.0 109.313 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 114.64 8.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.402 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' CZ ' ' HB1' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.546 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.41 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.546 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.513 0.197 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -75.17 -0.3 18.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.96 0.504 . . . . 0.0 111.944 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -85.23 5.87 28.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.051 0.541 . . . . 0.0 111.315 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -77.97 -6.65 55.1 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.087 0.555 . . . . 0.0 112.073 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 59' ' ' ARG . . . 67.77 -164.85 45.56 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.59 -12.55 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.868 1.667 . . . . 0.0 113.953 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' A' ' 57' ' ' GLY . 34.6 mtp-105 57.24 171.97 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.258 1.423 . . . . 0.0 113.355 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.26 138.19 26.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.39 140.08 19.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -149.4 -6.2 0.36 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.028 0.931 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -106.22 155.1 39.16 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 -18.48 32.46 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.216 2.611 . . . . 0.0 110.737 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -154.7 151.16 28.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.2 1.0 . . . . 0.0 108.494 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.04 172.44 14.24 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.12 167.07 22.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.886 0.875 . . . . 0.0 109.381 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.92 4.8 21.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.751 0.42 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.8 t -151.06 159.4 44.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.312 0.645 . . . . 0.0 110.044 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.29 9.6 10.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.86 0.464 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.1 m -76.64 5.22 7.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.933 0.493 . . . . 0.0 111.243 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -140.25 161.22 38.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -137.78 156.01 74.68 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.376 0.67 . . . . 0.0 110.119 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.23 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.922 2.415 . . . . 0.0 110.705 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.65 -8.25 19.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.068 3.179 . . . . 0.0 112.744 -174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HE2' ' CG ' ' A' ' 110' ' ' TYR . 20.0 ptmt -148.94 161.38 42.01 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.084 0.402 . . . . 0.0 111.269 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.74 5.73 64.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.762 0.696 . . . . 0.0 113.375 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' CG ' ' HE2' ' A' ' 108' ' ' LYS . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p -93.07 66.46 4.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.701 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 70.3 m -153.8 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.701 ' HD2' ' H ' ' A' ' 141' ' ' SER . 39.0 Cg_endo -82.44 -132.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.078 2.518 . . . . 0.0 110.267 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.9 p -66.19 1.54 1.5 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.521 0.728 . . . . 0.0 112.424 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.43 142.84 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -141.17 127.2 19.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.006 0.522 . . . . 0.0 109.721 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.493 HG23 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.493 ' H ' HG23 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.433 HE21 ' NE2' ' A' ' 238' ' ' GLN . 85.1 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.647 -0.131 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -148.56 165.82 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.095 0.558 . . . . 0.0 110.25 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -72.43 163.64 27.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.23 21.12 17.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.0 111.025 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.95 -160.16 48.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.78 155.39 47.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.221 0.608 . . . . 0.0 109.961 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -139.07 160.62 39.34 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.42 157.85 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.309 0.644 . . . . 0.0 110.132 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -66.83 150.09 49.65 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.88 0.472 . . . . 0.0 110.326 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -102.89 174.95 5.65 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.088 0.555 . . . . 0.0 111.618 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -111.57 141.8 25.29 Favored Pre-proline 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 -8.24 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.782 2.988 . . . . 0.0 112.425 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.88 29.64 2.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.186 0.594 . . . . 0.0 111.392 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.22 156.24 25.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.027 0.441 . . . . 0.0 112.103 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.25 43.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.059 0.944 . . . . 0.0 109.255 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.44 154.56 45.65 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.502 0.321 . . . . 0.0 111.193 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 m 54.78 6.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.437 1.495 . . . . 0.0 114.925 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -140.38 -16.6 0.93 Allowed 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.197 0.599 . . . . 0.0 111.333 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.2 t -158.35 167.65 29.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.901 0.48 . . . . 0.0 109.816 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -139.02 155.07 48.26 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.426 0.69 . . . . 0.0 110.006 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 61.38 154.12 0.11 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.841 1.256 . . . . 0.0 112.2 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.2 Cg_endo -70.79 133.65 24.13 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.365 2.044 . . . . 0.0 110.279 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 38.7 Cg_exo -60.47 -10.18 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.047 3.165 . . . . 0.0 114.255 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -147.19 159.61 43.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.103 0.41 . . . . 0.0 110.138 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.11 0.16 48.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.372 0.51 . . . . 0.0 112.781 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m -54.66 98.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 38.3 t -168.96 -50.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.716 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 141' ' ' SER . 76.8 Cg_endo -80.61 107.78 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.367 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p 50.69 12.45 0.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.472 1.509 . . . . 0.0 114.57 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.74 147.43 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.089 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -146.35 162.32 38.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.447 ' HB3' ' HZ2' ' A' ' 147' ' ' LYS . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' HA ' ' NE ' ' A' ' 152' ' ' ARG . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.402 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.473 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.473 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -147.31 161.9 40.04 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.968 0.507 . . . . 0.0 110.05 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.29 -8.13 55.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.857 0.463 . . . . 0.0 111.86 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -83.56 10.47 8.99 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.92 0.488 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.38 -168.73 11.74 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -125.54 149.85 47.96 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.529 -0.395 . . . . 0.0 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -121.29 162.13 20.79 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.519 0.728 . . . . 0.0 109.773 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.14 152.8 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.789 0.435 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.54 10.06 2.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.413 0.685 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -88.11 9.44 22.67 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.68 152.05 41.33 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.05 -8.83 20.36 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.301 2.667 . . . . 0.0 112.556 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -141.63 26.59 1.92 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -3.39 5.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.224 0.92 . . . . 0.0 112.835 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.11 11.09 11.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.452 0.701 . . . . 0.0 111.235 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.96 -7.51 2.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.913 0.485 . . . . 0.0 111.186 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -75.03 154.8 37.82 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 122.136 -0.353 . . . . 0.0 110.74 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -102.05 4.84 40.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 111.105 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 97.5 p -145.6 178.43 8.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.2 0.6 . . . . 0.0 110.33 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -77.01 9.11 3.17 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.074 0.55 . . . . 0.0 112.201 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -126.64 138.74 33.1 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 122.908 0.483 . . . . 0.0 110.08 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.74 166.0 26.01 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.709 2.94 . . . . 0.0 110.504 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.11 166.33 7.34 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.87 3.047 . . . . 0.0 111.893 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.32 14.57 1.49 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.138 0.575 . . . . 0.0 111.94 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -158.34 6.96 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.786 0.708 . . . . 0.0 112.651 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p -90.84 48.43 1.53 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.498 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 32.5 m -111.83 -39.02 0.11 Allowed Pre-proline 0 CA--C 1.528 0.123 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.433 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.498 ' CD ' ' H ' ' A' ' 141' ' ' SER . 29.7 Cg_exo -64.87 -171.44 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.001 2.468 . . . . 0.0 110.225 168.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.2 p -69.79 4.49 1.95 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.343 0.657 . . . . 0.0 112.5 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -41.56 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.059 0.543 . . . . 0.0 110.685 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 38.48 76.3 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.715 1.606 . . . . 0.0 113.793 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 152' ' ' ARG . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.495 ' H ' HD22 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.456 ' H ' HD13 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.483 ' H ' HG13 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.435 ' CD1' ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.435 ' H ' ' CD1' ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.58 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.58 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.339 0.114 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -139.16 162.95 33.72 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.359 0.664 . . . . 0.0 110.266 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -130.25 13.37 5.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.119 0.567 . . . . 0.0 111.177 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.93 155.77 39.53 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.532 0.333 . . . . 0.0 110.366 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.41 170.42 53.61 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.84 154.86 24.46 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -133.89 -20.32 1.98 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 111.355 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.81 148.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.513 1.525 . . . . 0.0 113.854 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.85 140.56 32.95 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.64 -23.22 0.09 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -101.55 156.46 35.16 Favored Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.09 -19.12 61.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.54 2.827 . . . . 0.0 111.721 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -150.28 136.69 18.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.268 1.027 . . . . 0.0 108.801 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -146.71 13.32 1.17 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 172.91 11.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.09 143.19 49.39 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.4 t -151.58 165.15 35.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.856 0.462 . . . . 0.0 110.439 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.91 9.14 25.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.457 0.703 . . . . 0.0 111.123 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.9 t -138.57 160.16 40.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.542 0.737 . . . . 0.0 110.616 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.31 15.94 16.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.584 0.754 . . . . 0.0 111.591 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -125.88 70.64 67.01 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.716 . . . . 0.0 110.195 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 83.9 Cg_endo -73.73 -22.19 18.11 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.566 2.844 . . . . 0.0 116.225 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 106' ' ' PRO . 88.1 Cg_endo -74.01 163.75 36.08 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 123.003 2.108 . . . . 0.0 111.015 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.587 ' HA ' ' HE2' ' A' ' 108' ' ' LYS . 11.6 mmpt? -101.05 18.24 20.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.564 0.746 . . . . 0.0 112.322 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.92 -1.33 74.29 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m -57.19 102.16 0.08 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.618 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.1 t -164.37 -48.38 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.488 -0.768 . . . . 0.0 112.182 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.618 ' HD2' ' H ' ' A' ' 141' ' ' SER . 44.7 Cg_endo -78.87 -146.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.074 2.516 . . . . 0.0 110.222 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.2 t -58.16 -14.93 7.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 112.749 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.19 140.68 22.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.421 ' HZ1' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -149.07 160.52 43.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 -178.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.661 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.432 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.513 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.915 -0.032 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 55.64 18.42 2.8 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.302 1.041 . . . . 0.0 113.235 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.85 161.62 37.51 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.534 0.734 . . . . 0.0 109.836 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -79.96 159.22 26.38 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.575 0.35 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.76 176.44 50.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.35 7.0 5.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.023 0.529 . . . . 0.0 111.268 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -81.41 166.88 20.0 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.001 0.52 . . . . 0.0 110.933 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.13 148.38 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.126 0.57 . . . . 0.0 109.691 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -81.39 171.64 14.52 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.235 0.614 . . . . 0.0 111.737 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -133.92 166.05 23.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -162.25 142.25 7.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.64 -2.58 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.02 3.147 . . . . 0.0 112.317 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -91.2 16.1 10.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -139.37 152.54 47.22 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.983 0.513 . . . . 0.0 110.182 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.12 35.62 1.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.451 0.7 . . . . 0.0 111.235 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 56.72 25.55 10.29 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.624 0.769 . . . . 0.0 111.708 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.4 p -76.04 168.36 20.19 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.656 0.782 . . . . 0.0 111.253 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -131.0 0.38 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.194 0.598 . . . . 0.0 111.058 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -116.99 1.69 12.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.387 0.675 . . . . 0.0 111.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -149.85 149.53 30.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.888 0.475 . . . . 0.0 110.44 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.56 149.89 41.96 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 108.995 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.3 149.77 63.96 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.195 2.597 . . . . 0.0 111.967 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.32 -170.48 0.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.872 3.715 . . . . 0.0 110.085 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -57.64 147.1 28.42 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.2 -170.27 41.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.564 ' HG ' ' CD1' ' A' ' 137' ' ' LEU . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.564 ' CD1' ' HG ' ' A' ' 128' ' ' CYS . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m -72.71 157.1 38.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 m 78.55 1.53 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.13 -31.52 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 123.483 2.28 . . . . 0.0 110.572 171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -168.27 -27.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.51 1.124 . . . . 0.0 109.809 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.82 145.82 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 125.499 1.52 . . . . 0.0 107.149 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.83 167.62 21.65 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.462 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.462 ' H ' HD13 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.137 0.018 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 57.82 176.26 0.05 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.61 1.164 . . . . 0.0 112.898 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -140.6 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.396 0.679 . . . . 0.0 110.213 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.03 -2.69 58.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.605 0.362 . . . . 0.0 111.183 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.11 169.24 38.74 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.22 -19.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.814 0.307 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -152.55 154.98 36.52 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.761 0.424 . . . . 0.0 110.913 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.12 136.4 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.01 31.09 1.6 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.997 0.519 . . . . 0.0 110.67 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.72 -11.77 59.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.346 1.058 . . . . 0.0 113.361 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -118.34 148.19 43.36 Favored Pre-proline 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.65 136.8 73.24 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.004 2.469 . . . . 0.0 111.39 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.0 t60 45.81 40.53 6.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.99 0.916 . . . . 0.0 112.937 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -67.03 -2.15 5.06 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.08 -4.53 44.78 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.007 0.367 . . . . 0.0 111.363 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.6 145.52 27.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.485 0.714 . . . . 0.0 109.25 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 m -147.0 154.74 41.6 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.542 0.337 . . . . 0.0 111.072 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -0.88 0.98 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.631 0.772 . . . . 0.0 111.491 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -146.75 164.26 33.33 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.319 1.047 . . . . 0.0 109.304 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -84.44 154.02 23.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.272 0.229 . . . . 0.0 110.999 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.405 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 6.8 p90 55.91 157.24 0.07 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 127.113 2.165 . . . . 0.0 113.7 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 105' ' ' PHE . 92.2 Cg_endo -75.07 171.43 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.575 2.85 . . . . 0.0 112.66 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.16 161.85 3.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.136 3.224 . . . . 0.0 112.829 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -109.27 157.31 18.96 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.37 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.35 -21.16 2.98 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.073 0.844 . . . . 0.0 113.721 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p -166.96 34.49 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.448 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.5 t -141.44 -61.14 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 141' ' ' SER . 83.0 Cg_endo -72.06 108.31 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.399 2.066 . . . . 0.0 111.722 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m 49.4 19.96 0.41 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.017 1.327 . . . . 0.0 112.677 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -151.12 147.16 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.494 ' H ' HD11 ' A' ' 144' ' ' ILE . 45.3 mmtm -145.24 142.39 29.47 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.644 0.656 . . . . 0.0 112.531 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.658 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 207' ' ' THR . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.458 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.548 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.548 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.337 0.113 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.4 m80 54.95 25.83 7.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.089 0.956 . . . . 0.0 113.364 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.0 167.84 23.02 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.9 0.48 . . . . 0.0 110.577 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -143.92 162.11 36.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.084 0.554 . . . . 0.0 110.534 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.57 167.88 50.82 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.53 10.95 8.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.238 0.615 . . . . 0.0 110.873 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -137.08 165.98 24.77 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.938 0.895 . . . . 0.0 109.946 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.51 141.86 43.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.297 0.639 . . . . 0.0 110.067 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.09 156.93 20.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.404 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -146.61 152.91 39.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.068 0.547 . . . . 0.0 110.258 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -102.57 156.36 35.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.94 -15.21 43.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.95 2.433 . . . . 0.0 110.916 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -154.32 140.14 18.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.682 0.793 . . . . 0.0 109.192 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -154.17 169.76 22.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.842 0.457 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.52 170.32 11.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.604 0.762 . . . . 0.0 110.828 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.56 2.78 35.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.244 0.618 . . . . 0.0 111.374 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.7 p -69.68 166.84 18.3 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.041 0.537 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.16 -20.85 63.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.931 0.493 . . . . 0.0 111.549 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.0 t -152.39 137.41 17.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.729 0.412 . . . . 0.0 109.973 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -154.02 161.47 41.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.881 0.472 . . . . 0.0 109.919 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -129.42 151.03 77.21 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.941 0.496 . . . . 0.0 110.259 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.13 150.4 82.12 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.952 2.434 . . . . 0.0 110.644 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.06 -11.13 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.989 3.126 . . . . 0.0 112.048 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -141.18 170.35 15.88 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 123.937 0.895 . . . . 0.0 109.972 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.03 -1.75 56.84 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.433 ' C ' ' CD ' ' A' ' 142' ' ' PRO . 14.6 m -159.26 154.54 25.44 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m 82.67 -11.77 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.433 ' CD ' ' C ' ' A' ' 140' ' ' SER . 47.8 Cg_endo -81.48 69.57 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 123.446 2.267 . . . . 0.0 110.39 172.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m 61.97 22.38 13.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.46 0.704 . . . . 0.0 112.317 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.53 157.15 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -140.8 141.83 34.72 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE1' ' HB1' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 187' ' ' VAL . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' A' ' 185' ' ' ARG . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.784 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.784 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.47 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . 0.541 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.582 ' HE2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.53 0.205 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -149.23 164.84 33.64 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.149 0.58 . . . . 0.0 110.855 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -146.92 149.92 34.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.433 0.693 . . . . 0.0 109.42 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -139.27 5.07 2.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.492 0.317 . . . . 0.0 111.847 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.03 7.88 82.3 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.0 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -135.63 13.15 3.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.661 0.73 . . . . 0.0 111.485 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -111.58 6.8 20.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.747 . . . . 0.0 111.176 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 t -84.56 50.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.526 0.73 . . . . 0.0 109.863 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.47 28.35 0.2 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.25 1.02 . . . . 0.0 111.825 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.5 28.65 0.54 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.069 0.948 . . . . 0.0 113.349 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.39 155.91 15.68 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.83 179.34 5.77 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.805 3.003 . . . . 0.0 111.436 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 57.77 24.12 10.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -105.85 8.55 32.76 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.57 20.15 3.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.128 0.571 . . . . 0.0 111.464 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -73.27 161.03 30.98 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.517 0.327 . . . . 0.0 111.04 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.8 m -112.51 6.64 18.62 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.204 0.602 . . . . 0.0 111.754 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -137.05 -3.55 1.99 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.272 0.629 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -141.61 165.82 26.45 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.566 0.746 . . . . 0.0 110.153 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -143.37 147.29 34.44 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.878 0.471 . . . . 0.0 110.248 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 58.6 148.98 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.893 1.677 . . . . 0.0 112.671 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.8 159.77 41.58 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.937 2.424 . . . . 0.0 110.773 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 109' ' ' GLY . 32.5 Cg_exo -61.04 177.74 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.073 3.182 . . . . 0.0 112.02 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -75.29 19.0 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.43 0.692 . . . . 0.0 110.953 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -75.38 -162.57 10.98 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.727 0.68 . . . . 0.0 112.525 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.429 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p -83.14 75.33 9.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.583 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.1 t -155.95 -37.23 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.583 ' CD ' ' H ' ' A' ' 141' ' ' SER . 34.7 Cg_exo -64.56 -152.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.132 3.221 . . . . 0.0 111.869 172.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -60.13 -6.27 1.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.891 0.476 . . . . 0.0 111.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.01 130.47 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.809 0.843 . . . . 0.0 109.462 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -154.67 118.21 4.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.52 0.2 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -148.01 167.28 25.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.015 0.526 . . . . 0.0 110.435 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -138.67 161.55 36.86 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.425 0.69 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -148.27 162.63 39.12 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.932 0.493 . . . . 0.0 110.014 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.12 6.41 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.03 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -142.07 153.26 44.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.921 0.861 . . . . 0.0 110.85 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.82 160.71 40.46 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.03 0.532 . . . . 0.0 111.106 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.53 141.22 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 124.051 0.94 . . . . 0.0 108.618 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.4 -46.24 7.77 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.24 176.3 12.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.395 0.678 . . . . 0.0 109.633 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -100.0 154.75 37.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.85 -31.4 93.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.297 2.665 . . . . 0.0 113.449 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -158.47 -16.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -73.09 155.81 39.34 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.157 0.583 . . . . 0.0 110.509 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.69 166.08 25.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.335 0.654 . . . . 0.0 110.509 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.99 10.59 11.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.233 0.613 . . . . 0.0 111.471 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -78.57 5.97 9.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.366 0.667 . . . . 0.0 111.952 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -138.5 155.08 48.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.238 0.615 . . . . 0.0 110.048 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.8 m -87.63 14.42 8.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.602 0.761 . . . . 0.0 112.799 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -121.35 153.33 37.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.601 0.36 . . . . 0.0 110.91 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.87 152.89 38.54 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.811 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.1 156.58 47.06 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.604 2.869 . . . . 0.0 110.906 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.18 -176.35 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.541 3.494 . . . . 0.0 110.734 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -58.5 151.45 20.26 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.33 -139.64 6.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -160.34 98.98 1.3 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' A' ' 142' ' ' PRO . 31.4 t -159.18 -48.41 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.518 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 141' ' ' SER . 34.2 Cg_exo -60.98 -173.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.555 2.17 . . . . 0.0 111.163 169.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.7 p -70.94 4.13 2.83 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -31.46 23.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.143 0.883 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 42.62 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 127.118 2.167 . . . . 0.0 115.036 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.588 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 160' ' ' ASP . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 158' ' ' ASP . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.698 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.698 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.486 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.53 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.53 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.409 ' OD2' ' HE2' ' A' ' 246' ' ' LYS . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 245' ' ' ASP . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -140.08 161.79 36.79 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.321 0.649 . . . . 0.0 110.463 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -87.9 161.39 17.51 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.621 0.368 . . . . 0.0 110.843 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.0 t30 60.27 167.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.927 1.291 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.03 176.32 40.82 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -146.92 165.15 30.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.57 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -150.72 150.44 31.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.039 0.535 . . . . 0.0 109.906 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.74 158.15 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.133 0.573 . . . . 0.0 110.366 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 155.81 39.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.102 -0.374 . . . . 0.0 110.264 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' HD2' ' H ' ' A' ' 63' ' ' TYR . 31.5 tpt85 -137.65 137.85 38.85 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -100.1 152.15 37.73 Favored Pre-proline 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.95 -17.42 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.111 2.541 . . . . 0.0 111.108 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -156.61 145.23 19.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.866 0.466 . . . . 0.0 110.452 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -155.43 160.76 40.89 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 123.999 0.92 . . . . 0.0 109.064 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.69 0.51 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.22 168.65 24.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.198 0.454 . . . . 0.0 111.015 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.9 m -89.97 15.42 10.04 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.437 0.695 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.55 -171.96 2.59 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.02 0.928 . . . . 0.0 109.577 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -53.29 137.92 33.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.792 0.33 . . . . 0.0 110.665 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -153.69 161.13 42.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.678 0.791 . . . . 0.0 109.545 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -125.35 121.29 24.97 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.35 159.13 40.41 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.261 2.64 . . . . 0.0 110.674 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.5 ' C ' ' H ' ' A' ' 109' ' ' GLY . 72.1 Cg_endo -70.31 157.52 59.07 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.282 2.655 . . . . 0.0 109.987 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 54.48 -5.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 114.78 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . 62.53 61.39 6.59 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.15 0.881 . . . . 0.0 114.007 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 58.48 4.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.493 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 28.0 m -146.28 -42.65 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.493 ' CD ' ' H ' ' A' ' 141' ' ' SER . 15.4 Cg_exo -69.73 -169.25 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.874 2.382 . . . . 0.0 110.599 173.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 60.8 p -63.41 -9.74 13.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.442 HD11 ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -73.22 -38.62 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.122 0.569 . . . . 0.0 109.742 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 56.85 -30.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.442 ' H ' HD11 ' A' ' 144' ' ' ILE . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.422 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.59 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.485 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.59 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.519 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.519 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.447 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.81 161.95 36.76 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.387 0.675 . . . . 0.0 110.417 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -136.24 161.4 35.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.195 0.598 . . . . 0.0 110.214 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -99.39 164.92 11.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.101 0.56 . . . . 0.0 110.489 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.38 -165.61 54.77 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.04 163.42 25.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.529 0.732 . . . . 0.0 110.607 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -118.83 -1.15 11.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.434 0.694 . . . . 0.0 111.164 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.56 151.82 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.96 0.504 . . . . 0.0 109.979 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.85 164.84 17.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.506 0.723 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -138.47 156.86 47.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.45 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -113.12 157.55 40.55 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.84 -13.68 37.35 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.07 2.514 . . . . 0.0 111.221 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -150.56 142.67 24.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.538 0.735 . . . . 0.0 109.521 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -158.02 176.36 12.63 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.999 0.52 . . . . 0.0 110.509 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.94 18.22 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.461 0.704 . . . . 0.0 110.159 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -124.45 6.71 8.32 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -130.57 -2.02 4.31 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.866 0.466 . . . . 0.0 111.417 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -157.18 166.99 31.7 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.687 0.795 . . . . 0.0 109.814 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -79.0 151.21 31.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -156.64 153.75 29.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.834 0.454 . . . . 0.0 110.649 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.58 145.06 19.25 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.78 117.83 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.383 2.722 . . . . 0.0 110.41 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.08 127.68 11.57 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.853 2.369 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.0 pttt 43.32 22.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.404 1.482 . . . . 0.0 113.568 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.53 -176.17 48.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p -149.69 119.19 6.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.3 m -157.1 169.18 11.04 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 126.545 1.938 . . . . 0.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.84 147.03 14.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.733 2.289 . . . . 0.0 113.213 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 m 62.69 -11.25 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.013 1.725 . . . . 0.0 114.671 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.67 18.3 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.483 1.038 . . . . 0.0 111.449 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.02 130.69 44.96 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.579 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.518 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.518 ' CD2' HD11 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.48 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.48 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.506 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.506 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.69 161.92 36.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -139.61 163.93 31.25 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.282 0.633 . . . . 0.0 110.138 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -138.44 9.72 2.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.882 0.473 . . . . 0.0 111.058 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.74 41.57 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.43 11.86 4.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.481 0.712 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -148.57 167.94 24.09 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.691 0.797 . . . . 0.0 110.279 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.71 140.6 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -145.56 35.44 1.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.095 0.474 . . . . 0.0 109.939 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.616 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 -127.97 179.39 5.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.53 0.732 . . . . 0.0 110.239 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.616 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.428 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ILE . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -101.24 151.65 37.76 Favored Pre-proline 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.65 -8.78 7.89 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.527 2.818 . . . . 0.0 113.563 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -129.93 13.49 5.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 111.62 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -72.67 126.17 29.25 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.13 -4.87 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.271 0.628 . . . . 0.0 111.341 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.58 162.28 41.25 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.011 0.525 . . . . 0.0 110.399 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -83.04 6.99 17.03 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.61 1.09 13.47 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -94.46 150.65 20.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.109 0.413 . . . . 0.0 110.957 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -156.86 172.95 17.73 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.184 0.594 . . . . 0.0 110.499 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 t80 49.68 83.88 0.21 Allowed Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.947 1.299 . . . . 0.0 112.95 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.35 151.15 62.69 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.819 3.012 . . . . 0.0 111.565 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.19 -13.66 37.02 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.861 3.041 . . . . 0.0 114.117 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -141.31 164.74 29.41 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.296 0.498 . . . . 0.0 111.421 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.99 8.88 48.88 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.978 0.799 . . . . 0.0 112.822 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m -76.19 91.64 3.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.704 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.3 t -158.47 -41.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 141' ' ' SER . 42.9 Cg_endo -81.23 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.603 2.202 . . . . 0.0 109.871 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -61.46 -9.33 5.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.555 0.742 . . . . 0.0 112.195 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 pp -114.2 159.8 13.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 122.94 0.496 . . . . 0.0 110.324 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -153.41 162.05 41.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.352 0.261 . . . . 0.0 110.396 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 165' ' ' GLY . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 164' ' ' ASP . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.43 ' H ' ' HG3' ' A' ' 188' ' ' GLU . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.46 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.46 ' CD2' HD11 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.504 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -139.01 6.45 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.879 0.472 . . . . 0.0 111.734 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -75.13 155.06 37.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.821 0.448 . . . . 0.0 110.432 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.22 155.62 38.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.381 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.0 46.0 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -132.24 11.29 4.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.325 0.65 . . . . 0.0 110.984 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -146.06 165.82 27.94 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.449 0.7 . . . . 0.0 110.344 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.38 139.19 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -145.58 22.8 1.46 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.355 0.662 . . . . 0.0 110.723 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -130.11 -4.77 4.44 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -172.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -100.9 153.65 37.61 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.36 -29.82 86.36 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.93 2.42 . . . . 0.0 111.965 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -161.58 157.54 24.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.634 0.773 . . . . 0.0 109.481 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -154.46 143.98 21.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.348 0.659 . . . . 0.0 109.314 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.2 164.22 38.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.995 0.518 . . . . 0.0 110.206 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.69 124.04 28.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.4 p -163.47 -172.31 2.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.281 0.632 . . . . 0.0 109.9 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.16 8.55 3.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.707 0.403 . . . . 0.0 111.138 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.0 t -140.24 169.41 17.74 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.043 0.937 . . . . 0.0 109.909 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.13 4.59 2.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.026 0.53 . . . . 0.0 111.623 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.71 154.17 80.96 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.241 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.17 115.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.251 2.634 . . . . 0.0 110.95 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.03 -5.46 4.89 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.388 3.392 . . . . 0.0 114.857 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -129.87 3.71 4.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.28 0.491 . . . . 0.0 112.282 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 -172.8 45.43 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 p -72.97 142.62 47.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.5 m -158.64 167.59 14.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.827 0.851 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.6 -5.03 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.046 3.164 . . . . 0.0 114.395 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.7 p -120.68 12.23 11.39 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.469 0.707 . . . . 0.0 111.973 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 145' ' ' LYS . 13.1 tt -149.97 176.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' H ' HG12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.68 169.88 7.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.697 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.487 ' H ' HD13 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.427 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -76.55 161.58 28.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.8 0.44 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -77.75 163.11 26.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.893 0.477 . . . . 0.0 110.748 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.88 19.5 16.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.438 0.695 . . . . 0.0 111.003 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.31 -1.49 86.2 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.43 156.3 46.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.93 0.892 . . . . 0.0 109.442 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -151.98 138.82 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.555 0.342 . . . . 0.0 110.235 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t 45.1 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 125.886 1.674 . . . . 0.0 112.972 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -64.91 130.48 43.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -98.63 -166.85 1.41 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 87' ' ' ARG . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' PHE . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -161.62 158.9 22.85 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.22 168.62 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.184 3.256 . . . . 0.0 113.772 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 59.19 9.11 1.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.202 1.401 . . . . 0.0 114.061 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -83.7 142.77 30.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 121.804 -0.56 . . . . 0.0 109.97 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.8 169.53 23.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.177 0.591 . . . . 0.0 109.86 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.11 -2.87 33.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.731 0.412 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -129.08 14.55 6.26 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.455 0.702 . . . . 0.0 111.862 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -134.35 158.03 44.87 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.279 0.632 . . . . 0.0 110.734 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -146.17 14.85 1.31 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.459 0.704 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.16 165.18 25.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 111.345 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.54 155.54 92.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.645 0.778 . . . . 0.0 111.042 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.14 151.14 84.43 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.852 2.368 . . . . 0.0 110.066 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.74 -6.34 18.84 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.105 3.204 . . . . 0.0 113.217 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -124.22 -3.54 7.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.369 0.531 . . . . 0.0 112.173 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.33 3.55 53.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 137' ' ' LEU . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.402 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p -155.75 162.39 40.53 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 142' ' ' PRO . 8.3 p -157.37 171.26 7.68 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.335 0.654 . . . . 0.0 109.538 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 141' ' ' SER . 96.1 Cg_endo -71.92 0.33 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 112.386 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -120.76 -15.68 8.34 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.793 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.45 125.36 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.45 -175.36 2.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.736 0.815 . . . . 0.0 112.295 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.634 HD11 ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 192' ' ' ILE . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.411 ' HG ' ' CG ' ' A' ' 213' ' ' TYR . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.402 ' H ' HG23 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -148.53 148.92 30.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.199 0.6 . . . . 0.0 109.773 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -152.79 -24.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 161.01 43.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.17 -0.331 . . . . 0.0 111.116 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 176.42 47.98 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.56 165.68 34.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.004 0.522 . . . . 0.0 110.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -87.54 166.96 14.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.927 0.491 . . . . 0.0 111.026 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.68 137.17 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.505 0.722 . . . . 0.0 109.193 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.51 28.06 0.99 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.01 0.524 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 7.16 3.9 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.411 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -99.59 152.11 37.69 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.32 -20.15 32.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.892 2.395 . . . . 0.0 111.159 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -160.63 157.71 27.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.571 0.748 . . . . 0.0 109.513 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 100' ' ' GLU . 18.2 ptmt -155.1 151.31 28.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.295 0.638 . . . . 0.0 109.582 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.12 -18.43 39.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 40.9 tt0 -155.47 152.24 28.71 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.8 p -70.85 -3.21 17.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -109.26 -2.82 17.65 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.241 0.617 . . . . 0.0 110.966 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -77.67 155.21 31.5 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.089 -0.382 . . . . 0.0 110.749 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.27 10.13 4.47 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.285 0.634 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.19 130.14 24.21 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.506 0.723 . . . . 0.0 109.959 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.75 146.72 26.9 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.464 2.776 . . . . 0.0 110.793 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.17 -10.95 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.752 2.968 . . . . 0.0 111.952 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.48 ' HZ3' ' HB2' ' A' ' 108' ' ' LYS . 10.3 mtmp? -140.5 166.97 23.26 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.59 0.756 . . . . 0.0 110.135 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -6.8 81.46 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p -92.84 79.18 4.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.685 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.1 t -159.1 -42.73 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 141' ' ' SER . 30.0 Cg_endo -82.68 -123.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.35 2.7 . . . . 0.0 111.079 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 p -64.81 -3.14 3.03 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.055 0.942 . . . . 0.0 112.675 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.51 136.47 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -153.88 95.62 1.89 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 155' ' ' ASN . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.624 ' H ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.529 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.529 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.539 ' CD2' HD11 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . 0.489 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.459 ' HE ' HG23 ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.459 HG23 ' HE ' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.531 HD21 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.531 ' HG3' HD21 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.329 0.109 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 54.52 22.22 3.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.181 0.992 . . . . 0.0 113.373 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -139.77 156.49 46.74 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.416 0.687 . . . . 0.0 109.969 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.64 10.66 2.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.176 0.59 . . . . 0.0 111.327 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.4 156.15 53.15 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.75 170.32 20.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -109.91 160.56 16.28 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.388 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.25 137.87 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 109.688 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.32 20.57 2.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.697 0.799 . . . . 0.0 110.511 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -78.1 -14.13 59.6 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.577 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -123.47 151.98 64.01 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.96 172.0 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.904 3.07 . . . . 0.0 110.72 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -61.57 150.94 34.58 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.626 0.251 . . . . 0.0 111.006 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -90.74 167.44 12.49 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.339 0.656 . . . . 0.0 111.295 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.38 178.04 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.996 0.519 . . . . 0.0 111.034 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.11 15.01 0.77 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.472 0.709 . . . . 0.0 112.74 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.3 t -132.31 150.19 52.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.963 0.505 . . . . 0.0 110.727 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.1 -13.55 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.081 0.552 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.0 m -82.65 1.71 37.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.881 0.472 . . . . 0.0 111.604 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -91.62 150.62 21.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.905 0.482 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -138.85 143.95 39.56 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.265 0.626 . . . . 0.0 109.897 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 168.55 21.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.906 3.071 . . . . 0.0 111.255 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.29 159.98 11.84 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.219 3.279 . . . . 0.0 112.874 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -112.23 14.69 20.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.848 0.859 . . . . 0.0 111.605 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.75 -121.02 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.242 0.925 . . . . 0.0 111.665 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.577 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 84.3 p -94.6 120.69 35.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.456 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 35.3 t -160.48 -43.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.653 -0.689 . . . . 0.0 112.18 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.456 ' CD ' ' H ' ' A' ' 141' ' ' SER . 16.9 Cg_exo -69.2 -168.32 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.966 2.444 . . . . 0.0 110.96 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 p -65.03 -1.45 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.574 0.349 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.0 pp -91.52 5.47 6.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.673 0.789 . . . . 0.0 111.235 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -47.1 132.84 12.04 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.836 0.854 . . . . 0.0 112.247 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 140' ' ' SER . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.508 ' H ' HD13 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.58 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.58 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.485 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.422 ' HG2' HD21 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.485 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' C ' HD11 ' A' ' 156' ' ' LEU . 58.2 ttm-85 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 169' ' ' LEU . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.452 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.478 ' H ' HG22 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 72' ' ' LEU . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 69' ' ' VAL . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.428 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.428 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 137' ' ' LEU . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' C ' HD22 ' A' ' 135' ' ' LEU . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.612 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 184' ' ' LEU . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.532 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.479 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.483 HG13 ' CG1' ' A' ' 149' ' ' VAL . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 69' ' ' VAL . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 81' ' ' ILE . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.721 0.296 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.483 ' CG1' HG13 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' ALA . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 161' ' ' PHE . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 189' ' ' LEU . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.592 ' H ' HD12 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 156' ' ' LEU . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 81' ' ' ILE . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.424 ' O ' HD12 ' A' ' 151' ' ' ILE . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 150' ' ' GLN . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.927 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 186' ' ' ALA . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.509 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.403 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.543 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.447 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CD2' HD13 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.402 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.624 0.25 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 . . . . . 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 tptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 192' ' ' ILE . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 188' ' ' GLU . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 156' ' ' LEU . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 CA-C-O 121.228 0.349 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 135' ' ' LEU . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 125' ' ' ILE . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.521 HD21 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.521 ' H ' HD21 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.543 ' H ' HD12 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.51 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.469 ' H ' HG12 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 . . . . . 0 N--CA 1.457 -0.075 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.412 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 137' ' ' LEU . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.936 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 169' ' ' LEU . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.424 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.514 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.418 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.434 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.457 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.587 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.536 ' H ' HG22 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 N--CA 1.457 -0.123 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' HD12 ' A' ' 156' ' ' LEU . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.405 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.46 0.041 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.96 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 187' ' ' VAL . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 185' ' ' ARG . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.492 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.492 ' H ' HD12 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 205' ' ' ILE . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.429 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.553 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.404 ' C ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.5 tptm . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.419 HG13 HD23 ' A' ' 137' ' ' LEU . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.841 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.41 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.77 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.77 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 220' ' ' VAL . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 211' ' ' LEU . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.411 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 203' ' ' ALA . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.62 ' HE2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 CA-C-O 121.375 0.431 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 173' ' ' LYS . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.5 HD12 ' H ' ' A' ' 186' ' ' ALA . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.5 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . 0.405 ' HA ' HD11 ' A' ' 196' ' ' LEU . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 229' ' ' ILE . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 226' ' ' GLN . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 63' ' ' TYR . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 137' ' ' LEU . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 136' ' ' TYR . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.423 ' C ' HD22 ' A' ' 135' ' ' LEU . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 134' ' ' LYS . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 129' ' ' ILE . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.728 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 186' ' ' ALA . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.508 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 189' ' ' LEU . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.674 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.498 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.522 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.522 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 235' ' ' ARG . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 N-CA-C 114.007 0.363 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.848 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.468 HD22 HD11 ' A' ' 81' ' ' ILE . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 114' ' ' LEU . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 129' ' ' ILE . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 124' ' ' LEU . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.529 0.204 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.41 HG13 HD13 ' A' ' 137' ' ' LEU . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.673 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 161' ' ' PHE . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.517 ' CD2' HD13 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 215' ' ' LYS . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HG3' ' CG ' ' A' ' 208' ' ' ASP . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 197' ' ' TYR . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.477 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 . . . . . 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.637 ' N ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 202' ' ' TYR . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.435 ' CD2' HG22 ' A' ' 162' ' ' VAL . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.433 HD11 ' CZ2' ' A' ' 154' ' ' TRP . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.506 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 197' ' ' TYR . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.606 ' HB2' HD12 ' A' ' 156' ' ' LEU . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 HG13 ' CG1' ' A' ' 149' ' ' VAL . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 135' ' ' LEU . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' C ' HD12 ' A' ' 137' ' ' LEU . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 136' ' ' TYR . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 146' ' ' ASP . 39.1 p . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG1' HG13 ' A' ' 69' ' ' VAL . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.854 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.471 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 189' ' ' LEU . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.624 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.624 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.517 ' C ' HD22 ' A' ' 239' ' ' LEU . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.401 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 184' ' ' LEU . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 196' ' ' LEU . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.411 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 113' ' ' LEU . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 91' ' ' LEU . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 69' ' ' VAL . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.81 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 219' ' ' ARG . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 219' ' ' ARG . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.557 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 189' ' ' LEU . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.558 ' CD2' HD13 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ASP . . . . . 0.466 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 211' ' ' LEU . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.515 ' H ' ' HB3' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.541 HD22 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 156' ' ' LEU . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.567 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.503 ' CE1' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 148' ' ' PRO . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.169 0.509 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.43 ' HZ2' ' HG ' ' A' ' 159' ' ' SER . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 154' ' ' TRP . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 202' ' ' TYR . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.482 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.647 ' H ' HD12 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' CE2' HD21 ' A' ' 169' ' ' LEU . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.542 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.406 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.438 HD22 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.438 ' HG2' HD22 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 244' ' ' ILE . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -147.86 152.49 37.71 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.108 0.563 . . . . 0.0 110.239 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -151.84 -32.64 0.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.489 0.315 . . . . 0.0 110.77 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.47 158.06 36.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.7 13.35 2.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.36 162.7 23.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.452 0.626 . . . . 0.0 110.792 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -138.92 157.16 46.54 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.333 0.653 . . . . 0.0 109.983 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.74 141.84 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.05 14.02 5.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 111.203 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' C ' HD11 ' A' ' 156' ' ' LEU . 58.2 ttm-85 -93.37 26.22 3.06 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.183 0.993 . . . . 0.0 111.475 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.444 ' CG ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 m95 -112.76 154.49 44.79 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.61 -14.86 30.54 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.118 2.545 . . . . 0.0 110.583 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -151.85 129.48 11.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -156.2 12.19 0.29 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.883 0.473 . . . . 0.0 111.914 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.8 155.46 37.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 111.49 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.16 1.88 4.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.145 0.578 . . . . 0.0 111.654 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -75.12 -15.17 60.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.842 0.457 . . . . 0.0 111.555 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -151.11 -54.24 0.14 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 t -163.88 158.7 20.2 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.068 0.395 . . . . 0.0 111.534 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -80.54 -1.2 40.93 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.146 0.578 . . . . 0.0 111.33 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.51 155.67 75.28 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.596 0.758 . . . . 0.0 109.715 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HD3' ' CG ' ' A' ' 95' ' ' TRP . 93.3 Cg_endo -76.23 150.22 32.76 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.394 2.729 . . . . 0.0 111.896 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.18 0.1 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.358 3.372 . . . . 0.0 111.93 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.64 164.68 22.37 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.472 0.709 . . . . 0.0 110.731 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.42 -1.12 69.19 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m -54.17 109.55 0.49 Allowed 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.7 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 41.3 t -167.25 -44.88 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.251 -0.88 . . . . 0.0 113.372 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 141' ' ' SER . 84.2 Cg_endo -75.08 -145.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 0.0 110.044 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.0 p -66.11 9.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 137.59 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.941 0.896 . . . . 0.0 108.6 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -138.8 163.94 30.92 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 123.587 0.755 . . . . 0.0 111.957 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 169' ' ' LEU . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.452 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.478 ' H ' HG22 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -147.85 172.59 13.91 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.049 0.54 . . . . 0.0 110.516 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.75 166.48 22.85 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.222 0.609 . . . . 0.0 110.086 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -129.8 9.22 5.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.024 0.53 . . . . 0.0 110.738 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.19 27.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.37 166.31 25.02 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.504 0.722 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 60' ' ' VAL . 51.7 ttm-85 60.56 172.18 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.493 1.117 . . . . 0.0 111.808 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 10.5 p -135.2 157.52 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 123.061 0.544 . . . . 0.0 109.959 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -136.68 52.51 1.95 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.004 0.921 . . . . 0.0 109.512 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -136.23 39.19 2.71 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.196 0.598 . . . . 0.0 111.719 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 72' ' ' LEU . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 69' ' ' VAL . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -166.02 165.23 10.8 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.1 153.78 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.736 2.957 . . . . 0.0 112.438 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -63.37 150.97 42.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.838 0.855 . . . . 0.0 111.22 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 165.16 20.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.112 0.565 . . . . 0.0 111.339 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 54.25 22.5 3.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.403 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.6 t -148.59 168.23 23.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.422 0.689 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.16 8.93 3.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.769 0.828 . . . . 0.0 110.431 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.8 p -131.76 6.1 4.32 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -90.81 142.16 28.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.938 0.335 . . . . 0.0 110.342 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -147.45 156.85 45.7 Favored Pre-proline 0 C--O 1.233 0.187 0 C-N-CA 123.841 0.856 . . . . 0.0 109.424 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.14 155.85 66.75 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.972 2.448 . . . . 0.0 110.794 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.86 134.98 66.1 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.614 2.876 . . . . 0.0 112.482 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 51.91 13.16 0.23 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.919 1.288 . . . . 0.0 114.173 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.39 13.25 81.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.389 0.54 . . . . 0.0 112.094 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.428 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.428 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 137' ' ' LEU . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' C ' HD22 ' A' ' 135' ' ' LEU . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -74.03 140.19 45.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -145.31 172.3 5.51 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.441 0.696 . . . . 0.0 109.259 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.85 -5.05 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.275 3.317 . . . . 0.0 115.186 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p -92.17 -21.26 20.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.909 0.777 . . . . 0.0 112.023 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 -25.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 41.88 43.88 2.73 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.063 0.945 . . . . 0.0 111.791 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.612 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 184' ' ' LEU . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.532 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.479 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.12 12.22 3.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.537 0.735 . . . . 0.0 111.081 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -143.09 150.8 40.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.226 0.61 . . . . 0.0 109.926 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -139.74 8.65 2.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.266 0.626 . . . . 0.0 111.343 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 4.64 90.13 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.59 165.4 20.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 117.397 0.599 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.03 18.49 3.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.08 0.952 . . . . 0.0 113.419 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.9 t -136.46 144.95 31.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.147 0.579 . . . . 0.0 109.723 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -130.21 169.52 15.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.668 0.787 . . . . 0.0 109.781 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.553 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -134.18 146.04 49.79 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.348 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.483 HG13 ' CG1' ' A' ' 149' ' ' VAL . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 69' ' ' VAL . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -152.08 148.12 20.89 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.49 -0.43 5.88 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.672 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -76.47 -6.26 50.99 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.434 0.561 . . . . 0.0 111.3 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 7.93 6.73 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.196 0.598 . . . . 0.0 112.223 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.18 4.3 8.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.245 0.618 . . . . 0.0 112.496 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.76 164.43 27.57 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.046 0.538 . . . . 0.0 110.779 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.7 p -84.65 9.76 12.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -171.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -140.81 154.4 46.22 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 118.464 0.574 . . . . 0.0 111.481 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.8 p 56.39 165.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.177 1.791 . . . . 0.0 113.598 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -142.64 15.12 1.97 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.955 0.502 . . . . 0.0 111.301 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 143.57 84.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.735 0.414 . . . . 0.0 110.612 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 153.55 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.419 2.746 . . . . 0.0 111.982 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.95 -24.72 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.389 2.726 . . . . 0.0 112.563 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -155.29 18.54 0.42 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.66 -1.47 88.82 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 81' ' ' ILE . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p -87.0 50.57 2.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.2 t -158.02 -45.95 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 141' ' ' SER . 33.2 Cg_exo -61.65 -43.1 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.991 2.461 . . . . 0.0 114.959 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -140.06 0.49 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.819 0.448 . . . . 0.0 111.742 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.63 156.23 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 119.65 11.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.188 0.449 . . . . 0.0 110.565 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.483 ' CG1' HG13 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' ALA . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 161' ' ' PHE . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 189' ' ' LEU . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.592 ' H ' HD12 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.403 0.144 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 t60 51.87 31.29 8.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 112.354 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -78.07 -15.69 58.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.572 0.349 . . . . 0.0 111.282 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -84.04 128.88 34.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.1 6.97 4.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -89.69 17.1 6.86 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.501 0.72 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.18 163.66 26.17 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.473 0.709 . . . . 0.0 111.628 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.25 178.15 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 123.754 0.822 . . . . 0.0 109.77 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.34 17.32 7.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.336 0.654 . . . . 0.0 111.097 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.02 9.7 20.41 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 156' ' ' LEU . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.412 ' CD2' ' HB3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -165.79 157.46 12.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 -6.45 6.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 124.36 3.373 . . . . 0.0 114.807 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -100.19 7.58 44.42 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -134.67 4.19 3.32 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.202 0.601 . . . . 0.0 111.061 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.48 32.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.584 0.354 . . . . 0.0 110.536 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 53.59 12.57 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.698 1.199 . . . . 0.0 113.409 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -158.73 171.02 20.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.527 0.731 . . . . 0.0 109.709 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.39 149.04 50.67 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.0 m -66.96 129.93 41.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -156.58 179.45 9.25 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.871 0.869 . . . . 0.0 109.005 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -74.26 146.22 84.04 Favored Pre-proline 0 CA--C 1.532 0.28 0 O-C-N 122.135 -0.353 . . . . 0.0 110.482 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 95' ' ' TRP . 82.3 Cg_endo -70.96 171.99 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.549 3.499 . . . . 0.0 111.667 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.36 155.85 28.44 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.512 2.808 . . . . 0.0 111.177 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.23 129.53 34.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.28 -4.91 23.18 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 81' ' ' ILE . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p -97.77 44.39 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.726 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 84.9 p -168.1 -31.17 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.726 ' HD2' ' H ' ' A' ' 141' ' ' SER . 62.8 Cg_endo -80.59 -23.4 5.93 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.818 1.685 . . . . 0.0 112.727 -171.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.8 m -146.91 -28.56 0.38 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.404 ' C ' HD12 ' A' ' 144' ' ' ILE . 2.5 pp -134.88 177.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.577 0.751 . . . . 0.0 109.313 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 114.64 8.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.424 ' O ' HD12 ' A' ' 151' ' ' ILE . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 150' ' ' GLN . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.927 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 186' ' ' ALA . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.509 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.403 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.543 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.447 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.513 0.197 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -75.17 -0.3 18.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.96 0.504 . . . . 0.0 111.944 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -85.23 5.87 28.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.051 0.541 . . . . 0.0 111.315 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -77.97 -6.65 55.1 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.087 0.555 . . . . 0.0 112.073 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 59' ' ' ARG . . . 67.77 -164.85 45.56 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.59 -12.55 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.868 1.667 . . . . 0.0 113.953 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 57' ' ' GLY . 34.6 mtp-105 57.24 171.97 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.258 1.423 . . . . 0.0 113.355 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.26 138.19 26.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.39 140.08 19.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -149.4 -6.2 0.36 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.028 0.931 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -106.22 155.1 39.16 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 -18.48 32.46 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.216 2.611 . . . . 0.0 110.737 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -154.7 151.16 28.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.2 1.0 . . . . 0.0 108.494 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.04 172.44 14.24 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.12 167.07 22.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.886 0.875 . . . . 0.0 109.381 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.92 4.8 21.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.751 0.42 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.8 t -151.06 159.4 44.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.312 0.645 . . . . 0.0 110.044 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.29 9.6 10.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.86 0.464 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.1 m -76.64 5.22 7.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.933 0.493 . . . . 0.0 111.243 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -140.25 161.22 38.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -137.78 156.01 74.68 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.376 0.67 . . . . 0.0 110.119 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.23 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.922 2.415 . . . . 0.0 110.705 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.65 -8.25 19.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.068 3.179 . . . . 0.0 112.744 -174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 110' ' ' TYR . 20.0 ptmt -148.94 161.38 42.01 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.084 0.402 . . . . 0.0 111.269 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.74 5.73 64.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.762 0.696 . . . . 0.0 113.375 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.441 ' CG ' ' HE2' ' A' ' 108' ' ' LYS . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.459 ' C ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p -93.07 66.46 4.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.786 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 70.3 m -153.8 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.786 ' HD2' ' H ' ' A' ' 141' ' ' SER . 39.0 Cg_endo -82.44 -132.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.078 2.518 . . . . 0.0 110.267 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 142' ' ' PRO . 40.9 p -66.19 1.54 1.5 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.521 0.728 . . . . 0.0 112.424 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.43 142.84 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -141.17 127.2 19.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.006 0.522 . . . . 0.0 109.721 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HA ' ' HE2' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CD2' HD13 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.402 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.647 -0.131 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -148.56 165.82 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.095 0.558 . . . . 0.0 110.25 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -72.43 163.64 27.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.23 21.12 17.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.0 111.025 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.95 -160.16 48.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.78 155.39 47.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.221 0.608 . . . . 0.0 109.961 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -139.07 160.62 39.34 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.42 157.85 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.309 0.644 . . . . 0.0 110.132 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -66.83 150.09 49.65 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.88 0.472 . . . . 0.0 110.326 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -102.89 174.95 5.65 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.088 0.555 . . . . 0.0 111.618 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -111.57 141.8 25.29 Favored Pre-proline 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 -8.24 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.782 2.988 . . . . 0.0 112.425 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.88 29.64 2.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.186 0.594 . . . . 0.0 111.392 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.22 156.24 25.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.027 0.441 . . . . 0.0 112.103 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.25 43.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.059 0.944 . . . . 0.0 109.255 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.44 154.56 45.65 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.502 0.321 . . . . 0.0 111.193 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 m 54.78 6.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.437 1.495 . . . . 0.0 114.925 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -140.38 -16.6 0.93 Allowed 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.197 0.599 . . . . 0.0 111.333 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.2 t -158.35 167.65 29.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.901 0.48 . . . . 0.0 109.816 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -139.02 155.07 48.26 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.426 0.69 . . . . 0.0 110.006 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 61.38 154.12 0.11 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.841 1.256 . . . . 0.0 112.2 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.79 133.65 24.13 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.365 2.044 . . . . 0.0 110.279 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.47 -10.18 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.047 3.165 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -147.19 159.61 43.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.103 0.41 . . . . 0.0 110.138 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.11 0.16 48.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.372 0.51 . . . . 0.0 112.781 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m -54.66 98.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.574 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 38.3 t -168.96 -50.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.716 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HD2' ' H ' ' A' ' 141' ' ' SER . 76.8 Cg_endo -80.61 107.78 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.367 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p 50.69 12.45 0.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.472 1.509 . . . . 0.0 114.57 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -149.74 147.43 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.089 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' N ' HD13 ' A' ' 144' ' ' ILE . 43.8 tptt -146.35 162.32 38.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 192' ' ' ILE . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 188' ' ' GLU . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -147.31 161.9 40.04 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.968 0.507 . . . . 0.0 110.05 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.29 -8.13 55.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.857 0.463 . . . . 0.0 111.86 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -83.56 10.47 8.99 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.92 0.488 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.38 -168.73 11.74 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -125.54 149.85 47.96 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.529 -0.395 . . . . 0.0 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -121.29 162.13 20.79 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.519 0.728 . . . . 0.0 109.773 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.14 152.8 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.789 0.435 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.54 10.06 2.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.413 0.685 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -88.11 9.44 22.67 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 156' ' ' LEU . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.68 152.05 41.33 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.05 -8.83 20.36 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.301 2.667 . . . . 0.0 112.556 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -141.63 26.59 1.92 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.0 -3.39 5.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.224 0.92 . . . . 0.0 112.835 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.11 11.09 11.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.452 0.701 . . . . 0.0 111.235 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.96 -7.51 2.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.913 0.485 . . . . 0.0 111.186 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -75.03 154.8 37.82 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 122.136 -0.353 . . . . 0.0 110.74 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -102.05 4.84 40.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 111.105 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 97.5 p -145.6 178.43 8.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.2 0.6 . . . . 0.0 110.33 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -77.01 9.11 3.17 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.074 0.55 . . . . 0.0 112.201 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -126.64 138.74 33.1 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 122.908 0.483 . . . . 0.0 110.08 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.74 166.0 26.01 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.709 2.94 . . . . 0.0 110.504 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.11 166.33 7.34 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.87 3.047 . . . . 0.0 111.893 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.32 14.57 1.49 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.138 0.575 . . . . 0.0 111.94 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -158.34 6.96 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.786 0.708 . . . . 0.0 112.651 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 135' ' ' LEU . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 125' ' ' ILE . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p -90.84 48.43 1.53 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.544 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 32.5 m -111.83 -39.02 0.11 Allowed Pre-proline 0 CA--C 1.528 0.123 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.433 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 141' ' ' SER . 29.7 Cg_exo -64.87 -171.44 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.001 2.468 . . . . 0.0 110.225 168.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.2 p -69.79 4.49 1.95 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.343 0.657 . . . . 0.0 112.5 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -41.56 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.059 0.543 . . . . 0.0 110.685 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 38.48 76.3 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.715 1.606 . . . . 0.0 113.793 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.521 HD21 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.521 ' H ' HD21 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.543 ' H ' HD12 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.51 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.469 ' H ' HG12 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.339 0.114 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -139.16 162.95 33.72 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.359 0.664 . . . . 0.0 110.266 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -130.25 13.37 5.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.119 0.567 . . . . 0.0 111.177 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.93 155.77 39.53 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.532 0.333 . . . . 0.0 110.366 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.41 170.42 53.61 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.84 154.86 24.46 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -133.89 -20.32 1.98 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 111.355 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.81 148.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.513 1.525 . . . . 0.0 113.854 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.85 140.56 32.95 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.64 -23.22 0.09 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -101.55 156.46 35.16 Favored Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.09 -19.12 61.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.54 2.827 . . . . 0.0 111.721 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -150.28 136.69 18.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.268 1.027 . . . . 0.0 108.801 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -146.71 13.32 1.17 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 172.91 11.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.09 143.19 49.39 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.4 t -151.58 165.15 35.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.856 0.462 . . . . 0.0 110.439 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.91 9.14 25.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.457 0.703 . . . . 0.0 111.123 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.9 t -138.57 160.16 40.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.542 0.737 . . . . 0.0 110.616 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.31 15.94 16.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.584 0.754 . . . . 0.0 111.591 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' C ' ' HD2' ' A' ' 107' ' ' PRO . 39.7 t80 -125.88 70.64 67.01 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.716 . . . . 0.0 110.195 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 83.9 Cg_endo -73.73 -22.19 18.11 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.566 2.844 . . . . 0.0 116.225 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 105' ' ' PHE . 88.1 Cg_endo -74.01 163.75 36.08 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 123.003 2.108 . . . . 0.0 111.015 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.586 ' HA ' ' HE2' ' A' ' 108' ' ' LYS . 11.6 mmpt? -101.05 18.24 20.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.564 0.746 . . . . 0.0 112.322 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.92 -1.33 74.29 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.412 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m -57.19 102.16 0.08 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.682 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.1 t -164.37 -48.38 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.488 -0.768 . . . . 0.0 112.182 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 141' ' ' SER . 44.7 Cg_endo -78.87 -146.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.074 2.516 . . . . 0.0 110.222 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 142' ' ' PRO . 15.2 t -58.16 -14.93 7.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 112.749 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.19 140.68 22.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 160.52 43.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 137' ' ' LEU . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.936 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 169' ' ' LEU . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.424 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.514 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.418 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.915 -0.032 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 55.64 18.42 2.8 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.302 1.041 . . . . 0.0 113.235 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.85 161.62 37.51 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.534 0.734 . . . . 0.0 109.836 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -79.96 159.22 26.38 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.575 0.35 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.76 176.44 50.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.35 7.0 5.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.023 0.529 . . . . 0.0 111.268 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -81.41 166.88 20.0 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.001 0.52 . . . . 0.0 110.933 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.13 148.38 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.126 0.57 . . . . 0.0 109.691 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -81.39 171.64 14.52 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.235 0.614 . . . . 0.0 111.737 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -133.92 166.05 23.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -162.25 142.25 7.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.64 -2.58 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.02 3.147 . . . . 0.0 112.317 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -91.2 16.1 10.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -139.37 152.54 47.22 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.983 0.513 . . . . 0.0 110.182 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.12 35.62 1.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.451 0.7 . . . . 0.0 111.235 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 56.72 25.55 10.29 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.624 0.769 . . . . 0.0 111.708 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.4 p -76.04 168.36 20.19 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.656 0.782 . . . . 0.0 111.253 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -131.0 0.38 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.194 0.598 . . . . 0.0 111.058 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -116.99 1.69 12.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.387 0.675 . . . . 0.0 111.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -149.85 149.53 30.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.888 0.475 . . . . 0.0 110.44 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.56 149.89 41.96 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 108.995 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.3 149.77 63.96 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.195 2.597 . . . . 0.0 111.967 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.32 -170.48 0.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.872 3.715 . . . . 0.0 110.085 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -57.64 147.1 28.42 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.2 -170.27 41.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.434 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m -72.71 157.1 38.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 m 78.55 1.53 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.13 -31.52 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 123.483 2.28 . . . . 0.0 110.572 171.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -168.27 -27.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.51 1.124 . . . . 0.0 109.809 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.82 145.82 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 125.499 1.52 . . . . 0.0 107.149 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.83 167.62 21.65 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.457 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.587 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.536 ' H ' HG22 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.137 0.018 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 57.82 176.26 0.05 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.61 1.164 . . . . 0.0 112.898 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -140.6 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.396 0.679 . . . . 0.0 110.213 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.03 -2.69 58.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.605 0.362 . . . . 0.0 111.183 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.11 169.24 38.74 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.22 -19.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.814 0.307 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -152.55 154.98 36.52 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.761 0.424 . . . . 0.0 110.913 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.12 136.4 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.01 31.09 1.6 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.997 0.519 . . . . 0.0 110.67 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.72 -11.77 59.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.346 1.058 . . . . 0.0 113.361 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' HD12 ' A' ' 156' ' ' LEU . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.405 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -118.34 148.19 43.36 Favored Pre-proline 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.65 136.8 73.24 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.004 2.469 . . . . 0.0 111.39 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.0 t60 45.81 40.53 6.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.99 0.916 . . . . 0.0 112.937 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -67.03 -2.15 5.06 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.08 -4.53 44.78 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.007 0.367 . . . . 0.0 111.363 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.6 145.52 27.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.485 0.714 . . . . 0.0 109.25 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 m -147.0 154.74 41.6 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.542 0.337 . . . . 0.0 111.072 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -0.88 0.98 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.631 0.772 . . . . 0.0 111.491 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -146.75 164.26 33.33 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.319 1.047 . . . . 0.0 109.304 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -84.44 154.02 23.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.272 0.229 . . . . 0.0 110.999 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 6.8 p90 55.91 157.24 0.07 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 127.113 2.165 . . . . 0.0 113.7 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 105' ' ' PHE . 92.2 Cg_endo -75.07 171.43 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.575 2.85 . . . . 0.0 112.66 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.16 161.85 3.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.136 3.224 . . . . 0.0 112.829 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -109.27 157.31 18.96 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.37 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.35 -21.16 2.98 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.073 0.844 . . . . 0.0 113.721 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p -166.96 34.49 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.523 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.5 t -141.44 -61.14 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 141' ' ' SER . 83.0 Cg_endo -72.06 108.31 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.399 2.066 . . . . 0.0 111.722 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m 49.4 19.96 0.41 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.017 1.327 . . . . 0.0 112.677 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -151.12 147.16 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.587 ' H ' HD13 ' A' ' 144' ' ' ILE . 45.3 mmtm -145.24 142.39 29.47 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.644 0.656 . . . . 0.0 112.531 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.96 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 187' ' ' VAL . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 185' ' ' ARG . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.492 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.492 ' H ' HD12 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 205' ' ' ILE . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.429 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.553 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.337 0.113 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.4 m80 54.95 25.83 7.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.089 0.956 . . . . 0.0 113.364 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.0 167.84 23.02 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.9 0.48 . . . . 0.0 110.577 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -143.92 162.11 36.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.084 0.554 . . . . 0.0 110.534 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.57 167.88 50.82 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.53 10.95 8.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.238 0.615 . . . . 0.0 110.873 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -137.08 165.98 24.77 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.938 0.895 . . . . 0.0 109.946 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.51 141.86 43.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.297 0.639 . . . . 0.0 110.067 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.09 156.93 20.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.404 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -146.61 152.91 39.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.068 0.547 . . . . 0.0 110.258 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -102.57 156.36 35.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.94 -15.21 43.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.95 2.433 . . . . 0.0 110.916 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -154.32 140.14 18.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.682 0.793 . . . . 0.0 109.192 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -154.17 169.76 22.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.842 0.457 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.52 170.32 11.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.604 0.762 . . . . 0.0 110.828 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.56 2.78 35.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.244 0.618 . . . . 0.0 111.374 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.7 p -69.68 166.84 18.3 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.041 0.537 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.16 -20.85 63.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.931 0.493 . . . . 0.0 111.549 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.0 t -152.39 137.41 17.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.729 0.412 . . . . 0.0 109.973 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -154.02 161.47 41.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.881 0.472 . . . . 0.0 109.919 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -129.42 151.03 77.21 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.941 0.496 . . . . 0.0 110.259 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.13 150.4 82.12 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.952 2.434 . . . . 0.0 110.644 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.06 -11.13 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.989 3.126 . . . . 0.0 112.048 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -141.18 170.35 15.88 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 123.937 0.895 . . . . 0.0 109.972 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.03 -1.75 56.84 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' C ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.433 ' C ' ' CD ' ' A' ' 142' ' ' PRO . 14.6 m -159.26 154.54 25.44 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m 82.67 -11.77 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.433 ' CD ' ' C ' ' A' ' 140' ' ' SER . 47.8 Cg_endo -81.48 69.57 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 123.446 2.267 . . . . 0.0 110.39 172.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m 61.97 22.38 13.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.46 0.704 . . . . 0.0 112.317 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -149.53 157.15 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.464 ' N ' HD13 ' A' ' 144' ' ' ILE . 24.5 tptm -140.8 141.83 34.72 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.419 HG13 HD23 ' A' ' 137' ' ' LEU . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.841 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.41 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.77 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.77 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 220' ' ' VAL . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 211' ' ' LEU . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.411 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 203' ' ' ALA . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.62 ' HE2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.53 0.205 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -149.23 164.84 33.64 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.149 0.58 . . . . 0.0 110.855 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -146.92 149.92 34.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.433 0.693 . . . . 0.0 109.42 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -139.27 5.07 2.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.492 0.317 . . . . 0.0 111.847 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.03 7.88 82.3 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.0 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -135.63 13.15 3.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.661 0.73 . . . . 0.0 111.485 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -111.58 6.8 20.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.747 . . . . 0.0 111.176 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 t -84.56 50.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.526 0.73 . . . . 0.0 109.863 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.47 28.35 0.2 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.25 1.02 . . . . 0.0 111.825 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.5 28.65 0.54 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.069 0.948 . . . . 0.0 113.349 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.39 155.91 15.68 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.83 179.34 5.77 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.805 3.003 . . . . 0.0 111.436 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 57.77 24.12 10.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -105.85 8.55 32.76 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.57 20.15 3.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.128 0.571 . . . . 0.0 111.464 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -73.27 161.03 30.98 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.517 0.327 . . . . 0.0 111.04 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.8 m -112.51 6.64 18.62 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.204 0.602 . . . . 0.0 111.754 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -137.05 -3.55 1.99 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.272 0.629 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -141.61 165.82 26.45 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.566 0.746 . . . . 0.0 110.153 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -143.37 147.29 34.44 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.878 0.471 . . . . 0.0 110.248 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 58.6 148.98 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.893 1.677 . . . . 0.0 112.671 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.8 159.77 41.58 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.937 2.424 . . . . 0.0 110.773 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 32.5 Cg_exo -61.04 177.74 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.073 3.182 . . . . 0.0 112.02 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -75.29 19.0 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.43 0.692 . . . . 0.0 110.953 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -75.38 -162.57 10.98 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.727 0.68 . . . . 0.0 112.525 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p -83.14 75.33 9.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.652 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.1 t -155.95 -37.23 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 141' ' ' SER . 34.7 Cg_exo -64.56 -152.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.132 3.221 . . . . 0.0 111.869 172.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -60.13 -6.27 1.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.891 0.476 . . . . 0.0 111.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.01 130.47 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.809 0.843 . . . . 0.0 109.462 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -154.67 118.21 4.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 173' ' ' LYS . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.5 HD12 ' H ' ' A' ' 186' ' ' ALA . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.5 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 189' ' ' LEU . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.405 ' HA ' HD11 ' A' ' 196' ' ' LEU . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 229' ' ' ILE . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 226' ' ' GLN . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.52 0.2 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -148.01 167.28 25.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.015 0.526 . . . . 0.0 110.435 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -138.67 161.55 36.86 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.425 0.69 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -148.27 162.63 39.12 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.932 0.493 . . . . 0.0 110.014 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.12 6.41 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.03 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -142.07 153.26 44.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.921 0.861 . . . . 0.0 110.85 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.82 160.71 40.46 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.03 0.532 . . . . 0.0 111.106 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.53 141.22 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 124.051 0.94 . . . . 0.0 108.618 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.4 -46.24 7.77 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.24 176.3 12.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.395 0.678 . . . . 0.0 109.633 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -100.0 154.75 37.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.85 -31.4 93.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.297 2.665 . . . . 0.0 113.449 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -158.47 -16.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -73.09 155.81 39.34 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.157 0.583 . . . . 0.0 110.509 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.69 166.08 25.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.335 0.654 . . . . 0.0 110.509 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.99 10.59 11.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.233 0.613 . . . . 0.0 111.471 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -78.57 5.97 9.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.366 0.667 . . . . 0.0 111.952 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -138.5 155.08 48.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.238 0.615 . . . . 0.0 110.048 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.8 m -87.63 14.42 8.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.602 0.761 . . . . 0.0 112.799 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -121.35 153.33 37.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.601 0.36 . . . . 0.0 110.91 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.87 152.89 38.54 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.811 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.1 156.58 47.06 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.604 2.869 . . . . 0.0 110.906 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.18 -176.35 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.541 3.494 . . . . 0.0 110.734 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -58.5 151.45 20.26 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.33 -139.64 6.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 63' ' ' TYR . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 137' ' ' LEU . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 136' ' ' TYR . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.423 ' C ' HD22 ' A' ' 135' ' ' LEU . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 134' ' ' LYS . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 129' ' ' ILE . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -160.34 98.98 1.3 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD3' ' A' ' 142' ' ' PRO . 31.4 t -159.18 -48.41 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.518 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 141' ' ' SER . 34.2 Cg_exo -60.98 -173.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.555 2.17 . . . . 0.0 111.163 169.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.7 p -70.94 4.13 2.83 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -31.46 23.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.143 0.883 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 42.62 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 127.118 2.167 . . . . 0.0 115.036 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.728 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 186' ' ' ALA . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.508 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.674 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.498 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.522 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.522 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 235' ' ' ARG . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -140.08 161.79 36.79 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.321 0.649 . . . . 0.0 110.463 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -87.9 161.39 17.51 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.621 0.368 . . . . 0.0 110.843 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.0 t30 60.27 167.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.927 1.291 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.03 176.32 40.82 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -146.92 165.15 30.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.57 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -150.72 150.44 31.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.039 0.535 . . . . 0.0 109.906 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.74 158.15 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.133 0.573 . . . . 0.0 110.366 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 155.81 39.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.102 -0.374 . . . . 0.0 110.264 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -137.65 137.85 38.85 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -100.1 152.15 37.73 Favored Pre-proline 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.95 -17.42 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.111 2.541 . . . . 0.0 111.108 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -156.61 145.23 19.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.866 0.466 . . . . 0.0 110.452 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -155.43 160.76 40.89 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 123.999 0.92 . . . . 0.0 109.064 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.69 0.51 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.22 168.65 24.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.198 0.454 . . . . 0.0 111.015 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.9 m -89.97 15.42 10.04 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.437 0.695 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.55 -171.96 2.59 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.02 0.928 . . . . 0.0 109.577 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -53.29 137.92 33.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.792 0.33 . . . . 0.0 110.665 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -153.69 161.13 42.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.678 0.791 . . . . 0.0 109.545 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -125.35 121.29 24.97 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.35 159.13 40.41 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.261 2.64 . . . . 0.0 110.674 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 109' ' ' GLY . 72.1 Cg_endo -70.31 157.52 59.07 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.282 2.655 . . . . 0.0 109.987 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 54.48 -5.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 114.78 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . 62.53 61.39 6.59 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.15 0.881 . . . . 0.0 114.007 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 58.48 4.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 28.0 m -146.28 -42.65 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 141' ' ' SER . 15.4 Cg_exo -69.73 -169.25 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.874 2.382 . . . . 0.0 110.599 173.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 60.8 p -63.41 -9.74 13.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -73.22 -38.62 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.122 0.569 . . . . 0.0 109.742 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 56.85 -30.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' H ' HD13 ' A' ' 144' ' ' ILE . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.848 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.81 161.95 36.76 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.387 0.675 . . . . 0.0 110.417 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -136.24 161.4 35.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.195 0.598 . . . . 0.0 110.214 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -99.39 164.92 11.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.101 0.56 . . . . 0.0 110.489 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.38 -165.61 54.77 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.04 163.42 25.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.529 0.732 . . . . 0.0 110.607 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -118.83 -1.15 11.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.434 0.694 . . . . 0.0 111.164 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.56 151.82 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.96 0.504 . . . . 0.0 109.979 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.85 164.84 17.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.506 0.723 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -138.47 156.86 47.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -113.12 157.55 40.55 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.84 -13.68 37.35 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.07 2.514 . . . . 0.0 111.221 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -150.56 142.67 24.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.538 0.735 . . . . 0.0 109.521 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -158.02 176.36 12.63 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.999 0.52 . . . . 0.0 110.509 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.94 18.22 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.461 0.704 . . . . 0.0 110.159 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -124.45 6.71 8.32 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -130.57 -2.02 4.31 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.866 0.466 . . . . 0.0 111.417 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -157.18 166.99 31.7 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.687 0.795 . . . . 0.0 109.814 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -79.0 151.21 31.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -156.64 153.75 29.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.834 0.454 . . . . 0.0 110.649 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.58 145.06 19.25 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.78 117.83 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.383 2.722 . . . . 0.0 110.41 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.08 127.68 11.57 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.853 2.369 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.0 pttt 43.32 22.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.404 1.482 . . . . 0.0 113.568 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.53 -176.17 48.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.468 HD22 HD11 ' A' ' 81' ' ' ILE . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 114' ' ' LEU . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 129' ' ' ILE . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 124' ' ' LEU . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p -149.69 119.19 6.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.3 m -157.1 169.18 11.04 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 126.545 1.938 . . . . 0.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.84 147.03 14.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.733 2.289 . . . . 0.0 113.213 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 m 62.69 -11.25 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.013 1.725 . . . . 0.0 114.671 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.432 ' C ' HD12 ' A' ' 144' ' ' ILE . 2.3 pp -133.67 18.3 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.483 1.038 . . . . 0.0 111.449 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.02 130.69 44.96 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.41 HG13 HD13 ' A' ' 137' ' ' LEU . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 161' ' ' PHE . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.517 ' CD2' HD13 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 215' ' ' LYS . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HG3' ' CG ' ' A' ' 208' ' ' ASP . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 197' ' ' TYR . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.477 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.69 161.92 36.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -139.61 163.93 31.25 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.282 0.633 . . . . 0.0 110.138 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -138.44 9.72 2.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.882 0.473 . . . . 0.0 111.058 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.74 41.57 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.43 11.86 4.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.481 0.712 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -148.57 167.94 24.09 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.691 0.797 . . . . 0.0 110.279 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.71 140.6 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -145.56 35.44 1.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.095 0.474 . . . . 0.0 109.939 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 -127.97 179.39 5.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.53 0.732 . . . . 0.0 110.239 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -101.24 151.65 37.76 Favored Pre-proline 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.65 -8.78 7.89 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.527 2.818 . . . . 0.0 113.563 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -129.93 13.49 5.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 111.62 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -72.67 126.17 29.25 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.13 -4.87 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.271 0.628 . . . . 0.0 111.341 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.58 162.28 41.25 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.011 0.525 . . . . 0.0 110.399 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -83.04 6.99 17.03 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.61 1.09 13.47 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -94.46 150.65 20.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.109 0.413 . . . . 0.0 110.957 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -156.86 172.95 17.73 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.184 0.594 . . . . 0.0 110.499 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 t80 49.68 83.88 0.21 Allowed Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.947 1.299 . . . . 0.0 112.95 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 49.7 Cg_exo -58.35 151.15 62.69 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.819 3.012 . . . . 0.0 111.565 176.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 32.4 Cg_exo -63.19 -13.66 37.02 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.861 3.041 . . . . 0.0 114.117 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -141.31 164.74 29.41 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.296 0.498 . . . . 0.0 111.421 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.99 8.88 48.88 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.978 0.799 . . . . 0.0 112.822 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m -76.19 91.64 3.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.3 t -158.47 -41.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.761 ' HD2' ' H ' ' A' ' 141' ' ' SER . 42.9 Cg_endo -81.23 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.603 2.202 . . . . 0.0 109.871 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -61.46 -9.33 5.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.555 0.742 . . . . 0.0 112.195 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 144' ' ' ILE . 1.7 pp -114.2 159.8 13.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 122.94 0.496 . . . . 0.0 110.324 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -153.41 162.05 41.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.352 0.261 . . . . 0.0 110.396 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.637 ' N ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 202' ' ' TYR . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.435 ' CD2' HG22 ' A' ' 162' ' ' VAL . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.433 HD11 ' CZ2' ' A' ' 154' ' ' TRP . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.506 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 197' ' ' TYR . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -139.01 6.45 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.879 0.472 . . . . 0.0 111.734 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -75.13 155.06 37.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.821 0.448 . . . . 0.0 110.432 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.22 155.62 38.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.381 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.0 46.0 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -132.24 11.29 4.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.325 0.65 . . . . 0.0 110.984 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -146.06 165.82 27.94 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.449 0.7 . . . . 0.0 110.344 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.38 139.19 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -145.58 22.8 1.46 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.355 0.662 . . . . 0.0 110.723 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -130.11 -4.77 4.44 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -172.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.606 ' HB2' HD12 ' A' ' 156' ' ' LEU . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 HG13 ' CG1' ' A' ' 149' ' ' VAL . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -100.9 153.65 37.61 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.36 -29.82 86.36 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.93 2.42 . . . . 0.0 111.965 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -161.58 157.54 24.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.634 0.773 . . . . 0.0 109.481 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -154.46 143.98 21.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.348 0.659 . . . . 0.0 109.314 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.2 164.22 38.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.995 0.518 . . . . 0.0 110.206 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.69 124.04 28.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.4 p -163.47 -172.31 2.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.281 0.632 . . . . 0.0 109.9 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.16 8.55 3.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.707 0.403 . . . . 0.0 111.138 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.0 t -140.24 169.41 17.74 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.043 0.937 . . . . 0.0 109.909 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.13 4.59 2.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.026 0.53 . . . . 0.0 111.623 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.71 154.17 80.96 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.241 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 52.3 Cg_exo -55.17 115.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.251 2.634 . . . . 0.0 110.95 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 36.9 Cg_exo -61.03 -5.46 4.89 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.388 3.392 . . . . 0.0 114.857 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -129.87 3.71 4.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.28 0.491 . . . . 0.0 112.282 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 -172.8 45.43 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 135' ' ' LEU . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' C ' HD12 ' A' ' 137' ' ' LEU . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 136' ' ' TYR . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 146' ' ' ASP . 39.1 p -72.97 142.62 47.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.5 m -158.64 167.59 14.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.827 0.851 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.6 -5.03 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.046 3.164 . . . . 0.0 114.395 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.7 p -120.68 12.23 11.39 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.469 0.707 . . . . 0.0 111.973 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' H ' ' A' ' 145' ' ' LYS . 13.1 tt -149.97 176.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.68 169.88 7.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG1' HG13 ' A' ' 69' ' ' VAL . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.854 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.471 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 189' ' ' LEU . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.624 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.624 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.517 ' C ' HD22 ' A' ' 239' ' ' LEU . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -76.55 161.58 28.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.8 0.44 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -77.75 163.11 26.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.893 0.477 . . . . 0.0 110.748 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.88 19.5 16.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.438 0.695 . . . . 0.0 111.003 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.31 -1.49 86.2 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.43 156.3 46.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.93 0.892 . . . . 0.0 109.442 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -151.98 138.82 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.555 0.342 . . . . 0.0 110.235 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t 45.1 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 125.886 1.674 . . . . 0.0 112.972 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -64.91 130.48 43.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -98.63 -166.85 1.41 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -161.62 158.9 22.85 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.22 168.62 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.184 3.256 . . . . 0.0 113.772 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 59.19 9.11 1.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.202 1.401 . . . . 0.0 114.061 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -83.7 142.77 30.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 121.804 -0.56 . . . . 0.0 109.97 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.8 169.53 23.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.177 0.591 . . . . 0.0 109.86 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.11 -2.87 33.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.731 0.412 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -129.08 14.55 6.26 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.455 0.702 . . . . 0.0 111.862 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -134.35 158.03 44.87 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.279 0.632 . . . . 0.0 110.734 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -146.17 14.85 1.31 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.459 0.704 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.16 165.18 25.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 111.345 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.54 155.54 92.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.645 0.778 . . . . 0.0 111.042 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.14 151.14 84.43 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.852 2.368 . . . . 0.0 110.066 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.74 -6.34 18.84 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.105 3.204 . . . . 0.0 113.217 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -124.22 -3.54 7.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.369 0.531 . . . . 0.0 112.173 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.33 3.55 53.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.401 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p -155.75 162.39 40.53 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 142' ' ' PRO . 8.3 p -157.37 171.26 7.68 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.335 0.654 . . . . 0.0 109.538 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 141' ' ' SER . 96.1 Cg_endo -71.92 0.33 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 112.386 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -120.76 -15.68 8.34 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.793 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.45 125.36 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.45 -175.36 2.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.736 0.815 . . . . 0.0 112.295 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.618 ' HA ' ' HE2' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 184' ' ' LEU . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 196' ' ' LEU . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.411 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -148.53 148.92 30.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.199 0.6 . . . . 0.0 109.773 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -152.79 -24.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 161.01 43.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.17 -0.331 . . . . 0.0 111.116 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 176.42 47.98 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.56 165.68 34.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.004 0.522 . . . . 0.0 110.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -87.54 166.96 14.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.927 0.491 . . . . 0.0 111.026 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.68 137.17 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.505 0.722 . . . . 0.0 109.193 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.51 28.06 0.99 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.01 0.524 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 7.16 3.9 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 113' ' ' LEU . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 91' ' ' LEU . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -99.59 152.11 37.69 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.32 -20.15 32.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.892 2.395 . . . . 0.0 111.159 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -160.63 157.71 27.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.571 0.748 . . . . 0.0 109.513 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 100' ' ' GLU . 18.2 ptmt -155.1 151.31 28.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.295 0.638 . . . . 0.0 109.582 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.12 -18.43 39.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 40.9 tt0 -155.47 152.24 28.71 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.8 p -70.85 -3.21 17.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -109.26 -2.82 17.65 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.241 0.617 . . . . 0.0 110.966 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -77.67 155.21 31.5 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.089 -0.382 . . . . 0.0 110.749 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.27 10.13 4.47 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.285 0.634 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.19 130.14 24.21 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.506 0.723 . . . . 0.0 109.959 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.75 146.72 26.9 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.464 2.776 . . . . 0.0 110.793 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.17 -10.95 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.752 2.968 . . . . 0.0 111.952 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -140.5 166.97 23.26 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.59 0.756 . . . . 0.0 110.135 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -6.8 81.46 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 69' ' ' VAL . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p -92.84 79.18 4.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.77 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.1 t -159.1 -42.73 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.77 ' HD2' ' H ' ' A' ' 141' ' ' SER . 30.0 Cg_endo -82.68 -123.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.35 2.7 . . . . 0.0 111.079 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 p -64.81 -3.14 3.03 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.055 0.942 . . . . 0.0 112.675 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.51 136.47 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -153.88 95.62 1.89 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.81 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 219' ' ' ARG . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 219' ' ' ARG . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.557 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 189' ' ' LEU . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.558 ' CD2' HD13 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ASP . . . . . 0.466 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 211' ' ' LEU . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.515 ' H ' ' HB3' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.541 HD22 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.329 0.109 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 54.52 22.22 3.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.181 0.992 . . . . 0.0 113.373 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -139.77 156.49 46.74 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.416 0.687 . . . . 0.0 109.969 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.64 10.66 2.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.176 0.59 . . . . 0.0 111.327 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.4 156.15 53.15 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.75 170.32 20.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -109.91 160.56 16.28 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.388 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.25 137.87 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 109.688 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.32 20.57 2.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.697 0.799 . . . . 0.0 110.511 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -78.1 -14.13 59.6 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 156' ' ' LEU . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.567 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -123.47 151.98 64.01 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.96 172.0 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.904 3.07 . . . . 0.0 110.72 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -61.57 150.94 34.58 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.626 0.251 . . . . 0.0 111.006 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -90.74 167.44 12.49 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.339 0.656 . . . . 0.0 111.295 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.38 178.04 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.996 0.519 . . . . 0.0 111.034 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.11 15.01 0.77 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.472 0.709 . . . . 0.0 112.74 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.3 t -132.31 150.19 52.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.963 0.505 . . . . 0.0 110.727 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.1 -13.55 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.081 0.552 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.0 m -82.65 1.71 37.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.881 0.472 . . . . 0.0 111.604 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -91.62 150.62 21.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.905 0.482 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -138.85 143.95 39.56 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.265 0.626 . . . . 0.0 109.897 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 168.55 21.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.906 3.071 . . . . 0.0 111.255 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.29 159.98 11.84 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.219 3.279 . . . . 0.0 112.874 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -112.23 14.69 20.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.848 0.859 . . . . 0.0 111.605 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.75 -121.02 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.242 0.925 . . . . 0.0 111.665 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.567 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.503 ' CE1' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 148' ' ' PRO . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.3 p -94.6 120.69 35.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 35.3 t -160.48 -43.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.653 -0.689 . . . . 0.0 112.18 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 141' ' ' SER . 16.9 Cg_exo -69.2 -168.32 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.966 2.444 . . . . 0.0 110.96 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 p -65.03 -1.45 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.574 0.349 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.477 ' C ' HD12 ' A' ' 144' ' ' ILE . 2.0 pp -91.52 5.47 6.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.673 0.789 . . . . 0.0 111.235 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -47.1 132.84 12.04 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.836 0.854 . . . . 0.0 112.247 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.43 ' HZ2' ' HG ' ' A' ' 159' ' ' SER . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 154' ' ' TRP . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 202' ' ' TYR . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.482 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.647 ' H ' HD12 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' CE2' HD21 ' A' ' 169' ' ' LEU . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.542 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.406 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.438 HD22 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.438 ' HG2' HD22 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 244' ' ' ILE . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' C ' HD11 ' A' ' 156' ' ' LEU . 58.2 ttm-85 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 169' ' ' LEU . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.489 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.452 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.478 ' H ' HG22 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 72' ' ' LEU . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 69' ' ' VAL . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.428 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.428 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 137' ' ' LEU . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' C ' HD22 ' A' ' 135' ' ' LEU . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.612 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.532 ' C ' HD13 ' A' ' 189' ' ' LEU . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.479 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' CD ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 72' ' ' LEU . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 69' ' ' VAL . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 81' ' ' ILE . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.721 0.296 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.483 ' CG1' HG13 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' ALA . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 161' ' ' PHE . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 189' ' ' LEU . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.592 ' H ' HD12 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 156' ' ' LEU . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 81' ' ' ILE . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.424 ' O ' HD12 ' A' ' 151' ' ' ILE . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 150' ' ' GLN . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.927 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 186' ' ' ALA . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.509 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.403 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.543 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.447 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p . . . . . 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CD2' HD13 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.443 HE21 ' NE2' ' A' ' 238' ' ' GLN . 85.1 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.402 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.624 0.25 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 . . . . . 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 tptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 192' ' ' ILE . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 189' ' ' LEU . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 188' ' ' GLU . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 156' ' ' LEU . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 CA-C-O 121.228 0.349 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 135' ' ' LEU . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 125' ' ' ILE . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.521 HD21 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.521 ' H ' HD21 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.543 ' H ' HD12 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.51 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.469 ' H ' HG12 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 . . . . . 0 N--CA 1.457 -0.075 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.412 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 137' ' ' LEU . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.936 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 169' ' ' LEU . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.424 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.458 ' N ' HD23 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.514 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.418 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.434 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.049 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.457 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.445 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.587 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.536 ' H ' HG22 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 N--CA 1.457 -0.123 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' HD12 ' A' ' 156' ' ' LEU . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.405 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.46 0.041 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.96 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 187' ' ' VAL . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 185' ' ' ARG . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.492 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.492 ' H ' HD12 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 205' ' ' ILE . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.429 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.553 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 . . . . . 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.5 tptm . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.419 HG13 HD23 ' A' ' 137' ' ' LEU . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.841 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.41 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.77 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.77 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 220' ' ' VAL . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 211' ' ' LEU . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.411 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 203' ' ' ALA . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.62 ' H ' ' HE2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 CA-C-O 121.375 0.431 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 173' ' ' LYS . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.5 HD12 ' H ' ' A' ' 186' ' ' ALA . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.5 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . 0.405 ' HA ' HD11 ' A' ' 196' ' ' LEU . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 229' ' ' ILE . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 226' ' ' GLN . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 63' ' ' TYR . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 137' ' ' LEU . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 136' ' ' TYR . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.423 ' C ' HD22 ' A' ' 135' ' ' LEU . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 134' ' ' LYS . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 129' ' ' ILE . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.728 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 186' ' ' ALA . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.508 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.674 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.498 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.522 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.522 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 235' ' ' ARG . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 N-CA-C 114.007 0.363 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.848 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.468 HD22 HD11 ' A' ' 81' ' ' ILE . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 114' ' ' LEU . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 124' ' ' LEU . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.529 0.204 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.41 HG13 HD13 ' A' ' 137' ' ' LEU . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.673 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 161' ' ' PHE . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.517 ' CD2' HD13 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 215' ' ' LYS . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HG3' ' CG ' ' A' ' 208' ' ' ASP . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 197' ' ' TYR . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.477 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 . . . . . 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 CA-C-O 119.94 -0.367 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 202' ' ' TYR . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.435 ' CD2' HG22 ' A' ' 162' ' ' VAL . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.433 HD11 ' CZ2' ' A' ' 154' ' ' TRP . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 211' ' ' LEU . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.506 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 197' ' ' TYR . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.606 ' HB2' HD12 ' A' ' 156' ' ' LEU . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 HG13 ' CG1' ' A' ' 149' ' ' VAL . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' C ' HD12 ' A' ' 137' ' ' LEU . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 136' ' ' TYR . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 146' ' ' ASP . 39.1 p . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG1' HG13 ' A' ' 69' ' ' VAL . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.854 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.471 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 189' ' ' LEU . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.624 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.624 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.517 ' C ' HD22 ' A' ' 239' ' ' LEU . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.401 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 184' ' ' LEU . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.411 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 113' ' ' LEU . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 69' ' ' VAL . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.81 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 219' ' ' ARG . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 219' ' ' ARG . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.557 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 189' ' ' LEU . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.558 ' CD2' HD13 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . 0.466 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 211' ' ' LEU . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.515 ' H ' ' HB3' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.541 HD22 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 156' ' ' LEU . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.567 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.503 ' CE1' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 148' ' ' PRO . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.169 0.509 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.43 ' HZ2' ' HG ' ' A' ' 159' ' ' SER . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 154' ' ' TRP . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 202' ' ' TYR . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.482 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.647 ' H ' HD12 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' CE2' HD21 ' A' ' 169' ' ' LEU . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.542 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.406 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.438 HD22 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.438 ' HG2' HD22 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 244' ' ' ILE . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -147.86 152.49 37.71 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.108 0.563 . . . . 0.0 110.239 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -151.84 -32.64 0.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.489 0.315 . . . . 0.0 110.77 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.47 158.06 36.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.7 13.35 2.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.36 162.7 23.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.452 0.626 . . . . 0.0 110.792 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -138.92 157.16 46.54 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.333 0.653 . . . . 0.0 109.983 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.74 141.84 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.05 14.02 5.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.403 0.681 . . . . 0.0 111.203 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' C ' HD11 ' A' ' 156' ' ' LEU . 58.2 ttm-85 -93.37 26.22 3.06 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.183 0.993 . . . . 0.0 111.475 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.51 147.76 44.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 44.8 t -76.93 119.27 20.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -68.68 -5.9 22.98 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 125.742 1.901 . . . . 0.0 114.204 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -81.25 128.89 34.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.57 127.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -86.71 145.57 26.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.66 151.3 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.99 -8.75 0.45 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.88 -0.4 . . . . 0.0 113.206 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.54 6.05 84.02 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.168 -0.796 . . . . 0.0 114.441 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.05 151.28 57.31 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 118.677 1.239 . . . . 0.0 110.28 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.94 163.67 21.58 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.93 3.087 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.28 -5.74 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.988 3.125 . . . . 0.0 111.974 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.65 113.16 8.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.59 147.65 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.265 0.555 . . . . 0.0 111.14 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.25 168.36 20.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.08 -20.29 38.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.8 -23.07 25.52 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.551 1.069 . . . . 0.0 110.968 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.01 -42.78 69.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -26.58 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.106 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.3 m -68.13 -27.11 66.17 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.49 -14.82 31.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.498 0.319 . . . . 0.0 111.099 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.4 m -75.21 -43.4 52.11 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.072 0.149 . . . . 0.0 110.833 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.12 155.32 17.56 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.195 -0.316 . . . . 0.0 111.038 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 88' ' ' PHE . 5.4 mmp_? -122.34 163.19 20.17 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.125 0.97 . . . . 0.0 108.731 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 60.65 -17.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.429 1.491 . . . . 0.0 114.169 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 86' ' ' ARG . 8.4 m-30 -70.19 -17.67 63.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.997 0.817 . . . . 0.0 111.329 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.69 -150.57 38.5 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.95 146.4 65.07 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.896 2.398 . . . . 0.0 109.392 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.82 171.2 17.59 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.624 0.25 . . . . 0.0 111.454 -175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.94 145.66 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.05 158.55 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.909 0.385 . . . . 0.0 111.301 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -146.38 144.26 29.62 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.444 ' CG ' ' HD3' ' A' ' 106' ' ' PRO . 5.4 m95 -112.76 154.49 44.79 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 122.492 0.317 . . . . 0.0 111.131 -174.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.61 -14.86 30.54 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.118 2.545 . . . . 0.0 110.583 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -151.85 129.48 11.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -156.2 12.19 0.29 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.883 0.473 . . . . 0.0 111.914 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.8 155.46 37.56 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 111.49 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.16 1.88 4.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.145 0.578 . . . . 0.0 111.654 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -75.12 -15.17 60.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.842 0.457 . . . . 0.0 111.555 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -151.11 -54.24 0.14 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.5 t -163.88 158.7 20.2 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.068 0.395 . . . . 0.0 111.534 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -80.54 -1.2 40.93 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.146 0.578 . . . . 0.0 111.33 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.51 155.67 75.28 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.596 0.758 . . . . 0.0 109.715 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HD3' ' CG ' ' A' ' 95' ' ' TRP . 93.3 Cg_endo -76.23 150.22 32.76 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.394 2.729 . . . . 0.0 111.896 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.18 0.1 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.358 3.372 . . . . 0.0 111.93 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.64 164.68 22.37 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.472 0.709 . . . . 0.0 110.731 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.42 -1.12 69.19 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.532 -0.593 . . . . 0.0 113.538 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.88 135.12 43.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.329 1.064 . . . . 0.0 110.779 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.33 157.04 38.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 111.768 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.61 130.57 42.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -156.77 163.61 39.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.268 0.556 . . . . 0.0 112.371 -173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.1 158.41 40.42 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -124.85 169.9 11.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.865 0.364 . . . . 0.0 111.249 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.67 -27.73 67.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -167.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -121.63 152.33 39.43 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-N 119.367 0.985 . . . . 0.0 112.169 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -96.84 -6.79 35.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.1 m -78.63 -26.32 45.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.228 0.467 . . . . 0.0 111.24 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.3 t -82.0 -9.14 59.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 122.05 -0.406 . . . . 0.0 110.477 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.05 -41.96 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -84.23 -32.83 24.28 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.758 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.58 76.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.851 0.75 . . . . 0.0 112.212 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.05 -40.75 21.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.888 -0.508 . . . . 0.0 109.83 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.06 -25.57 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.231 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -22.47 34.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.77 -0.581 . . . . 0.0 110.708 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -83.88 11.2 8.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.853 0.461 . . . . 0.0 112.237 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.5 p -139.29 -175.24 4.1 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.697 0.399 . . . . 0.0 111.807 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.4 mt -94.66 151.15 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.383 0.673 . . . . 0.0 110.54 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.05 162.62 32.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.75 155.69 44.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.79 1.236 . . . . 0.0 108.17 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.86 -13.24 31.44 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.178 -0.326 . . . . 0.0 110.99 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.51 -28.29 5.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.399 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -168.85 177.29 5.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.477 1.138 . . . . 0.0 110.697 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.32 162.88 16.49 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -143.03 142.76 31.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.386 0.274 . . . . 0.0 110.718 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.53 138.31 48.22 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 64.5 m -90.77 39.7 0.99 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.429 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.15 11.16 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 m -54.17 109.55 0.49 Allowed 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.632 -0.667 . . . . 0.0 109.674 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.7 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 41.3 t -167.25 -44.88 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.251 -0.88 . . . . 0.0 113.372 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 141' ' ' SER . 84.2 Cg_endo -75.08 -145.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 0.0 110.044 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.0 p -66.11 9.95 0.13 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 137.59 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.941 0.896 . . . . 0.0 108.6 175.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -138.8 163.94 30.92 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 123.587 0.755 . . . . 0.0 111.957 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.2 12.57 0.5 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.879 1.672 . . . . 0.0 115.256 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -140.64 111.4 6.89 Favored Pre-proline 0 CA--C 1.529 0.153 0 CA-C-N 118.582 0.628 . . . . 0.0 109.957 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.56 161.63 7.42 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.622 2.882 . . . . 0.0 111.692 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.54 142.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.584 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -67.7 139.06 56.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.9 mm -139.74 136.88 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 122.907 0.483 . . . . 0.0 109.777 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -147.48 102.47 3.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 122.757 0.423 . . . . 0.0 110.541 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -83.77 -163.87 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.807 3.671 . . . . 0.0 108.429 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.485 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.7 t-105 -141.14 168.16 20.46 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.787 0.722 . . . . 0.0 111.131 170.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 2.1 m-20 -116.63 83.46 1.97 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.409 0.683 . . . . 0.0 109.185 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -59.21 -10.35 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.408 1.083 . . . . 0.0 113.368 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.6 t -114.51 -13.08 12.22 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 160' ' ' ASP . 37.0 t70 -91.59 -10.94 38.69 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.778 0.717 . . . . 0.0 110.515 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.0 m -50.17 -3.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 158' ' ' ASP . 9.6 m-20 -117.56 108.87 16.01 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.469 0.708 . . . . 0.0 109.334 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.422 ' CD1' ' HB3' ' A' ' 186' ' ' ALA . 3.4 m-85 -99.82 76.98 2.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 147.79 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.6 tpt -134.87 -30.29 1.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.704 -0.189 . . . . 0.0 111.453 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -155.52 146.11 22.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.005 0.366 . . . . 0.0 110.242 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.68 5.21 76.69 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.405 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.6 m -77.21 -13.11 60.0 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 118.344 1.072 . . . . 0.0 111.886 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -154.1 104.38 2.44 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.85 178.25 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.758 2.972 . . . . 0.0 109.962 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 169' ' ' LEU . 7.6 mp -64.0 131.75 48.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.53 138.25 10.88 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.31 -18.01 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.429 2.753 . . . . 0.0 114.821 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -6.03 35.96 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.523 0.601 . . . . 0.0 111.346 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.28 2.38 7.07 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.832 0.453 . . . . 0.0 111.51 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 95.2 m -83.41 148.95 26.99 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.035 0.445 . . . . 0.0 109.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 65.0 mt -135.57 153.91 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -108.85 145.89 34.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.99 113.05 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.95 159.85 15.03 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 120.983 0.213 . . . . 0.0 112.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.27 5.68 45.95 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 118.592 -1.116 . . . . 0.0 114.505 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.25 139.6 36.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 119.757 1.778 . . . . 0.0 110.278 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.96 168.19 21.21 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.577 2.851 . . . . 0.0 111.083 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 99.6 mtt180 -83.08 -40.11 0.8 Allowed Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 32.2 Cg_exo -62.25 -12.75 28.47 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.247 2.631 . . . . 0.0 114.798 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.99 157.42 16.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.994 0.816 . . . . 0.0 110.761 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 187' ' ' VAL . 85.3 mtt85 -90.08 177.31 6.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.426 -0.806 . . . . 0.0 108.887 173.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -69.85 13.24 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.274 -0.266 . . . . 0.0 111.28 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 185' ' ' ARG . 74.8 t -59.47 -47.96 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.129 0.572 . . . . 0.0 111.89 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.5 -25.24 60.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.758 -0.163 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.489 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.1 tt -80.52 -51.65 8.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.591 1.156 . . . . 0.0 110.554 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.58 -27.85 60.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.698 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -38.08 36.75 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.455 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.7 pt -67.14 -44.87 87.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.716 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -68.83 -20.35 64.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.98 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -88.49 -11.97 44.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.8 -17.21 23.36 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.588 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -130.64 -21.31 2.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.588 ' CD2' HD13 ' A' ' 196' ' ' LEU . 24.3 m-85 -140.91 42.28 1.82 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.231 0.923 . . . . 0.0 109.83 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.06 164.39 13.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.369 0.509 . . . . 0.0 113.7 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.58 9.97 4.68 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.73 148.75 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.323 0.649 . . . . 0.0 111.18 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -114.28 -29.98 6.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.203 0.201 . . . . 0.0 110.576 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -148.49 149.57 31.88 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.84 158.16 43.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.46 0.704 . . . . 0.0 109.674 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.8 -175.94 47.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.96 159.29 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.183 0.516 . . . . 0.0 111.251 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -67.92 134.5 50.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.999 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 p -135.52 159.65 40.94 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.903 0.858 . . . . 0.0 112.677 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -87.37 123.62 69.45 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.431 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -4.81 14.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.711 2.274 . . . . 0.0 111.008 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.58 -45.12 65.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.781 0.432 . . . . 0.0 111.258 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.61 12.99 2.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.989 0.181 . . . . 0.0 111.318 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 57.96 49.02 12.43 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.475 0.71 . . . . 0.0 110.5 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -125.73 144.84 49.58 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.968 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.63 144.66 51.85 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.835 3.023 . . . . 0.0 113.398 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -132.3 -10.11 3.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 176.29 -129.26 1.48 Allowed Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.074 0.852 . . . . 0.0 111.997 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -55.95 -165.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.241 2.216 . . . . 0.0 113.571 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -150.75 -171.52 19.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.37 163.42 39.51 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.905 0.383 . . . . 0.0 111.682 -175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.49 169.24 13.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.22 103.29 4.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.83 147.83 20.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.947 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 22.6 t -148.92 26.0 0.91 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.951 0.901 . . . . 0.0 108.684 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.09 -37.38 75.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 48.9 tt0 -159.5 -179.83 8.27 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.016 0.825 . . . . 0.0 111.762 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.452 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 5.4 tt0 -56.17 -11.81 1.3 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.918 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.8 m -67.3 -35.84 80.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.527 -0.733 . . . . 0.0 109.533 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.26 -33.18 61.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.18 -32.37 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.73 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.094 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -26.11 17.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.729 0.695 . . . . 0.0 111.842 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 tt -83.42 -17.4 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.194 0.452 . . . . 0.0 110.726 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.1 m -98.77 -13.48 20.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.361 0.265 . . . . 0.0 110.372 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.16 64.66 3.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -3.81 22.91 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.285 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -144.4 140.25 28.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -157.11 179.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.478 ' H ' HG22 ' A' ' 237' ' ' VAL . 12.5 tt0 -119.84 138.75 53.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.962 0.505 . . . . 0.0 110.476 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.2 -30.63 2.4 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.104 0.562 . . . . 0.0 111.75 -174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 47.98 43.74 18.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.941 0.496 . . . . 0.0 111.311 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -122.12 129.39 52.3 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.733 0.413 . . . . 0.0 111.159 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 65.44 -145.02 48.25 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.68 10.05 10.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.156 0.582 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.33 149.86 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.67 0.788 . . . . 0.0 109.458 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -131.51 -32.27 1.53 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -158.76 179.07 9.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 50.7 26.98 2.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.197 2.199 . . . . 0.0 115.633 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.83 149.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.54 142.18 33.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.68 115.8 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 167.04 14.13 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 119.301 -0.381 . . . . 0.0 110.539 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.97 156.87 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.225 2.617 . . . . 0.0 112.143 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -79.88 159.17 26.5 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 122.98 0.512 . . . . 0.0 111.077 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.194 -1.384 . . . . 0.0 109.664 -178.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.232 0.086 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -147.85 172.59 13.91 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.049 0.54 . . . . 0.0 110.516 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.75 166.48 22.85 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.222 0.609 . . . . 0.0 110.086 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -129.8 9.22 5.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.024 0.53 . . . . 0.0 110.738 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.19 27.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.37 166.31 25.02 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.504 0.722 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 60' ' ' VAL . 51.7 ttm-85 60.56 172.18 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.493 1.117 . . . . 0.0 111.808 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 10.5 p -135.2 157.52 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 123.061 0.544 . . . . 0.0 109.959 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -136.68 52.51 1.95 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.004 0.921 . . . . 0.0 109.512 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -136.23 39.19 2.71 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.196 0.598 . . . . 0.0 111.719 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -108.93 155.48 20.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.927 -0.483 . . . . 0.0 111.025 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.8 t -69.32 122.93 19.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -76.06 -5.07 44.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.135 1.522 . . . . 0.0 112.01 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -75.52 121.87 23.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.82 121.4 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-O 121.103 0.478 . . . . 0.0 109.769 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.44 143.86 27.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 72' ' ' LEU . 14.5 t -135.21 146.97 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.58 -8.52 0.95 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.823 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.66 13.31 67.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.75 0.775 . . . . 0.0 113.66 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 69' ' ' VAL . 51.8 mt -57.57 148.3 56.59 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.539 1.169 . . . . 0.0 111.417 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.82 155.71 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.408 3.406 . . . . 0.0 113.357 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.29 -1.03 10.41 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.355 3.37 . . . . 0.0 112.474 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -134.61 31.59 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.95 0.9 . . . . 0.0 109.345 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.2 145.01 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 122.223 1.011 . . . . 0.0 113.432 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.8 t70 -145.4 162.8 36.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.25 171.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.06 -26.34 15.63 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.409 1.004 . . . . 0.0 112.981 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -79.87 -29.81 40.07 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.941 0.791 . . . . 0.0 110.593 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.5 tp10 -71.03 -47.24 59.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.694 0.398 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.89 -30.99 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.623 -176.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 96.0 m -69.71 -27.84 65.32 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.44 -14.6 26.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.1 m -72.94 -49.96 26.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.965 0.348 . . . . 0.0 110.799 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.06 153.73 24.73 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -86.59 -19.06 29.94 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -141.84 -1.81 1.23 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.785 0.72 . . . . 0.0 112.871 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -83.35 159.8 21.78 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.203 0.456 . . . . 0.0 110.906 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.9 -60.69 0.05 OUTLIER Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.95 10.31 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.526 1 C-N-CA 125.346 4.031 . . . . 0.0 114.614 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.97 170.53 13.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.386 0.539 . . . . 0.0 112.166 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -131.4 146.24 33.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.27 160.06 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.74 130.42 14.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.086 0.469 . . . . 0.0 111.12 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -166.02 165.23 10.8 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.551 1.14 . . . . 0.0 109.289 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.1 153.78 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.736 2.957 . . . . 0.0 112.438 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -63.37 150.97 42.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -144.48 11.87 1.5 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.838 0.855 . . . . 0.0 111.22 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 165.16 20.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.112 0.565 . . . . 0.0 111.339 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 54.25 22.5 3.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.403 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.6 t -148.59 168.23 23.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.422 0.689 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.16 8.93 3.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.769 0.828 . . . . 0.0 110.431 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 84.8 p -131.76 6.1 4.32 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -90.81 142.16 28.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.938 0.335 . . . . 0.0 110.342 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -147.45 156.85 45.7 Favored Pre-proline 0 C--O 1.233 0.187 0 C-N-CA 123.841 0.856 . . . . 0.0 109.424 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.14 155.85 66.75 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.972 2.448 . . . . 0.0 110.794 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.86 134.98 66.1 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.614 2.876 . . . . 0.0 112.482 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 51.91 13.16 0.23 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.919 1.288 . . . . 0.0 114.173 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.39 13.25 81.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.389 0.54 . . . . 0.0 112.094 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -84.72 159.5 20.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.714 0.757 . . . . 0.0 110.065 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 161.2 42.83 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.11 0.481 . . . . 0.0 111.795 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.25 135.82 53.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.38 165.62 35.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -146.79 166.75 25.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.428 ' HD2' ' H ' ' A' ' 117' ' ' ASP . 2.6 t80 -114.25 162.89 15.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -87.18 -22.12 25.49 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.428 ' H ' ' HD2' ' A' ' 115' ' ' PHE . 21.0 m-20 -132.81 156.8 46.46 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 122.544 0.337 . . . . 0.0 110.524 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.54 -11.34 40.42 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.5 p -85.17 -29.32 24.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.005 0.366 . . . . 0.0 111.754 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.5 t -81.62 -27.52 34.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.45 -33.6 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -86.52 -25.48 25.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.234 -0.291 . . . . 0.0 111.172 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.16 -35.03 42.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.434 0.561 . . . . 0.0 111.22 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 137' ' ' LEU . 1.9 tm? -75.76 -49.33 18.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.916 0.486 . . . . 0.0 109.862 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.9 -28.31 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 122.384 -0.197 . . . . 0.0 110.915 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.39 -21.76 41.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.349 0.522 . . . . 0.0 111.162 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.49 5.97 13.7 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.426 0.29 . . . . 0.0 110.526 174.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HG ' ' A' ' 137' ' ' LEU . 86.3 m -129.68 -172.38 2.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.144 0.977 . . . . 0.0 110.733 -175.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.17 154.03 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.096 0.558 . . . . 0.0 111.053 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -134.99 157.54 46.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.219 0.608 . . . . 0.0 110.968 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.3 tp10 -146.04 152.44 39.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.005 0.922 . . . . 0.0 108.653 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -68.32 -3.5 11.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.1 -0.375 . . . . 0.0 111.308 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -116.43 -21.64 4.69 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.382 -0.677 . . . . 0.0 113.202 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' C ' HD22 ' A' ' 135' ' ' LEU . 12.6 ptpt -169.13 179.79 3.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.318 1.059 . . . . 0.0 110.805 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.5 mm? -110.75 160.76 16.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -141.21 145.29 35.43 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 120.761 0.315 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.23 162.04 20.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.869 0.468 . . . . 0.0 109.946 176.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 70.6 m -122.95 53.05 1.31 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.104 0.561 . . . . 0.0 111.14 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.28 -2.55 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -74.03 140.19 45.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 96.4 p -145.31 172.3 5.51 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.441 0.696 . . . . 0.0 109.259 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.85 -5.05 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.275 3.317 . . . . 0.0 115.186 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p -92.17 -21.26 20.49 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.909 0.777 . . . . 0.0 112.023 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 -25.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 41.88 43.88 2.73 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.063 0.945 . . . . 0.0 111.791 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.56 27.77 0.35 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 75.4 mmtt 62.04 161.36 0.11 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.796 1.238 . . . . 0.0 112.676 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 147' ' ' LYS . 36.8 Cg_endo -59.76 162.83 14.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.802 2.335 . . . . 0.0 110.89 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 m -116.0 147.32 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -78.65 141.4 38.01 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 29.6 mm -138.88 144.24 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 123.474 0.71 . . . . 0.0 109.723 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -148.16 97.95 3.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -85.17 -161.46 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.904 3.736 . . . . 0.0 106.842 169.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 65.1 t-105 -146.52 159.91 42.8 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 119.97 1.259 . . . . 0.0 112.508 169.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -119.75 92.2 3.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.612 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -69.73 6.88 1.0 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.15 0.98 . . . . 0.0 113.0 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.2 m -104.02 -20.74 13.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.119 0.418 . . . . 0.0 111.357 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.48 -16.7 23.12 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.425 0.557 . . . . 0.0 110.635 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 m -43.82 -18.26 0.02 OUTLIER 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 169.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -113.03 121.84 45.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.727 0.694 . . . . 0.0 109.993 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 186' ' ' ALA . 4.5 p90 -119.37 98.35 6.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.113 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.37 152.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.544 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.7 ttt -140.02 -0.19 1.69 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.233 0.213 . . . . 0.0 111.294 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 59.54 169.62 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.891 1.276 . . . . 0.0 112.297 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.32 -164.71 33.01 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 62.8 m -84.42 19.04 2.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.891 0.876 . . . . 0.0 112.739 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.55 152.72 67.04 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.31 -173.49 1.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.146 3.231 . . . . 0.0 110.002 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 45.4 mt -121.35 124.49 44.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.381 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.98 147.69 17.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.034 0.933 . . . . 0.0 108.868 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.4 -19.9 24.01 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.282 2.654 . . . . 0.0 114.037 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -90.55 7.06 41.02 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.365 0.529 . . . . 0.0 111.403 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -125.43 16.56 8.27 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 124.706 1.202 . . . . 0.0 109.603 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.8 m -109.79 153.73 23.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.803 -0.444 . . . . 0.0 109.803 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.16 157.11 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 1.7 t80 -111.12 149.14 31.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.4 129.25 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -114.55 171.76 13.91 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.03 7.84 57.16 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.199 -0.778 . . . . 0.0 113.415 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.76 121.95 86.32 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 118.838 1.319 . . . . 0.0 107.609 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.05 -31.22 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.067 2.511 . . . . 0.0 112.778 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -149.98 167.42 13.04 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 124.271 1.028 . . . . 0.0 108.737 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.61 139.94 29.77 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.832 2.355 . . . . 0.0 110.925 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.4 pt? -144.66 141.88 29.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.895 0.478 . . . . 0.0 110.325 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -93.82 46.8 1.19 Allowed 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.516 0.674 . . . . 0.0 110.172 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 161' ' ' PHE . . . 62.34 14.94 7.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.368 1.467 . . . . 0.0 114.897 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.1 -57.24 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.52 -26.77 62.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.53 -0.272 . . . . 0.0 111.307 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.532 ' C ' HD13 ' A' ' 189' ' ' LEU . 2.8 tm? -74.21 -51.79 14.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.289 1.036 . . . . 0.0 110.865 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.44 -29.29 62.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.856 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -27.94 36.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.46 -45.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.799 0.727 . . . . 0.0 110.968 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.55 -25.14 66.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.995 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -91.0 -17.34 26.46 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -90.03 -5.5 56.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.588 1.085 . . . . 0.0 109.898 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.77 -72.88 0.69 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -110.27 -16.44 13.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.18 50.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 117.845 0.293 . . . . 0.0 112.708 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.78 137.62 0.82 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.75 0.691 . . . . 0.0 111.634 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.84 156.25 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.603 1.161 . . . . 0.0 108.512 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 43.1 t -153.37 -50.93 0.1 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.136 0.425 . . . . 0.0 110.888 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -149.09 140.44 23.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.33 171.07 17.82 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.074 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -172.36 163.13 35.21 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.4 pp -88.99 155.27 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 117.769 0.784 . . . . 0.0 110.104 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -78.0 142.44 38.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 p -140.04 163.33 33.0 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.022 0.915 . . . . 0.0 112.437 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -88.27 123.76 67.82 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.934 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.09 -8.17 22.37 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.851 2.367 . . . . 0.0 111.176 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.79 -44.52 9.92 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.943 0.497 . . . . 0.0 111.372 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.3 -8.45 27.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 52.33 32.53 11.18 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -169.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.8 t80 -121.52 150.12 54.11 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 124.273 1.029 . . . . 0.0 109.707 -172.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 81.9 Cg_exo -49.35 137.98 30.63 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.171 2.581 . . . . 0.0 112.301 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -121.79 8.36 9.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.583 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.27 164.18 37.26 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.39 176.48 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.487 1.115 . . . . 0.0 113.255 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -163.72 -174.18 33.25 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -153.27 159.93 42.66 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.031 0.443 . . . . 0.0 111.822 -175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.31 149.17 14.67 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.051 0 C-N-CA 123.977 0.911 . . . . 0.0 108.74 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.81 113.83 13.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.23 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.9 28.35 0.22 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.373 0.669 . . . . 0.0 110.473 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.509 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 27.9 m -71.28 73.86 0.69 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.001 0.92 . . . . 0.0 111.928 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.51 -3.53 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -145.36 163.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.042 0.449 . . . . 0.0 110.711 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -61.37 -10.21 6.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.15 -0.344 . . . . 0.0 110.591 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.1 m -67.75 -41.79 82.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.832 -0.543 . . . . 0.0 109.714 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -73.44 -31.66 63.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.17 -33.15 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.54 -22.09 38.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.85 -1.64 31.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.613 0.642 . . . . 0.0 112.639 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.17 -21.77 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.5 0.591 . . . . 0.0 110.928 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.7 m -88.82 -6.03 57.64 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 170.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.61 69.59 0.93 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.84 3.19 8.55 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.881 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -136.32 138.22 41.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.82 161.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -84.2 -77.76 0.26 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.303 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 56.2 mt 59.62 163.81 0.05 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.777 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -138.64 127.26 23.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -163.47 142.89 8.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.538 0.735 . . . . 0.0 109.02 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.6 -132.97 52.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.61 10.72 35.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.179 0.592 . . . . 0.0 111.534 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.34 147.18 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.097 0.559 . . . . 0.0 110.523 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -125.37 -8.5 6.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.981 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 167.86 22.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.598 0.359 . . . . 0.0 111.709 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 56.01 117.6 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.634 1.974 . . . . 0.0 115.373 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.98 166.37 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.638 169.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -132.83 137.99 46.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 121.235 -0.186 . . . . 0.0 110.976 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.96 125.42 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.479 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.95 161.22 29.27 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 41.9 Cg_endo -61.25 156.4 45.83 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.606 2.204 . . . . 0.0 112.323 -174.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -74.12 162.04 29.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.899 0.879 . . . . 0.0 111.656 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.89 -176.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.12 12.22 3.58 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.537 0.735 . . . . 0.0 111.081 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -143.09 150.8 40.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.226 0.61 . . . . 0.0 109.926 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -139.74 8.65 2.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.266 0.626 . . . . 0.0 111.343 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 4.64 90.13 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.59 165.4 20.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 117.397 0.599 . . . . 0.0 110.63 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.03 18.49 3.16 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.08 0.952 . . . . 0.0 113.419 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.9 t -136.46 144.95 31.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.147 0.579 . . . . 0.0 109.723 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -130.21 169.52 15.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.668 0.787 . . . . 0.0 109.781 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.553 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -134.18 146.04 49.79 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.348 -178.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -134.57 162.66 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.7 t -72.4 129.61 38.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 171.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -65.93 -3.04 4.52 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 125.73 1.894 . . . . 0.0 112.466 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -77.44 111.85 13.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.46 148.18 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.393 0.616 . . . . 0.0 110.049 -172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -108.11 149.8 28.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.283 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 72' ' ' LEU . 56.5 t -136.37 146.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.04 -6.29 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 120.063 -0.298 . . . . 0.0 112.382 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.26 20.29 44.46 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.578 -0.568 . . . . 0.0 112.481 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.483 HD21 HG11 ' A' ' 69' ' ' VAL . 81.4 mt -59.45 144.97 83.37 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 117.882 0.841 . . . . 0.0 110.904 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.21 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.965 3.11 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.46 154.92 38.71 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.464 2.776 . . . . 0.0 111.851 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.63 27.42 5.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.121 0.968 . . . . 0.0 112.919 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.36 144.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.28 0.562 . . . . 0.0 111.316 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.29 171.28 14.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -57.74 -21.27 40.25 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.21 -21.54 27.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.281 0.946 . . . . 0.0 111.283 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -75.15 -42.66 55.64 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.72 -28.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.1 m -68.29 -27.83 66.65 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.07 -13.42 41.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.645 0.378 . . . . 0.0 111.264 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.6 m -79.91 -30.85 40.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.749 0.25 . . . . 0.0 110.816 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -106.29 63.9 0.66 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.031 -0.418 . . . . 0.0 111.752 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.93 1.55 3.33 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.566 0.346 . . . . 0.0 111.661 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtm-85 -115.84 6.05 14.22 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.722 0.809 . . . . 0.0 111.963 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.469 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 2.4 m-85 -109.87 -9.08 14.81 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.729 0.412 . . . . 0.0 111.008 174.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.71 -159.85 45.25 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.1 141.51 79.55 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.777 2.985 . . . . 0.0 111.31 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.08 170.15 21.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.836 0.351 . . . . 0.0 111.936 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.6 mm -120.23 143.97 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.88 153.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.564 0.346 . . . . 0.0 110.629 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -155.0 145.96 22.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.339 0.59 . . . . 0.0 111.836 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -152.08 148.12 20.89 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 124.544 1.137 . . . . 0.0 108.092 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.49 -0.43 5.88 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.672 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -76.47 -6.26 50.99 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.434 0.561 . . . . 0.0 111.3 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 7.93 6.73 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.196 0.598 . . . . 0.0 112.223 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.18 4.3 8.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.245 0.618 . . . . 0.0 112.496 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.76 164.43 27.57 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.046 0.538 . . . . 0.0 110.779 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.7 p -84.65 9.76 12.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -171.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -140.81 154.4 46.22 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 118.464 0.574 . . . . 0.0 111.481 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.8 p 56.39 165.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.177 1.791 . . . . 0.0 113.598 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -142.64 15.12 1.97 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.955 0.502 . . . . 0.0 111.301 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.71 143.57 84.87 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 122.735 0.414 . . . . 0.0 110.612 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 153.55 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.419 2.746 . . . . 0.0 111.982 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.95 -24.72 14.9 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.389 2.726 . . . . 0.0 112.563 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -155.29 18.54 0.42 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.66 -1.47 88.82 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.593 -0.56 . . . . 0.0 112.268 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -95.13 154.63 17.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.895 0.847 . . . . 0.0 109.646 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.07 156.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.874 0.368 . . . . 0.0 111.749 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 133.01 50.84 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 81' ' ' ILE . 3.2 pp -159.29 166.48 31.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.941 0.4 . . . . 0.0 111.968 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.75 154.46 34.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.469 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 6.3 p90 -120.09 167.45 12.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.088 0.47 . . . . 0.0 111.504 -173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -74.54 -20.72 59.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.43 133.2 54.64 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.587 1.085 . . . . 0.0 112.013 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -87.42 -15.1 38.74 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -81.22 -24.31 37.5 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.5 m -72.84 -17.63 61.53 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.51 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.33 -41.44 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.92 -34.32 20.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -172.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.11 78.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.16 -0.337 . . . . 0.0 111.892 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.2 tm? -82.26 -45.43 15.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 71.8 mt -66.7 -22.22 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.51 -22.25 17.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.863 -0.523 . . . . 0.0 112.408 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -87.3 6.27 34.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.4 m -126.56 177.7 6.34 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.932 0.493 . . . . 0.0 111.251 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 80.1 mt -75.07 147.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -143.57 163.97 31.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.351 0.596 . . . . 0.0 112.345 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.17 159.95 42.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.651 1.18 . . . . 0.0 108.318 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.03 -10.38 13.83 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 122.213 -0.304 . . . . 0.0 111.362 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -21.54 5.64 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.776 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -177.26 5.39 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.386 1.093 . . . . 0.0 111.885 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.6 tp -125.47 154.89 41.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.782 1.233 . . . . 0.0 109.28 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.55 133.43 36.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.029 0.442 . . . . 0.0 110.275 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.12 143.12 33.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.518 0.727 . . . . 0.0 110.579 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.1 25.46 6.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.722 0.809 . . . . 0.0 112.152 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.31 -12.11 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.19 0.596 . . . . 0.0 111.359 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 79.5 p -87.0 50.57 2.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.519 0.728 . . . . 0.0 110.9 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.2 t -158.02 -45.95 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 141' ' ' SER . 33.2 Cg_exo -61.65 -43.1 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.991 2.461 . . . . 0.0 114.959 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -140.06 0.49 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.819 0.448 . . . . 0.0 111.742 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.63 156.23 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 119.65 11.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.188 0.449 . . . . 0.0 110.565 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 140' ' ' SER . 21.0 t0 -151.87 -92.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.52 0.728 . . . . 0.0 109.04 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -141.92 150.33 55.95 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 123.477 0.711 . . . . 0.0 109.432 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.43 156.58 21.2 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.605 2.87 . . . . 0.0 112.118 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.483 ' CG1' HG13 ' A' ' 69' ' ' VAL . 60.4 t -92.66 126.79 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -80.02 132.0 35.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.7 mt -139.99 152.63 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 122.659 0.384 . . . . 0.0 111.085 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -147.29 110.79 3.99 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.061 0.544 . . . . 0.0 110.284 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -81.33 -165.9 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.374 3.382 . . . . 0.0 107.589 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 77.0 t-105 -127.55 145.09 50.97 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 120.075 1.307 . . . . 0.0 113.331 169.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.34 56.5 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.467 1.107 . . . . 0.0 111.346 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.07 -11.99 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.0 m -108.83 11.39 26.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.477 0.58 . . . . 0.0 111.747 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -127.95 -24.97 3.12 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.67 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.6 m -51.24 -17.68 0.75 Allowed 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.24 119.38 33.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.495 0.589 . . . . 0.0 110.248 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' ALA . 11.4 m-85 -120.64 100.76 7.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.306 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 81.3 t -93.69 146.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 44.6 ttm -138.37 -3.46 1.73 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.118 0.167 . . . . 0.0 111.37 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.18 160.61 43.21 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.991 -0.443 . . . . 0.0 110.562 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -136.07 11.0 4.18 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 119.865 -0.409 . . . . 0.0 112.324 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.5 m -87.08 -11.19 50.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.783 0.792 . . . . 0.0 111.742 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -150.87 129.24 6.0 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.66 169.9 19.02 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.035 3.157 . . . . 0.0 111.617 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.85 134.48 47.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -153.63 144.37 15.96 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.37 -21.87 46.97 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.575 2.85 . . . . 0.0 114.213 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -1.31 57.46 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.333 0.515 . . . . 0.0 110.803 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.79 2.59 9.46 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.753 0.821 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 42.6 m -99.21 154.86 17.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.509 0.324 . . . . 0.0 110.277 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.99 150.07 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.21 142.2 31.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.7 107.95 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.15 165.95 20.91 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.324 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.91 -0.94 80.05 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.503 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.28 131.85 77.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.705 1.253 . . . . 0.0 110.085 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.03 176.87 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.38 3.387 . . . . 0.0 113.017 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 76.3 mtp85 -105.96 -39.83 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.017 -0.992 . . . . 0.0 113.596 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 52.4 Cg_endo -79.62 59.64 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.908 2.406 . . . . 0.0 110.857 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 -170.34 3.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.652 0.781 . . . . 0.0 111.447 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 187' ' ' VAL . 72.3 mtp180 -129.55 171.95 12.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.23 1.412 . . . . 0.0 107.794 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 161' ' ' PHE . . . -68.4 8.96 0.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.171 -0.331 . . . . 0.0 111.222 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 185' ' ' ARG . 79.3 t -63.29 -46.94 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.158 0.583 . . . . 0.0 112.159 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -70.58 -26.35 63.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.425 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 189' ' ' LEU . 3.5 tt -80.3 -49.95 10.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.625 0.77 . . . . 0.0 110.159 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.04 -26.13 61.19 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.957 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -80.4 -39.27 28.65 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.352 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.95 -40.88 86.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 119.322 0.965 . . . . 0.0 110.204 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -67.31 -28.0 67.63 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.967 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.32 -10.72 58.98 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -92.14 -20.32 21.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.572 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -125.16 -36.27 2.54 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.592 ' H ' HD12 ' A' ' 196' ' ' LEU . 32.4 m-85 -144.59 67.4 1.25 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.343 0.974 . . . . 0.0 109.769 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.91 -174.59 8.13 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.65 0.643 . . . . 0.0 113.05 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 104.66 16.98 15.9 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.29 153.09 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.266 0.626 . . . . 0.0 111.4 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.7 m -119.4 -37.47 3.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -150.01 150.21 31.45 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -155.7 153.51 30.08 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.73 0.412 . . . . 0.0 111.31 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -169.79 172.28 43.65 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 1.6 pp -127.27 135.71 62.68 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 47.22 -0.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.31 157.38 31.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.548 1.522 . . . . 0.0 114.456 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -145.9 138.38 13.74 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.74 -2.8 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.209 3.273 . . . . 0.0 112.717 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.83 -47.76 83.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.409 0.549 . . . . 0.0 109.987 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.75 17.52 0.45 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.986 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 66.9 44.22 2.09 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.327 0.651 . . . . 0.0 109.876 175.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 63.5 t80 -124.25 146.3 51.27 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.08 -173.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 79.6 Cg_exo -53.74 111.84 0.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.166 3.244 . . . . 0.0 113.602 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -104.37 -23.77 13.16 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.812 0.845 . . . . 0.0 110.193 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 141.51 147.71 4.93 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.374 0.511 . . . . 0.0 112.33 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 131.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.871 2.068 . . . . 0.0 115.913 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -81.38 174.87 54.5 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.717 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -152.69 157.7 41.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.052 0.453 . . . . 0.0 110.951 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.88 150.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.93 113.27 11.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.855 0.298 . . . . 0.0 110.408 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -165.87 28.61 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.066 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.477 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 20.0 m -70.08 80.55 0.5 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.714 0.406 . . . . 0.0 111.254 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -7.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -146.53 174.32 11.52 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.785 0.803 . . . . 0.0 111.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.55 -12.71 47.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.917 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 49.8 m -69.31 -36.73 77.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.606 -0.684 . . . . 0.0 109.471 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -71.77 -35.29 70.02 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.7 -35.46 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -78.2 -23.36 47.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.45 -15.68 17.83 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 119.0 0.818 . . . . 0.0 112.405 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.5 tt -91.44 -18.49 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 118.617 0.644 . . . . 0.0 110.446 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.9 m -99.7 -8.65 24.05 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 122.344 0.257 . . . . 0.0 110.637 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.36 63.17 1.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -62.34 -14.6 41.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -138.59 141.48 39.19 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 t -154.42 156.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -171.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.61 107.74 7.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.8 mt -149.27 165.48 31.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.547 1.139 . . . . 0.0 109.72 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.95 131.57 27.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -157.84 131.93 8.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.82 -136.16 48.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -92.87 15.48 14.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 110.806 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.55 149.2 12.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.768 0.827 . . . . 0.0 110.088 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -140.97 157.65 45.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.42 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.8 pttt 49.5 8.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.121 2.169 . . . . 0.0 116.768 173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -144.72 146.2 32.08 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.673 1.124 . . . . 0.0 113.2 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 30.8 m -149.06 177.72 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.141 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -134.24 130.46 37.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 t -144.0 129.38 15.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -153.22 166.39 15.63 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 122.81 0.444 . . . . 0.0 109.945 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.96 153.31 32.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.107 2.538 . . . . 0.0 111.666 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -78.16 152.85 32.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.797 -178.464 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.403 0.144 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 t60 51.87 31.29 8.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 112.354 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -78.07 -15.69 58.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.572 0.349 . . . . 0.0 111.282 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -84.04 128.88 34.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.1 6.97 4.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -89.69 17.1 6.86 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.501 0.72 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.18 163.66 26.17 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.473 0.709 . . . . 0.0 111.628 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.25 178.15 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.067 0 C-N-CA 123.754 0.822 . . . . 0.0 109.77 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.34 17.32 7.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.336 0.654 . . . . 0.0 111.097 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.02 9.7 20.41 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -104.98 155.08 19.29 Favored 'General case' 0 C--N 1.337 0.049 0 CA-C-N 118.452 0.569 . . . . 0.0 109.729 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 156' ' ' LEU . 23.5 p -96.32 142.8 28.02 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -82.71 0.07 45.12 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 125.487 1.742 . . . . 0.0 113.519 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.66 112.69 9.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.92 127.75 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.809 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -88.1 147.37 24.97 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -122.65 130.65 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -109.14 -2.2 31.57 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.178 0.418 . . . . 0.0 112.128 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.11 126.25 3.97 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.5 mt -147.79 153.79 43.11 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 124.489 1.116 . . . . 0.0 108.252 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.39 156.42 21.62 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.347 2.698 . . . . 0.0 112.521 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -59.04 -20.39 53.43 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.873 3.049 . . . . 0.0 112.667 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.09 113.14 10.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.8 145.84 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 121.421 0.629 . . . . 0.0 112.015 -171.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.3 t70 -147.69 168.24 22.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.714 1.605 . . . . 0.0 106.809 172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -45.73 -38.56 7.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.84 -26.36 59.65 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.488 0.585 . . . . 0.0 111.316 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 12.4 tp10 -75.55 -45.55 37.26 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.76 -29.6 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.257 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.6 m -70.8 -28.3 64.54 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.94 -17.98 26.94 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.1 m -78.3 -31.5 48.89 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.116 0.417 . . . . 0.0 111.706 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -76.43 166.26 23.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 110.826 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -122.25 150.27 42.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.081 0.953 . . . . 0.0 108.737 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 55.45 14.6 1.19 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.621 0.768 . . . . 0.0 111.933 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -121.07 94.67 4.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.638 1.175 . . . . 0.0 108.58 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.61 -141.84 2.01 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.84 129.93 25.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.217 2.612 . . . . 0.0 111.821 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.03 169.95 22.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 109.11 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.1 mt -123.49 145.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -124.61 160.86 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.493 0.717 . . . . 0.0 110.612 -175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -144.26 131.96 21.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.363 0.601 . . . . 0.0 111.307 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.412 ' CD2' ' HB3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -165.79 157.46 12.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.635 1.174 . . . . 0.0 109.108 175.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.08 -6.45 6.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 124.36 3.373 . . . . 0.0 114.807 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -100.19 7.58 44.42 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -134.67 4.19 3.32 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.202 0.601 . . . . 0.0 111.061 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.48 32.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.584 0.354 . . . . 0.0 110.536 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 53.59 12.57 0.39 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.698 1.199 . . . . 0.0 113.409 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.9 t -158.73 171.02 20.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.527 0.731 . . . . 0.0 109.709 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.39 149.04 50.67 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.0 m -66.96 129.93 41.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.096 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -156.58 179.45 9.25 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.871 0.869 . . . . 0.0 109.005 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -74.26 146.22 84.04 Favored Pre-proline 0 CA--C 1.532 0.28 0 O-C-N 122.135 -0.353 . . . . 0.0 110.482 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 95' ' ' TRP . 82.3 Cg_endo -70.96 171.99 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.549 3.499 . . . . 0.0 111.667 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.36 155.85 28.44 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.512 2.808 . . . . 0.0 111.177 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.23 129.53 34.56 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.28 -4.91 23.18 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.61 -1.105 . . . . 0.0 115.299 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.04 144.73 38.95 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.657 1.729 . . . . 0.0 112.422 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.56 170.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.58 0.752 . . . . 0.0 111.112 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.32 141.89 51.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 81' ' ' ILE . 4.2 pp -158.14 172.93 17.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 122.118 -0.364 . . . . 0.0 111.284 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.04 169.92 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -115.66 157.44 24.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.043 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.3 -15.5 61.4 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.296 -0.253 . . . . 0.0 111.659 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -129.17 137.86 51.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.53 -10.56 51.34 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.4 p -88.65 -25.79 22.22 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.21 -0.306 . . . . 0.0 110.875 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.4 t -73.73 -22.58 59.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.63 -32.22 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -87.41 -37.17 17.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.815 -0.553 . . . . 0.0 110.959 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.45 -32.67 74.19 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.295 0.498 . . . . 0.0 111.581 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -86.17 -42.88 13.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.233 -0.292 . . . . 0.0 110.296 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.92 -13.54 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 122.472 -0.142 . . . . 0.0 110.664 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -98.55 -23.85 15.35 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.496 -0.753 . . . . 0.0 111.269 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 26.97 1.44 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.198 0.599 . . . . 0.0 111.658 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 29.0 p -139.78 -174.48 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.834 0.454 . . . . 0.0 111.649 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.6 mt -72.05 151.57 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.699 0.8 . . . . 0.0 109.905 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -139.77 158.8 43.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.351 0.596 . . . . 0.0 112.105 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -145.48 154.86 42.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.759 1.224 . . . . 0.0 108.097 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.38 -5.01 9.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.111 -0.368 . . . . 0.0 111.282 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.99 -25.81 4.64 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.346 -0.696 . . . . 0.0 113.252 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -169.12 177.92 4.64 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.397 1.098 . . . . 0.0 110.641 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.69 159.77 18.58 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -137.83 136.83 37.55 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 38.9 mt -101.66 148.7 24.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.192 0.597 . . . . 0.0 109.487 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.48 129.33 44.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -151.1 4.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.371 0.668 . . . . 0.0 110.242 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 p -97.77 44.39 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.186 0.994 . . . . 0.0 111.14 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.726 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 84.9 p -168.1 -31.17 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.726 ' HD2' ' H ' ' A' ' 141' ' ' SER . 62.8 Cg_endo -80.59 -23.4 5.93 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.818 1.685 . . . . 0.0 112.727 -171.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.8 m -146.91 -28.56 0.38 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 144' ' ' ILE . 2.5 pp -134.88 177.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.577 0.751 . . . . 0.0 109.313 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 114.64 8.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -152.1 -88.44 0.06 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -153.46 158.92 32.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 123.608 0.763 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.72 178.96 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.638 2.892 . . . . 0.0 110.786 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 25.6 m -126.67 140.5 48.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.424 ' O ' HD12 ' A' ' 151' ' ' ILE . 55.4 tt0 -80.82 137.39 36.21 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.019 0.528 . . . . 0.0 110.474 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 150' ' ' GLN . 1.1 mp -131.44 146.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.047 0.939 . . . . 0.0 109.184 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -148.77 100.54 3.48 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.92 -169.7 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.758 3.639 . . . . 0.0 107.29 169.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -136.19 152.99 51.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.684 1.584 . . . . 0.0 113.162 171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -108.91 77.08 1.05 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.86 1.264 . . . . 0.0 110.185 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.927 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -66.68 5.4 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.923 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.0 p -93.28 -14.5 26.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -103.11 -20.4 14.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.52 0.328 . . . . 0.0 110.983 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.1 m -40.25 -27.76 0.05 OUTLIER 'General case' 0 C--N 1.34 0.187 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 171.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.92 121.36 38.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 24.2 p90 -120.35 110.17 16.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.386 0.612 . . . . 0.0 110.641 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.5 t -90.72 151.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.032 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.8 tpt -111.51 -35.88 5.67 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.054 0.142 . . . . 0.0 111.12 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.56 29.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.571 0.348 . . . . 0.0 110.827 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.47 17.31 18.82 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.892 0.758 . . . . 0.0 111.351 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.5 m -82.27 -4.07 56.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.466 0.706 . . . . 0.0 112.678 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -149.36 133.8 9.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.09 173.9 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.405 3.403 . . . . 0.0 113.029 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.2 mt -129.61 146.48 51.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.346 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -153.48 147.2 18.41 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.538 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.32 -23.35 45.79 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.381 2.721 . . . . 0.0 113.779 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.84 0.74 55.41 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.177 0.444 . . . . 0.0 111.162 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.15 17.59 11.59 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.75 1.22 . . . . 0.0 109.998 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.3 m -106.37 154.66 20.48 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mt -131.33 157.23 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -111.83 151.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.87 120.32 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.27 146.09 17.55 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.69 81.2 0.88 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.69 60.91 9.0 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.197 0.999 . . . . 0.0 108.858 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.03 157.79 59.99 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.755 2.97 . . . . 0.0 111.854 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.08 154.56 0.11 Allowed Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.712 1.605 . . . . 0.0 112.64 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 133.13 27.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.795 2.33 . . . . 0.0 110.044 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 186' ' ' ALA . 3.5 pp -158.45 152.8 24.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.78 0.432 . . . . 0.0 110.454 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.89 36.69 0.51 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.637 0.775 . . . . 0.0 112.001 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.509 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 57.1 18.15 3.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.925 0.89 . . . . 0.0 112.931 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.88 -48.62 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.71 -30.78 64.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.69 -29.12 30.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.39 0.541 . . . . 0.0 110.758 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.56 28.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -25.94 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.657 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.07 -46.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.634 0.652 . . . . 0.0 110.273 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -69.44 -18.11 63.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.648 -0.657 . . . . 0.0 110.245 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.7 t70 -91.52 -24.43 19.64 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -81.37 -16.92 50.79 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.141 0.882 . . . . 0.0 112.465 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -123.43 -27.69 4.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 196' ' ' LEU . 25.1 m-85 -141.35 44.91 1.75 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.09 . . . . 0.0 110.157 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -66.71 165.85 40.4 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 123.518 0.58 . . . . 0.0 114.115 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.59 1.17 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.127 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.6 p -55.55 146.83 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.878 0.839 . . . . 0.0 112.108 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.3 t -125.6 -41.36 2.01 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.363 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -149.84 133.12 16.44 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -164.01 173.09 12.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 174.73 168.02 34.86 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.37 152.9 3.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.912 0.856 . . . . 0.0 110.786 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -83.53 151.05 25.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.382 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -133.47 154.42 50.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.916 0.865 . . . . 0.0 111.877 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -73.31 126.4 90.15 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.52 -6.17 18.37 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.97 2.446 . . . . 0.0 111.347 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -97.46 -36.98 10.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.101 0.561 . . . . 0.0 111.625 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.88 -9.21 19.13 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 51.41 32.91 9.21 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.403 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.0 t80 -126.68 149.5 68.48 Favored Pre-proline 0 N--CA 1.464 0.252 0 C-N-CA 123.634 0.773 . . . . 0.0 110.622 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 75.0 Cg_exo -52.93 143.72 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.676 2.917 . . . . 0.0 112.367 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.06 29.33 1.48 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.15 16.04 48.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -140.14 163.8 31.77 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.286 1.543 . . . . 0.0 111.553 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -159.22 -179.03 33.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.37 159.52 43.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.92 0.39 . . . . 0.0 111.449 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -151.02 148.49 14.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.32 122.19 14.46 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.446 0.566 . . . . 0.0 111.471 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -166.68 34.99 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.822 0.849 . . . . 0.0 110.278 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.543 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 49.4 m -69.11 76.9 0.34 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.042 0.537 . . . . 0.0 111.545 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 -3.06 0.32 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -146.75 160.03 42.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.082 0.467 . . . . 0.0 111.157 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.447 ' HA ' HG13 ' A' ' 229' ' ' ILE . 68.5 tp60 -52.11 -24.71 7.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.11 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.8 m -74.1 -28.71 61.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.693 -0.63 . . . . 0.0 110.358 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.33 -33.76 73.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 226' ' ' GLN . 2.0 mt -69.35 -33.01 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.7 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.386 -0.34 . . . . 0.0 111.865 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.56 -16.53 27.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.494 0.588 . . . . 0.0 112.032 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.8 tt -87.38 -17.57 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.961 0.8 . . . . 0.0 109.159 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -87.0 -4.84 59.21 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -86.81 46.83 1.41 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -64.45 -23.7 67.37 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.552 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -152.67 119.98 5.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 70.0 t -148.93 158.97 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.145 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -99.49 116.39 31.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 110.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.2 mt -151.75 162.15 41.48 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.885 1.274 . . . . 0.0 108.756 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.17 125.09 52.67 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -161.9 141.82 10.13 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 53.86 -138.68 37.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.18 12.59 17.53 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.131 0.572 . . . . 0.0 110.798 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.58 149.74 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.938 0.895 . . . . 0.0 109.314 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.86 -5.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -150.84 5.55 0.5 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -147.24 133.69 19.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.032 0.833 . . . . 0.0 112.592 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.69 151.91 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 170.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -128.18 136.25 50.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.26 116.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 252' ' ' PRO . 46.1 mtmt -145.93 162.16 36.83 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.837 -170.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 251' ' ' LYS . 37.9 Cg_endo -60.4 151.07 77.22 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.564 2.176 . . . . 0.0 111.871 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -77.56 156.06 31.14 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.656 0.782 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.321 -179.674 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.513 0.197 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -75.17 -0.3 18.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.96 0.504 . . . . 0.0 111.944 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -85.23 5.87 28.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.051 0.541 . . . . 0.0 111.315 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -77.97 -6.65 55.1 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.087 0.555 . . . . 0.0 112.073 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 59' ' ' ARG . . . 67.77 -164.85 45.56 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 61.59 -12.55 0.05 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.868 1.667 . . . . 0.0 113.953 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 57' ' ' GLY . 34.6 mtp-105 57.24 171.97 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.258 1.423 . . . . 0.0 113.355 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.26 138.19 26.38 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.39 140.08 19.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -149.4 -6.2 0.36 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.028 0.931 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -122.76 156.38 34.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -92.64 143.14 26.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.7 1.22 35.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 124.75 1.281 . . . . 0.0 113.29 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -75.56 108.75 8.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.1 123.73 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -88.02 147.13 25.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.4 149.25 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.77 -6.99 0.9 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.804 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.84 10.08 66.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 117.659 0.729 . . . . 0.0 113.403 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -51.38 138.95 27.93 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 118.356 1.078 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.99 159.98 8.66 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.402 2.735 . . . . 0.0 112.382 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.4 153.81 45.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.426 2.751 . . . . 0.0 111.723 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 49.31 39.36 15.82 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.555 0.742 . . . . 0.0 112.356 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.14 143.07 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.89 0.852 . . . . 0.0 112.212 -176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.96 161.51 35.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.45 -23.4 15.87 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.3 -25.98 33.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.441 0.564 . . . . 0.0 111.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.1 -42.65 56.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.864 0.466 . . . . 0.0 109.9 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.2 -28.86 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -178.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.5 m -69.87 -30.55 68.03 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.92 -12.44 50.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.411 0.284 . . . . 0.0 111.217 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.8 m -78.34 -56.68 4.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.699 0.227 . . . . 0.0 110.443 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -70.24 -45.68 65.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 50.24 16.66 0.27 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.295 1.438 . . . . 0.0 113.84 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.19 -3.0 1.6 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.211 0.604 . . . . 0.0 112.131 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 2.7 m-85 -96.49 1.14 51.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.68 0.392 . . . . 0.0 112.008 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.29 -151.18 46.52 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 140.0 45.06 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.226 2.617 . . . . 0.0 109.753 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.0 mt -121.07 166.54 13.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.957 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.5 mt -134.15 137.87 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -138.7 162.1 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.029 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -147.1 137.42 23.43 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.001 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -106.22 155.1 39.16 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.794 0.437 . . . . 0.0 110.893 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.72 -18.48 32.46 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.216 2.611 . . . . 0.0 110.737 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -154.7 151.16 28.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.2 1.0 . . . . 0.0 108.494 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.04 172.44 14.24 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.12 167.07 22.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.886 0.875 . . . . 0.0 109.381 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.92 4.8 21.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.751 0.42 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.8 t -151.06 159.4 44.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.312 0.645 . . . . 0.0 110.044 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -83.29 9.6 10.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.86 0.464 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.1 m -76.64 5.22 7.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.933 0.493 . . . . 0.0 111.243 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -140.25 161.22 38.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -137.78 156.01 74.68 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.376 0.67 . . . . 0.0 110.119 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.23 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.922 2.415 . . . . 0.0 110.705 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.65 -8.25 19.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 124.068 3.179 . . . . 0.0 112.744 -174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 110' ' ' TYR . 20.0 ptmt -148.94 161.38 42.01 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 118.084 0.402 . . . . 0.0 111.269 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.74 5.73 64.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.762 0.696 . . . . 0.0 113.375 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.441 ' CG ' ' HE2' ' A' ' 108' ' ' LYS . 5.5 m-30 -83.65 140.5 32.14 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.242 1.021 . . . . 0.0 110.071 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.57 164.14 36.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -126.92 133.05 50.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -153.68 163.96 39.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.116 0.484 . . . . 0.0 111.799 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.14 173.32 14.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 176.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 5.3 p90 -142.91 164.8 29.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.918 0.39 . . . . 0.0 111.066 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -82.43 -13.53 56.63 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.7 103.32 12.94 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.677 0.671 . . . . 0.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.67 -16.71 61.69 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.8 m -73.56 -19.78 60.8 Favored 'General case' 0 C--O 1.23 0.073 0 O-C-N 121.626 -0.672 . . . . 0.0 109.73 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 t -85.27 -18.84 32.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.01 -49.49 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -80.41 -34.58 36.13 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 122.365 -0.209 . . . . 0.0 110.594 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.39 76.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.1 tm? -83.7 -42.06 17.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.3 -0.25 . . . . 0.0 110.734 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.69 -31.13 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.069 0.395 . . . . 0.0 109.939 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.18 -21.9 27.27 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 122.113 -0.367 . . . . 0.0 111.872 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.73 7.34 23.98 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.9 m -131.46 -174.43 3.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 78.4 mt -75.16 148.78 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.806 0.336 . . . . 0.0 110.55 -173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.85 161.31 40.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 112.364 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -149.86 158.18 43.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.883 1.273 . . . . 0.0 108.555 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.59 -14.28 57.07 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.975 -0.453 . . . . 0.0 111.326 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.45 -20.62 8.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.629 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -168.85 174.41 6.51 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.412 1.106 . . . . 0.0 111.11 -175.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.7 mm? -118.56 162.24 18.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.667 0.787 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -144.16 147.48 33.73 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.013 0.435 . . . . 0.0 110.969 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.31 155.25 35.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.359 0.664 . . . . 0.0 110.387 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 68.8 m -110.86 41.58 1.78 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.577 0.751 . . . . 0.0 111.32 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.38 -1.52 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 57.1 p -93.07 66.46 4.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.321 0.648 . . . . 0.0 109.307 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.786 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 70.3 m -153.8 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.786 ' HD2' ' H ' ' A' ' 141' ' ' SER . 39.0 Cg_endo -82.44 -132.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.078 2.518 . . . . 0.0 110.267 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 142' ' ' PRO . 40.9 p -66.19 1.54 1.5 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.521 0.728 . . . . 0.0 112.424 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.43 142.84 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -141.17 127.2 19.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.006 0.522 . . . . 0.0 109.721 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 140' ' ' SER . 35.7 t70 -158.79 -78.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.49 0.316 . . . . 0.0 110.6 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -159.09 148.15 14.41 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.629 0.772 . . . . 0.0 109.26 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.78 161.19 3.28 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.351 2.701 . . . . 0.0 111.902 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.9 147.51 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.03 0 C-N-CA 122.124 0.169 . . . . 0.0 111.334 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -86.8 146.95 26.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 27.6 mm -137.92 144.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.383 0.673 . . . . 0.0 110.249 -172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -146.03 100.27 4.25 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 122.533 0.333 . . . . 0.0 111.44 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -85.27 -158.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 125.243 3.962 . . . . 0.0 107.441 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 155' ' ' ASN . 65.3 t-105 -128.18 158.03 39.19 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 110.992 168.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.434 ' N ' ' CG ' ' A' ' 154' ' ' TRP . 16.5 m-80 -111.39 105.43 14.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 109.814 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 1.4 mp -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.763 0.825 . . . . 0.0 110.729 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -84.69 -26.75 27.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.215 -174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -87.45 -14.8 39.5 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.783 0.719 . . . . 0.0 111.585 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -48.22 -25.91 1.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.079 0.152 . . . . 0.0 111.06 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -151.99 56.13 0.84 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.05 0.94 . . . . 0.0 109.82 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.22 136.71 56.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 111.267 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.04 139.21 26.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.9 ttt -113.03 -21.92 10.84 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.416 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -151.66 -29.39 0.17 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.058 0.39 . . . . 0.0 111.699 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.43 58.13 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.794 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.7 t -75.52 -13.22 60.35 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.834 0.817 . . . . 0.0 112.754 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -120.58 150.49 52.41 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -169.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.4 167.01 28.39 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.217 3.278 . . . . 0.0 111.518 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.87 16.32 23.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.588 0.755 . . . . 0.0 111.279 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 14.3 t70 -67.97 142.28 95.21 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 75.0 Cg_exo -53.44 -18.89 12.05 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.508 2.805 . . . . 0.0 114.305 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -72.56 -15.26 61.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.356 0.525 . . . . 0.0 111.441 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 10.3 mmpt? -127.36 -8.47 5.79 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.352 0.661 . . . . 0.0 111.805 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 41.0 m -89.21 153.28 21.05 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.893 0.378 . . . . 0.0 110.205 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 60.7 mt -134.06 154.62 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.08 145.7 36.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.36 111.75 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.37 129.86 10.04 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 153.01 -5.77 0.41 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.431 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.8 m -91.48 144.43 29.62 Favored Pre-proline 0 CA--C 1.528 0.126 0 CA-C-N 119.031 1.416 . . . . 0.0 109.594 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 27.5 Cg_endo -82.58 -172.36 1.4 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.936 3.091 . . . . 0.0 109.516 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 99.5 mtt180 -76.73 -36.43 1.66 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 91.4 Cg_endo -76.63 -166.34 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.73 2.287 . . . . 0.0 111.394 177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER 50.24 146.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 129.192 2.997 . . . . 0.0 116.357 -177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -88.32 66.5 8.4 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.925 0.89 . . . . 0.0 113.148 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 58.21 14.48 2.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.8 t -61.87 -37.02 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.461 0.304 . . . . 0.0 111.383 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.26 -35.04 66.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.203 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.6 pp -84.62 -24.52 29.08 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.703 0.683 . . . . 0.0 110.353 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.46 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -78.4 -42.96 28.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -75.8 -34.79 60.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.233 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -69.12 -51.99 38.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 118.891 -1.123 . . . . 0.0 109.42 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.9 mmm -64.11 -16.86 62.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.356 -0.937 . . . . 0.0 110.068 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -99.11 -1.9 38.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 -9.82 10.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -124.7 -26.17 3.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -176.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.545 ' CD2' HD13 ' A' ' 196' ' ' LEU . 31.5 m-85 -141.63 -7.69 0.98 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.906 1.684 . . . . 0.0 114.309 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 173.37 -134.76 3.02 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.402 1.001 . . . . 0.0 112.118 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -136.28 -140.44 4.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.6 p -160.77 150.88 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.386 0.674 . . . . 0.0 109.914 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.1 t -115.59 -40.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.27 133.16 17.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -165.76 169.99 14.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.138 0.426 . . . . 0.0 110.864 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.85 169.9 33.63 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 121.994 -0.441 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 22.6 mt -81.12 131.72 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.34 145.19 55.35 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -127.78 155.78 43.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.157 0.979 . . . . 0.0 112.809 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -77.84 122.32 85.44 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.768 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.71 -11.69 18.53 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.244 2.629 . . . . 0.0 112.395 173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.43 -46.21 70.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.987 0.515 . . . . 0.0 111.419 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.64 14.43 2.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.452 0.168 . . . . 0.0 111.414 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 57.87 49.18 12.38 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.377 0.671 . . . . 0.0 110.138 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 62.7 t80 -130.56 145.09 56.05 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.509 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 80.7 Cg_exo -51.47 150.66 15.28 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 124.192 3.261 . . . . 0.0 114.167 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -133.81 12.8 4.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.391 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.73 31.31 8.81 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.32 168.72 22.57 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.924 0.862 . . . . 0.0 109.476 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -157.09 -179.46 32.04 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 118.344 0.52 . . . . 0.0 111.988 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -151.98 160.1 43.57 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.168 0.509 . . . . 0.0 110.826 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 90.9 t -144.28 150.55 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.951 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.84 102.42 4.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.43 32.76 0.32 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 109.817 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.9 t -74.28 79.63 1.83 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.76 0.824 . . . . 0.0 110.327 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.38 -4.31 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -154.14 168.34 26.83 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.624 0.647 . . . . 0.0 110.954 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -58.51 -10.87 2.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 56.3 p -68.0 -38.61 82.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.651 -0.655 . . . . 0.0 109.775 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -32.77 62.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.24 -35.03 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.64 -30.63 59.55 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.88 -21.61 21.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.9 tt -87.29 -18.46 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.739 0.7 . . . . 0.0 110.655 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -94.14 -12.29 28.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 171.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.82 59.59 1.47 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -75.14 -9.83 58.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.697 -174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -139.07 123.74 18.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.4 p -163.84 -175.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 237' ' ' VAL . 34.5 tt0 -98.5 135.99 39.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.881 0.31 . . . . 0.0 110.953 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.13 -25.85 3.2 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.443 HE21 ' NE2' ' A' ' 238' ' ' GLN . 85.1 mt-30 48.13 45.47 19.65 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.749 0.42 . . . . 0.0 111.847 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -126.43 144.01 50.99 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.924 0.392 . . . . 0.0 111.604 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.73 -141.8 44.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.32 16.95 10.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.146 0.578 . . . . 0.0 110.947 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.21 151.23 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.002 0.921 . . . . 0.0 110.139 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -131.44 -36.6 1.26 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -140.88 0.67 1.61 Allowed 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -128.27 108.28 10.47 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.488 0.586 . . . . 0.0 110.536 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.1 m -145.47 178.56 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.204 -178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.04 136.45 33.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.54 121.3 13.88 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.402 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 45.7 pttt -164.09 160.63 16.69 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 48.4 Cg_endo -62.64 152.66 76.71 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.625 2.217 . . . . 0.0 111.446 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -79.93 160.45 25.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.662 0.785 . . . . 0.0 111.069 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.28 -1.343 . . . . 0.0 109.785 -178.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.647 -0.131 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -148.56 165.82 30.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.095 0.558 . . . . 0.0 110.25 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -72.43 163.64 27.67 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.916 0.486 . . . . 0.0 110.936 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.23 21.12 17.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.0 111.025 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.95 -160.16 48.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.78 155.39 47.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.221 0.608 . . . . 0.0 109.961 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -139.07 160.62 39.34 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.454 0.702 . . . . 0.0 109.983 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p -135.42 157.85 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.309 0.644 . . . . 0.0 110.132 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -66.83 150.09 49.65 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.88 0.472 . . . . 0.0 110.326 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -102.89 174.95 5.65 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.088 0.555 . . . . 0.0 111.618 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -128.87 158.24 39.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -75.77 132.43 40.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -68.62 -0.16 4.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 125.81 1.943 . . . . 0.0 113.698 -174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.44 122.07 25.35 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.1 t -131.89 116.25 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.894 0.378 . . . . 0.0 110.112 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.82 148.82 32.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.921 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 t -140.83 155.25 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.35 -0.16 0.18 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.822 -0.704 . . . . 0.0 114.147 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.72 6.97 82.7 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 118.27 1.035 . . . . 0.0 113.336 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.29 152.34 53.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.828 0.814 . . . . 0.0 110.957 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.49 165.08 21.27 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.055 3.17 . . . . 0.0 111.389 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.05 -8.22 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.014 3.143 . . . . 0.0 112.364 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -135.64 113.69 11.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.65 148.42 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.468 0.652 . . . . 0.0 111.502 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.73 170.91 14.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 107.715 171.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.55 -23.25 38.8 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.91 -19.79 26.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.16 0.891 . . . . 0.0 110.834 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.62 -42.68 51.02 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -28.06 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -70.78 -24.72 62.64 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.98 -18.67 28.55 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.623 0.369 . . . . 0.0 110.528 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -75.95 -38.66 57.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -94.49 37.62 1.12 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -66.0 -16.62 64.06 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.791 -0.568 . . . . 0.0 110.557 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -88.71 0.32 56.57 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 0.0 110.789 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.67 -54.72 2.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.378 0.671 . . . . 0.0 109.966 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.17 -170.43 15.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.592 0.615 . . . . 0.0 111.764 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.8 141.5 95.79 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.502 3.468 . . . . 0.0 112.772 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.53 171.33 20.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.204 0.602 . . . . 0.0 110.634 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.0 mt -121.68 142.47 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.1 m -130.45 157.12 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -154.08 151.58 29.46 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -111.57 141.8 25.29 Favored Pre-proline 0 CA--C 1.53 0.181 0 O-C-N 121.998 -0.439 . . . . 0.0 110.482 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.41 -8.24 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.782 2.988 . . . . 0.0 112.425 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.88 29.64 2.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.186 0.594 . . . . 0.0 111.392 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.22 156.24 25.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.027 0.441 . . . . 0.0 112.103 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.32 160.25 43.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.059 0.944 . . . . 0.0 109.255 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.44 154.56 45.65 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.502 0.321 . . . . 0.0 111.193 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 m 54.78 6.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.437 1.495 . . . . 0.0 114.925 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -140.38 -16.6 0.93 Allowed 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.197 0.599 . . . . 0.0 111.333 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.2 t -158.35 167.65 29.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.901 0.48 . . . . 0.0 109.816 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -139.02 155.07 48.26 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.426 0.69 . . . . 0.0 110.006 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 61.38 154.12 0.11 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.841 1.256 . . . . 0.0 112.2 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.79 133.65 24.13 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.365 2.044 . . . . 0.0 110.279 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.47 -10.18 12.94 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.047 3.165 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -147.19 159.61 43.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.103 0.41 . . . . 0.0 110.138 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.11 0.16 48.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.372 0.51 . . . . 0.0 112.781 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -77.14 145.72 37.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.125 0.962 . . . . 0.0 110.411 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 152.39 37.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -133.14 107.47 8.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.3 173.0 12.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.406 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.64 158.01 43.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.318 177.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -96.02 161.59 13.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.53 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -70.11 -28.32 65.3 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.107 0.563 . . . . 0.0 112.064 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -136.43 170.18 16.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.603 0.361 . . . . 0.0 110.738 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -104.59 -7.71 19.5 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.0 p -91.1 -31.58 16.19 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.034 0.379 . . . . 0.0 111.147 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -75.0 -25.18 58.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.62 -29.39 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -85.54 -33.15 21.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -37.95 58.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.69 -40.46 25.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.182 -0.324 . . . . 0.0 110.556 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.4 mt -64.14 -34.04 66.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.618 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.79 -21.61 51.4 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.356 -0.215 . . . . 0.0 111.441 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.76 9.26 19.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.672 0.389 . . . . 0.0 111.541 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 76.5 m -131.46 -175.51 3.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.294 0.637 . . . . 0.0 111.24 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.4 mt -80.52 151.11 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.23 0.612 . . . . 0.0 110.77 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.31 159.27 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.08 0.467 . . . . 0.0 112.052 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -147.93 154.46 40.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.752 1.221 . . . . 0.0 108.261 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.43 -10.8 27.48 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.918 -0.489 . . . . 0.0 111.293 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.18 -26.35 5.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.302 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -167.29 -178.13 3.94 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.304 1.052 . . . . 0.0 110.827 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.04 161.21 26.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -140.11 148.37 41.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.038 0.447 . . . . 0.0 111.046 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.49 138.97 52.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.334 0.653 . . . . 0.0 109.672 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.4 m -94.98 119.07 32.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.58 7.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 122.203 0.201 . . . . 0.0 111.533 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.3 m -54.66 98.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.704 0.802 . . . . 0.0 112.223 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.574 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 38.3 t -168.96 -50.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.716 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HD2' ' H ' ' A' ' 141' ' ' SER . 76.8 Cg_endo -80.61 107.78 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.367 -174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p 50.69 12.45 0.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.472 1.509 . . . . 0.0 114.57 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -149.74 147.43 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.089 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' N ' HD13 ' A' ' 144' ' ' ILE . 43.8 tptt -146.35 162.32 38.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 111.658 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.52 18.69 7.19 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.637 1.575 . . . . 0.0 115.178 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -151.66 125.49 4.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 121.679 -0.638 . . . . 0.0 110.342 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.96 176.85 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.873 3.049 . . . . 0.0 110.457 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.2 m -109.96 143.55 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.17 144.71 42.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 31.9 mm -135.72 136.21 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 122.888 0.475 . . . . 0.0 109.784 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -144.12 93.45 6.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 122.872 0.469 . . . . 0.0 110.98 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.44 -161.69 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 124.676 3.584 . . . . 0.0 107.419 170.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -130.98 147.76 52.66 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 120.998 -1.064 . . . . 0.0 111.844 169.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -97.16 67.1 2.15 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.267 0.556 . . . . 0.0 110.817 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -6.41 17.66 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.0 t -96.96 -4.09 40.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.617 -0.23 . . . . 0.0 111.192 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -126.9 -17.19 4.97 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.234 0.47 . . . . 0.0 111.751 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 69.0 m -49.26 -31.87 9.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.84 122.41 38.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 34.7 p90 -130.29 124.65 32.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -94.72 148.94 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.32 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.3 ttm -130.54 -9.21 4.1 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.233 0.213 . . . . 0.0 111.22 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -150.69 144.89 25.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.048 -0.408 . . . . 0.0 110.439 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -119.37 9.12 11.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.429 0.538 . . . . 0.0 112.246 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.3 t -79.76 -15.33 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.552 0.676 . . . . 0.0 111.792 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -134.55 142.52 42.99 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 121.988 0.115 . . . . 0.0 111.28 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.76 165.28 26.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.445 3.43 . . . . 0.0 111.547 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.24 136.1 46.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -150.28 147.06 20.94 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 123.306 0.642 . . . . 0.0 109.364 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.39 -21.88 31.56 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.511 2.808 . . . . 0.0 114.074 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -84.89 1.54 46.71 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.151 0.432 . . . . 0.0 111.225 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.5 11.48 9.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.265 1.026 . . . . 0.0 110.599 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -93.54 153.66 18.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.918 0.39 . . . . 0.0 110.194 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 81.8 mt -134.45 155.9 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -114.02 147.02 39.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.1 t -133.74 125.1 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -115.29 175.58 16.04 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.69 70.48 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.505 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.33 131.64 94.31 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 118.608 1.204 . . . . 0.0 108.423 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.92 -42.69 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.871 2.381 . . . . 0.0 111.425 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 160.19 18.06 Favored Pre-proline 0 CA--C 1.528 0.118 0 C-N-CA 125.417 1.487 . . . . 0.0 107.265 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.83 136.78 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.734 2.956 . . . . 0.0 113.798 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.64 169.37 10.45 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 109.918 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -81.16 43.51 0.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.213 0.605 . . . . 0.0 110.332 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.54 22.38 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.768 1.227 . . . . 0.0 112.944 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.79 -53.11 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 192' ' ' ILE . 4.4 pt-20 -72.54 -38.03 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.405 -0.185 . . . . 0.0 110.623 -176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 189' ' ' LEU . 2.8 tm? -64.7 -46.28 83.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.1 0.96 . . . . 0.0 110.873 -173.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.88 -35.07 57.7 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.308 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.14 -27.71 54.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 188' ' ' GLU . 6.2 pt -84.86 -42.91 16.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.601 0.637 . . . . 0.0 110.7 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.4 mmt -64.2 -21.85 66.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 32.3 t70 -91.88 -25.44 18.94 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.87 -20.51 32.96 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 119.703 1.138 . . . . 0.0 113.553 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -105.67 -34.24 7.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 196' ' ' LEU . 38.1 m-85 -141.33 -31.26 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.443 1.474 . . . . 0.0 112.814 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.35 -160.3 49.29 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.204 0.456 . . . . 0.0 112.809 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.4 5.59 89.43 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.316 -0.713 . . . . 0.0 113.287 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.52 143.25 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.385 1.093 . . . . 0.0 109.837 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 79.5 m -124.23 -34.13 2.98 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 119.782 -0.151 . . . . 0.0 111.098 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -156.37 149.36 24.11 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -166.12 169.86 14.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.2 0.524 . . . . 0.0 111.249 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -158.49 164.93 33.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.3 pp -130.34 137.53 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 43.77 -6.22 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.91 163.87 21.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 120.991 1.723 . . . . 0.0 114.406 -170.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.82 142.4 17.13 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.506 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.27 -4.52 15.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.047 3.165 . . . . 0.0 112.6 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.39 -46.03 90.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.674 0.67 . . . . 0.0 110.283 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.07 12.85 0.86 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.148 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 67.03 48.53 1.23 Allowed 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 84.4 t80 -139.24 149.1 59.64 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.442 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 72.7 Cg_exo -52.96 139.3 61.02 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.245 2.63 . . . . 0.0 114.064 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -134.13 -29.46 1.26 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.29 1.436 . . . . 0.0 109.891 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.9 156.91 7.13 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 117.68 0.218 . . . . 0.0 113.112 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 65.25 158.8 0.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.552 1.941 . . . . 0.0 115.043 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -110.24 167.92 12.87 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 12.5 ptp85 -153.11 153.83 33.61 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.04 0.448 . . . . 0.0 111.816 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 55.1 t -145.3 158.09 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.902 0.881 . . . . 0.0 108.946 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.5 107.58 5.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -159.88 26.1 0.18 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.914 0.486 . . . . 0.0 111.394 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 22.9 m -69.6 80.24 0.42 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.076 0.551 . . . . 0.0 111.271 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.37 -10.39 0.49 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 227' ' ' SER . 17.2 pt20 -152.78 177.21 10.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.162 0.505 . . . . 0.0 111.468 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.44 -14.78 61.69 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 91.3 p -69.16 -33.16 72.97 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.454 -0.779 . . . . 0.0 109.547 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.05 -35.49 61.88 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.69 -32.27 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.75 -23.22 31.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.41 -11.52 27.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.403 0.547 . . . . 0.0 112.343 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -115.24 -20.88 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 118.722 0.692 . . . . 0.0 112.814 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.0 m -97.1 6.73 48.02 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.03 0.377 . . . . 0.0 111.688 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -96.5 -22.08 17.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 58.55 -37.49 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -142.43 153.25 43.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.3 p -157.19 159.82 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -71.06 154.01 42.12 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.426 0.69 . . . . 0.0 111.793 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.28 163.03 37.69 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 124.333 1.053 . . . . 0.0 109.719 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.74 47.49 0.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -139.37 138.79 36.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.63 0.252 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 63.01 -146.1 50.31 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -82.09 6.52 16.08 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.991 0.517 . . . . 0.0 111.334 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.08 128.14 62.21 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -142.82 9.31 1.74 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -31.35 0.31 Allowed 'General case' 0 C--N 1.341 0.236 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -158.82 153.35 24.35 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 120.124 1.329 . . . . 0.0 114.148 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.51 152.08 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.791 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.08 133.85 48.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.526 0.33 . . . . 0.0 110.181 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.23 122.37 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -149.28 164.59 20.42 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.186 -174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.63 152.19 42.6 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.414 2.743 . . . . 0.0 112.026 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.94 -14.71 43.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.871 0.468 . . . . 0.0 111.509 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.292 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -147.31 161.9 40.04 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.968 0.507 . . . . 0.0 110.05 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.29 -8.13 55.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.857 0.463 . . . . 0.0 111.86 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -83.56 10.47 8.99 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.92 0.488 . . . . 0.0 111.289 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.38 -168.73 11.74 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -125.54 149.85 47.96 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.529 -0.395 . . . . 0.0 110.218 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -121.29 162.13 20.79 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.519 0.728 . . . . 0.0 109.773 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.14 152.8 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.789 0.435 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.54 10.06 2.47 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.413 0.685 . . . . 0.0 110.886 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -88.11 9.44 22.67 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -106.0 153.39 22.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 156' ' ' LEU . 41.0 t -88.73 134.65 33.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -96.71 2.23 51.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 124.818 1.324 . . . . 0.0 111.582 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -79.96 64.97 4.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.2 t -75.21 118.89 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.047 0.451 . . . . 0.0 109.933 -172.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -81.99 145.58 30.19 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -125.73 129.51 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.5 -27.79 10.29 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.332 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.26 129.55 8.53 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 117.684 0.742 . . . . 0.0 112.094 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -147.35 153.28 44.08 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.306 1.042 . . . . 0.0 108.647 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 57.8 Cg_exo -54.79 151.93 30.48 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.606 2.871 . . . . 0.0 112.596 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.5 Cg_exo -61.95 -9.63 14.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 124.121 3.214 . . . . 0.0 114.339 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.93 40.43 2.34 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 142.62 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.759 0.79 . . . . 0.0 112.446 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 21.4 t70 -145.36 165.92 27.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.199 1.8 . . . . 0.0 106.44 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -50.96 -36.26 37.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.775 0.716 . . . . 0.0 112.358 -175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.17 -25.72 59.89 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.722 -0.611 . . . . 0.0 111.107 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 7.1 tp10 -76.35 -42.97 43.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -27.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.6 m -70.73 -26.09 63.23 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.16 -15.53 27.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.385 0.274 . . . . 0.0 111.411 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -71.3 -45.31 63.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -83.71 159.91 21.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -132.08 7.29 4.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.4 ttt-85 -139.25 -12.02 1.22 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.415 0.552 . . . . 0.0 112.473 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 13.7 m-85 -73.13 139.89 46.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.862 -0.524 . . . . 0.0 110.461 -178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.5 -158.2 20.57 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.19 138.74 44.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.372 2.715 . . . . 0.0 110.985 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 165.71 29.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.642 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.8 mm -121.94 149.91 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.16 157.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.831 0.348 . . . . 0.0 111.484 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -147.29 138.6 23.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.68 152.05 41.33 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 122.514 0.326 . . . . 0.0 110.383 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.05 -8.83 20.36 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.301 2.667 . . . . 0.0 112.556 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -141.63 26.59 1.92 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.0 -3.39 5.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.224 0.92 . . . . 0.0 112.835 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.11 11.09 11.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.452 0.701 . . . . 0.0 111.235 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -135.96 -7.51 2.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.913 0.485 . . . . 0.0 111.186 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.4 m -75.03 154.8 37.82 Favored 'General case' 0 C--O 1.232 0.146 0 O-C-N 122.136 -0.353 . . . . 0.0 110.74 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -102.05 4.84 40.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.261 0.624 . . . . 0.0 111.105 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 97.5 p -145.6 178.43 8.14 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.2 0.6 . . . . 0.0 110.33 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -77.01 9.11 3.17 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.074 0.55 . . . . 0.0 112.201 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -126.64 138.74 33.1 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 122.908 0.483 . . . . 0.0 110.08 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.74 166.0 26.01 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.709 2.94 . . . . 0.0 110.504 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.11 166.33 7.34 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.87 3.047 . . . . 0.0 111.893 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -79.32 14.57 1.49 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.138 0.575 . . . . 0.0 111.94 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -158.34 6.96 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.786 0.708 . . . . 0.0 112.651 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -77.04 169.96 17.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.602 0.361 . . . . 0.0 111.122 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.54 165.94 30.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 111.557 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -128.03 136.53 51.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.13 162.61 40.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.51 -0.119 . . . . 0.0 110.755 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.93 155.35 38.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.038 0.446 . . . . 0.0 111.494 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.87 142.65 34.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.248 1.019 . . . . 0.0 108.813 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -81.57 -13.83 57.57 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -86.34 79.41 9.04 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -68.48 -10.37 55.05 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.3 m -79.23 -22.77 44.35 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.3 t -88.47 -16.76 31.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.44 -40.32 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -76.15 -33.23 59.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.46 65.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 2.5 tm? -81.84 -37.45 26.99 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 122.093 -0.379 . . . . 0.0 110.456 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 135' ' ' LEU . 43.0 mt -64.72 -27.69 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.7 -18.85 33.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.762 -0.586 . . . . 0.0 111.225 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.97 14.04 11.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.125 0.57 . . . . 0.0 111.846 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -137.17 178.81 6.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.706 0.402 . . . . 0.0 111.846 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.85 152.91 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.912 0.885 . . . . 0.0 110.1 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -138.47 159.78 41.22 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -145.81 153.85 41.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.668 1.187 . . . . 0.0 108.302 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -65.86 -6.33 11.85 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.003 -0.435 . . . . 0.0 111.362 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.14 -25.04 4.9 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.314 -0.714 . . . . 0.0 113.28 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -167.5 -176.23 3.13 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.38 1.09 . . . . 0.0 110.894 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 125' ' ' ILE . 79.0 mt -120.46 153.46 36.58 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.25 129.09 33.08 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.93 147.19 36.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.796 0.438 . . . . 0.0 110.795 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 60.4 m -82.37 102.42 11.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.637 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.61 -11.04 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.674 0.39 . . . . 0.0 110.135 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.9 p -90.84 48.43 1.53 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.759 0.824 . . . . 0.0 110.542 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.544 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 32.5 m -111.83 -39.02 0.11 Allowed Pre-proline 0 CA--C 1.528 0.123 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.433 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 141' ' ' SER . 29.7 Cg_exo -64.87 -171.44 0.17 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.001 2.468 . . . . 0.0 110.225 168.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 64.2 p -69.79 4.49 1.95 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.343 0.657 . . . . 0.0 112.5 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -41.56 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.059 0.543 . . . . 0.0 110.685 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 38.48 76.3 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.715 1.606 . . . . 0.0 113.793 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -138.26 32.46 2.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 62.24 162.26 0.11 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.794 1.238 . . . . 0.0 112.41 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.33 150.93 18.86 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.504 2.803 . . . . 0.0 112.581 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.06 138.28 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.443 -176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -82.63 135.79 34.95 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.699 0.399 . . . . 0.0 110.593 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.44 142.31 41.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 123.706 0.802 . . . . 0.0 109.492 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -144.0 92.98 6.16 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 0.0 111.396 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -86.76 -153.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.606 1 C-N-CA 125.601 4.201 . . . . 0.0 107.205 169.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -148.19 157.36 43.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -117.37 94.64 4.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.488 1.115 . . . . 0.0 109.286 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 156' ' ' LEU . 4.3 mp -69.12 -16.62 63.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 125.22 1.408 . . . . 0.0 112.86 -169.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.1 t -123.48 17.37 9.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -126.74 -30.13 2.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.072 -0.393 . . . . 0.0 110.395 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.4 m -57.83 -4.37 0.29 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -84.01 122.53 28.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.394 0.543 . . . . 0.0 110.458 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 10.2 m-85 -102.99 155.69 18.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.01 146.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 O-C-N 121.79 -0.569 . . . . 0.0 110.731 -171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 43.9 tpp -150.69 29.33 0.68 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.43 153.57 26.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 162.13 2.95 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.356 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.1 t -150.99 -31.37 0.17 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.531 1.166 . . . . 0.0 113.395 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -143.5 141.23 18.62 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.71 163.75 33.25 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 124.089 3.193 . . . . 0.0 110.594 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.81 129.22 54.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.312 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.21 164.71 20.44 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.03 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.491 3.461 . . . . 0.0 115.46 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -81.09 -13.05 59.1 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.982 0.81 . . . . 0.0 111.452 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.26 12.76 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.187 0.995 . . . . 0.0 111.298 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 59.1 m -87.85 149.54 24.06 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.73 158.87 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -112.43 144.58 41.63 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.58 117.5 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.43 136.25 13.43 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.13 -4.64 1.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.978 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 m -82.49 129.44 62.95 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.181 1.491 . . . . 0.0 109.081 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -85.44 133.29 4.53 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.38 2.72 . . . . 0.0 110.731 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 55.48 -178.19 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.96 0.904 . . . . 0.0 111.419 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.0 143.29 93.12 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.987 1.792 . . . . 0.0 110.124 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.521 HD21 ' H ' ' A' ' 188' ' ' GLU . 45.9 tp -149.32 143.42 25.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.466 0.306 . . . . 0.0 110.296 -174.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -80.79 37.79 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.911 0.484 . . . . 0.0 111.24 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.409 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 54.01 16.06 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.768 1.227 . . . . 0.0 113.697 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.28 -49.7 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.57 0.348 . . . . 0.0 110.971 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.521 ' H ' HD21 ' A' ' 184' ' ' LEU . 56.9 mt-10 -76.36 -45.77 30.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -174.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.2 tp -43.51 -61.5 1.36 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.636 1.574 . . . . 0.0 111.707 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.67 55.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.53 -173.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -34.44 53.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.656 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 19.0 pt -76.06 -36.65 31.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 120.045 1.293 . . . . 0.0 110.331 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 87.6 mmm -69.22 -19.38 63.96 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.467 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -91.54 -16.13 27.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.44 -35.82 30.16 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.832 0.742 . . . . 0.0 112.041 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.543 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -99.15 -40.67 7.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.543 ' H ' HD12 ' A' ' 196' ' ' LEU . 45.4 m-85 -147.38 66.2 1.13 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.026 0.83 . . . . 0.0 110.822 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.97 165.1 34.79 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 112.036 -0.425 . . . . 0.0 112.036 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.56 14.13 1.97 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.46 155.29 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.378 0.671 . . . . 0.0 111.416 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.7 t -120.43 -30.9 4.46 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.363 0.265 . . . . 0.0 110.341 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -153.61 150.97 29.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.39 158.16 33.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.009 0.433 . . . . 0.0 111.396 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.54 160.7 24.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.5 pp -79.07 158.04 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.235 -0.568 . . . . 0.0 111.276 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.29 142.41 58.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.946 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.55 156.48 46.29 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.803 0.811 . . . . 0.0 112.292 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -96.32 121.76 59.46 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.547 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 -5.46 17.06 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.578 2.185 . . . . 0.0 111.304 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.43 -47.12 62.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.969 0.507 . . . . 0.0 111.116 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 211' ' ' LEU . 2.2 pt? -137.05 13.65 3.08 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.01 49.62 9.29 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.083 0.553 . . . . 0.0 110.483 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 70.1 t80 -132.19 146.02 59.83 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.482 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 59.9 Cg_exo -54.74 153.28 24.9 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.308 2.672 . . . . 0.0 113.609 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -125.78 6.5 7.41 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.949 0.499 . . . . 0.0 110.937 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 91.54 161.26 36.95 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 63.22 175.74 0.16 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.319 1.047 . . . . 0.0 112.179 -173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -151.59 -174.31 22.23 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -155.63 159.03 39.28 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 120.918 0.389 . . . . 0.0 111.437 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.12 171.07 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 C-N-CA 123.45 0.7 . . . . 0.0 109.286 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.14 104.21 3.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.859 0.361 . . . . 0.0 110.424 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -156.45 141.82 17.52 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.0 109.865 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 39.6 m -148.75 27.53 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.206 0.603 . . . . 0.0 110.109 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -79.04 -31.73 44.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -170.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -149.31 -176.03 5.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.853 0.835 . . . . 0.0 112.375 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.06 -12.38 18.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.765 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.1 m -67.46 -35.5 79.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.687 -0.633 . . . . 0.0 109.346 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.51 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.8 OUTLIER -71.5 -38.54 71.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.75 -33.25 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.36 -18.21 34.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -100.93 -8.95 21.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.416 0.553 . . . . 0.0 112.118 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.4 tt -117.64 -14.68 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.2 m -108.1 10.6 28.07 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.957 0.344 . . . . 0.0 111.572 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.18 -20.58 25.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 236' ' ' PHE . 15.1 tpt180 62.22 -36.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 235' ' ' ARG . 83.5 m-85 -145.1 146.76 31.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 238' ' ' GLN . 1.9 t -142.89 169.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.469 ' H ' HG12 ' A' ' 237' ' ' VAL . 53.8 tt0 -118.92 140.83 49.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 240' ' ' GLN . 0.1 OUTLIER -155.87 162.99 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 239' ' ' LEU . 65.8 tt0 -144.51 118.86 9.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -159.08 151.96 22.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.5 -134.44 52.33 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.72 15.0 30.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 0.0 111.87 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.41 158.53 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 121.44 0.638 . . . . 0.0 111.674 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -143.51 -166.06 2.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.374 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER 63.79 -158.93 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.504 1.121 . . . . 0.0 113.554 176.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 31.5 mmt180 -69.72 154.02 42.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.086 1.354 . . . . 0.0 112.883 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.58 164.09 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.629 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.58 142.95 50.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.417 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.88 125.8 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -149.48 163.76 23.71 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-O 119.591 -0.242 . . . . 0.0 110.438 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.12 154.89 37.01 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.397 2.732 . . . . 0.0 111.979 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -82.09 171.05 14.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 122.911 0.484 . . . . 0.0 110.696 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.564 -1.684 . . . . 0.0 111.092 -175.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 120.339 0.114 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -139.16 162.95 33.72 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.359 0.664 . . . . 0.0 110.266 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -130.25 13.37 5.61 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.119 0.567 . . . . 0.0 111.177 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.93 155.77 39.53 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.532 0.333 . . . . 0.0 110.366 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.41 170.42 53.61 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.84 154.86 24.46 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -133.89 -20.32 1.98 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.165 0.586 . . . . 0.0 111.355 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.81 148.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.513 1.525 . . . . 0.0 113.854 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -141.85 140.56 32.95 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.64 -23.22 0.09 Allowed 'General case' 0 C--N 1.338 0.086 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.21 160.26 25.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 31.4 t -77.03 134.22 38.87 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 171.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -75.46 -4.23 38.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 126.131 2.144 . . . . 0.0 112.217 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -81.07 120.93 25.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -133.12 134.96 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.698 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -92.52 149.08 21.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.54 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.3 t -137.36 140.89 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.54 -6.36 1.0 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.001 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.64 13.82 57.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.673 0.737 . . . . 0.0 112.489 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.99 147.89 52.77 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.606 0.703 . . . . 0.0 110.592 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.62 161.92 9.16 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.591 2.86 . . . . 0.0 112.65 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.35 -15.32 18.71 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.988 3.125 . . . . 0.0 112.914 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -140.79 115.61 9.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.13 145.58 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 121.692 0.758 . . . . 0.0 111.656 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -142.27 166.29 25.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 106.712 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -55.89 -22.94 28.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.869 0.759 . . . . 0.0 112.743 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.62 -26.92 34.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.535 0.607 . . . . 0.0 110.89 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.9 -43.07 59.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.421 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.36 -29.37 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.4 m -70.28 -24.27 63.02 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.0 -12.25 29.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.576 0.351 . . . . 0.0 111.59 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.2 m -75.93 -36.94 59.19 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.264 -0.273 . . . . 0.0 110.353 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -92.47 159.01 15.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 ttt-85 -137.02 138.67 40.73 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 48.69 28.45 1.84 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.952 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -92.82 5.91 49.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.566 0.346 . . . . 0.0 111.372 -177.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.22 174.32 34.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.597 0.617 . . . . 0.0 111.876 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.16 147.55 83.99 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.783 2.988 . . . . 0.0 109.701 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.03 166.56 28.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 111.583 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.3 mt -127.33 147.59 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 158.38 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 120.927 0.394 . . . . 0.0 111.831 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -148.23 139.97 23.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -101.55 156.46 35.16 Favored Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 122.412 0.285 . . . . 0.0 111.179 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.09 -19.12 61.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.54 2.827 . . . . 0.0 111.721 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -150.28 136.69 18.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.268 1.027 . . . . 0.0 108.801 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -146.71 13.32 1.17 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 172.91 11.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.09 143.19 49.39 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.4 t -151.58 165.15 35.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.856 0.462 . . . . 0.0 110.439 -177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.91 9.14 25.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.457 0.703 . . . . 0.0 111.123 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.9 t -138.57 160.16 40.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.542 0.737 . . . . 0.0 110.616 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.31 15.94 16.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.584 0.754 . . . . 0.0 111.591 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' C ' ' HD2' ' A' ' 107' ' ' PRO . 39.7 t80 -125.88 70.64 67.01 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.716 . . . . 0.0 110.195 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 83.9 Cg_endo -73.73 -22.19 18.11 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.566 2.844 . . . . 0.0 116.225 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 105' ' ' PHE . 88.1 Cg_endo -74.01 163.75 36.08 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 123.003 2.108 . . . . 0.0 111.015 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 108' ' ' LYS . 11.6 mmpt? -101.05 18.24 20.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.564 0.746 . . . . 0.0 112.322 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.92 -1.33 74.29 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.41 161.38 38.03 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.64 168.62 24.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.92 132.71 53.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.48 166.05 32.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.876 0.369 . . . . 0.0 111.165 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -152.82 164.01 38.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.005 0.431 . . . . 0.0 110.703 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CE2' ' CE2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.16 151.19 38.05 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -175.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -94.56 -3.49 49.63 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.94 86.31 5.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.43 -16.96 64.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.0 p -80.38 -23.06 40.7 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 t -86.48 -22.79 26.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.87 -45.34 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -74.21 -37.06 63.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.26 87.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.34 -41.47 33.41 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.287 -0.258 . . . . 0.0 110.388 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.92 -22.6 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.6 -16.68 23.0 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.934 -0.479 . . . . 0.0 111.789 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.55 23.45 8.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.202 0.601 . . . . 0.0 111.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -137.67 179.04 6.65 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.77 155.62 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.464 0.706 . . . . 0.0 110.524 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.15 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.412 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 35.2 tt0 -135.5 153.79 51.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.624 1.169 . . . . 0.0 108.245 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.13 -9.39 16.31 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.05 -0.406 . . . . 0.0 111.073 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.19 -25.97 5.09 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.211 -0.772 . . . . 0.0 113.549 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HE3' ' OE1' ' A' ' 131' ' ' GLU . 6.9 ptpt -168.14 179.57 4.51 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.487 1.143 . . . . 0.0 111.54 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.11 159.99 14.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -142.76 141.71 31.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -112.17 162.54 15.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.9 p -120.54 133.81 55.35 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.39 11.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.8 m -57.19 102.16 0.08 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.993 0.517 . . . . 0.0 111.124 -177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.682 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.1 t -164.37 -48.38 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.488 -0.768 . . . . 0.0 112.182 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 141' ' ' SER . 44.7 Cg_endo -78.87 -146.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.074 2.516 . . . . 0.0 110.222 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 142' ' ' PRO . 15.2 t -58.16 -14.93 7.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 112.749 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.19 140.68 22.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 160.52 43.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.607 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 27.02 4.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.12 1.368 . . . . 0.0 114.046 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -148.28 132.88 8.89 Favored Pre-proline 0 CA--C 1.531 0.247 0 O-C-N 121.845 -0.535 . . . . 0.0 110.511 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.94 175.57 11.02 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.778 2.985 . . . . 0.0 110.746 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.89 144.59 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.26 140.89 43.48 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 137' ' ' LEU . 28.2 mm -138.45 138.28 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 123.559 0.744 . . . . 0.0 109.399 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.52 96.88 4.4 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.404 0.282 . . . . 0.0 111.362 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.19 -159.75 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 125.117 3.878 . . . . 0.0 107.738 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 71.7 t-105 -134.02 150.53 51.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.976 1.262 . . . . 0.0 112.554 169.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -109.92 76.12 0.97 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.667 0.746 . . . . 0.0 110.341 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.936 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -71.21 0.1 8.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.951 0.9 . . . . 0.0 112.671 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -93.67 -12.78 28.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.958 0.345 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -118.83 -16.87 9.25 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -60.0 -0.65 0.23 Allowed 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -104.28 121.69 43.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 110.25 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -103.37 152.69 21.3 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.033 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.1 t -153.33 137.53 9.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.048 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 95.6 mmm -136.44 -12.95 1.8 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.213 0.205 . . . . 0.0 111.53 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -154.23 160.02 41.62 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.775 0.43 . . . . 0.0 110.467 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -133.68 9.55 4.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.564 0.602 . . . . 0.0 111.949 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.5 m -86.38 3.7 42.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.032 0.933 . . . . 0.0 112.461 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 12.3 tt0 -136.15 131.61 18.81 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.433 -0.317 . . . . 0.0 110.41 -172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.34 167.28 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.139 3.226 . . . . 0.0 113.722 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 169' ' ' LEU . 3.1 mm? -108.13 22.47 15.9 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.034 0.933 . . . . 0.0 109.687 176.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -64.2 146.86 97.41 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.095 0.958 . . . . 0.0 110.332 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.77 -21.0 13.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.446 2.764 . . . . 0.0 114.798 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.0 mmm-85 -88.89 9.77 23.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.459 0.572 . . . . 0.0 111.154 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -138.21 12.23 2.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.766 1.227 . . . . 0.0 110.215 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -122.04 155.81 34.85 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.967 0.413 . . . . 0.0 111.195 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.16 160.9 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.424 ' CD1' ' HE3' ' A' ' 251' ' ' LYS . 4.5 t80 -118.16 146.06 44.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.8 128.11 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -103.06 146.25 16.51 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.58 102.22 0.38 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.933 0.777 . . . . 0.0 112.202 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -130.76 58.63 40.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.982 0.913 . . . . 0.0 109.632 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.86 150.78 87.64 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.055 3.17 . . . . 0.0 111.888 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 60.64 155.17 0.11 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.24 119.83 3.94 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.074 2.516 . . . . 0.0 111.878 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -160.22 152.83 21.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.81 0.844 . . . . 0.0 110.266 173.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.86 57.33 2.55 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.051 0.941 . . . . 0.0 112.938 -173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 56.38 11.66 0.87 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.69 1.196 . . . . 0.0 113.724 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.51 -38.62 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 122.536 0.334 . . . . 0.0 110.564 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.37 -31.48 68.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 119.29 -0.386 . . . . 0.0 112.0 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 37.1 tp -73.99 -54.67 7.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.0 0.92 . . . . 0.0 110.826 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.68 -31.96 67.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.118 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -75.69 -32.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.722 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 pt -77.36 -51.83 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-N 119.335 0.971 . . . . 0.0 111.256 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.2 ptm -77.47 -7.27 55.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.155 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -90.55 -23.83 20.77 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.68 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -75.84 -11.35 59.96 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.215 0.461 . . . . 0.0 110.325 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.1 mt -103.66 -69.28 0.81 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.169 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -147.22 79.48 1.5 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.97 161.2 29.12 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.197 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 138.55 8.92 1.06 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.067 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.69 150.3 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.45 -36.9 1.85 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.263 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -149.06 143.89 26.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.96 166.71 31.9 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.597 0.236 . . . . 0.0 110.444 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.06 172.92 37.02 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.4 131.9 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.514 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.0 t70 -67.92 133.29 48.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -128.18 158.55 37.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 122.133 0.968 . . . . 0.0 112.755 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -93.48 125.77 52.71 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.494 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.48 -8.18 23.02 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.989 2.46 . . . . 0.0 111.316 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -91.19 -49.4 6.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.898 0.479 . . . . 0.0 111.099 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.49 -7.6 46.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 52.86 30.5 9.23 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.418 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 59.9 t80 -126.46 149.83 68.77 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.577 0.751 . . . . 0.0 110.703 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 71.7 Cg_exo -52.67 148.52 27.59 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.341 2.694 . . . . 0.0 112.999 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -109.01 10.35 26.23 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.596 0.358 . . . . 0.0 111.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.21 40.08 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.819 -0.434 . . . . 0.0 113.195 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -148.12 174.2 12.19 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.623 0.711 . . . . 0.0 110.903 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.56 173.94 24.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -147.25 155.72 42.31 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.147 0.499 . . . . 0.0 110.934 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 39.2 t -147.24 149.27 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.897 0.879 . . . . 0.0 108.87 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.67 111.37 10.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.41 28.78 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.453 0.701 . . . . 0.0 110.829 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 15.3 m -70.85 74.85 0.62 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.123 0.569 . . . . 0.0 111.416 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.63 -4.97 0.65 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -148.7 165.78 30.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.327 0.512 . . . . 0.0 111.181 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -63.95 -10.25 20.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.307 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.8 p -68.37 -42.83 78.58 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.831 -0.543 . . . . 0.0 109.655 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -70.94 -32.02 68.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 36.4 mm -63.21 -34.7 68.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.74 -18.75 32.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.41 -5.6 32.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.602 0.637 . . . . 0.0 111.182 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 tt -110.53 -21.39 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.9 m -100.06 1.18 42.12 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.7 49.31 0.94 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.22 -57.4 10.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.852 -174.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -62.75 118.01 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.596 0.634 . . . . 0.0 110.913 174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.8 p -163.41 170.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -61.14 148.49 40.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.347 0.521 . . . . 0.0 110.705 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 93.0 mt -139.98 -47.3 0.44 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.347 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 42.84 61.58 2.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.049 0.94 . . . . 0.0 111.957 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.31 132.14 33.23 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.903 0.481 . . . . 0.0 110.701 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 59.77 -136.14 50.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.22 -4.66 58.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.98 0.512 . . . . 0.0 111.099 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 244' ' ' ILE . 1.8 mp -97.94 153.21 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -130.59 -25.77 2.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -157.23 11.64 0.22 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -128.78 129.92 46.32 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.628 1.104 . . . . 0.0 113.939 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.36 151.87 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.872 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 134.35 54.83 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.1 t -147.69 127.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -157.27 166.67 16.12 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.98 158.8 10.6 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.516 2.81 . . . . 0.0 112.979 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -76.93 65.62 2.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.248 0.619 . . . . 0.0 111.185 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 117.236 -1.364 . . . . 0.0 109.963 178.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.915 -0.032 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 55.64 18.42 2.8 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.302 1.041 . . . . 0.0 113.235 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.85 161.62 37.51 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.534 0.734 . . . . 0.0 109.836 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -79.96 159.22 26.38 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.575 0.35 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.76 176.44 50.86 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.35 7.0 5.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.023 0.529 . . . . 0.0 111.268 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -81.41 166.88 20.0 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.001 0.52 . . . . 0.0 110.933 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.13 148.38 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 123.126 0.57 . . . . 0.0 109.691 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -81.39 171.64 14.52 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.235 0.614 . . . . 0.0 111.737 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -133.92 166.05 23.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -129.69 160.86 32.06 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 35.3 t -77.45 133.23 38.67 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -75.7 2.26 12.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 125.988 2.055 . . . . 0.0 113.601 -171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -83.58 128.32 34.43 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.35 137.85 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.577 -171.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -103.04 146.05 28.96 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.743 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.63 154.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.35 -3.43 0.53 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.93 -0.372 . . . . 0.0 112.195 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.0 6.65 80.63 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 117.539 0.669 . . . . 0.0 112.994 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -60.57 145.89 86.46 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 118.046 0.923 . . . . 0.0 111.401 -174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.58 167.5 24.02 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.518 3.479 . . . . 0.0 111.743 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.36 -1.96 8.23 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 124.284 3.323 . . . . 0.0 112.485 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -143.81 109.0 5.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.01 147.0 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.767 0.794 . . . . 0.0 112.016 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 38.0 t70 -146.05 167.09 24.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.751 1.62 . . . . 0.0 107.065 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.83 -33.98 38.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.63 0.65 . . . . 0.0 111.89 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.88 -21.7 54.54 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.226 -0.296 . . . . 0.0 111.5 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 10.7 tp10 -78.56 -45.5 21.64 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.084 -0.385 . . . . 0.0 109.979 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.4 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.2 m -71.41 -30.21 65.82 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.71 -11.59 41.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.632 0.373 . . . . 0.0 111.444 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.0 m -82.15 -45.84 14.6 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.26 0.224 . . . . 0.0 110.451 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -75.05 -36.04 61.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 55.66 -50.33 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.331 2.652 . . . . 0.0 117.394 172.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -84.3 -3.53 58.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.645 0.778 . . . . 0.0 111.386 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -83.41 158.09 22.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.003 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.21 -167.55 24.8 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.21 143.23 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.512 2.808 . . . . 0.0 110.015 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -150.91 175.06 12.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.621 0.368 . . . . 0.0 111.341 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.93 150.17 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.41 162.46 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 122.768 0.427 . . . . 0.0 111.461 -173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -150.6 126.99 10.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.009 0.433 . . . . 0.0 111.605 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -162.25 142.25 7.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.05 0.94 . . . . 0.0 109.177 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.64 -2.58 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 124.02 3.147 . . . . 0.0 112.317 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -91.2 16.1 10.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -139.37 152.54 47.22 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.983 0.513 . . . . 0.0 110.182 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.12 35.62 1.92 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.451 0.7 . . . . 0.0 111.235 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 56.72 25.55 10.29 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.624 0.769 . . . . 0.0 111.708 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.4 p -76.04 168.36 20.19 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.656 0.782 . . . . 0.0 111.253 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -131.0 0.38 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.194 0.598 . . . . 0.0 111.058 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -116.99 1.69 12.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.387 0.675 . . . . 0.0 111.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -149.85 149.53 30.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.888 0.475 . . . . 0.0 110.44 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.56 149.89 41.96 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 123.77 0.828 . . . . 0.0 108.995 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.3 149.77 63.96 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.195 2.597 . . . . 0.0 111.967 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.32 -170.48 0.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.872 3.715 . . . . 0.0 110.085 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -57.64 147.1 28.42 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.2 -170.27 41.42 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -95.13 162.46 13.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.09 162.98 38.87 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.813 0.445 . . . . 0.0 111.071 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.75 142.3 50.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.691 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.7 mt -138.23 157.18 46.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -150.67 160.37 43.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -121.74 170.0 10.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.33 -171.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -107.15 -10.36 15.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.618 0.367 . . . . 0.0 111.387 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.17 156.91 43.79 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -116.33 -4.44 11.85 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 53.7 m -89.07 -28.87 19.83 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.145 0.429 . . . . 0.0 109.958 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -75.74 -26.74 57.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.84 -33.35 62.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -80.32 -32.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.14 -35.47 64.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.49 -38.07 19.0 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.794 0.27 . . . . 0.0 110.718 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.99 -22.14 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.11 -17.9 24.31 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.842 -0.536 . . . . 0.0 111.533 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.35 14.37 5.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.893 0.477 . . . . 0.0 111.494 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -139.93 179.9 6.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.409 0.683 . . . . 0.0 110.892 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.4 mt -71.31 147.1 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.938 0.495 . . . . 0.0 110.048 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.77 160.78 38.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 133' ' ' GLY . 10.0 tp10 -150.12 154.19 37.65 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 107.82 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.41 -11.34 57.53 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.602 -0.687 . . . . 0.0 110.994 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 131' ' ' GLU . . . -107.47 -19.78 9.07 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.546 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.434 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -169.13 172.98 7.06 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.321 1.061 . . . . 0.0 111.112 -176.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.434 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.0 mm? -123.8 155.53 37.79 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.329 0.652 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -140.09 134.04 30.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.691 0.281 . . . . 0.0 110.283 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.62 141.32 47.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.6 m -88.37 133.14 34.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.07 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.153 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.8 m -72.71 157.1 38.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 m 78.55 1.53 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.13 -31.52 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 123.483 2.28 . . . . 0.0 110.572 171.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -168.27 -27.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.51 1.124 . . . . 0.0 109.809 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.82 145.82 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 125.499 1.52 . . . . 0.0 107.149 175.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.83 167.62 21.65 Favored 'General case' 0 C--N 1.337 0.053 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.2 t70 53.7 13.7 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.387 1.875 . . . . 0.0 114.689 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -138.78 93.04 10.93 Favored Pre-proline 0 CA--C 1.53 0.188 0 O-C-N 121.781 -0.574 . . . . 0.0 109.966 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.97 174.32 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 124.535 3.49 . . . . 0.0 111.891 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.71 149.8 15.09 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -105.41 133.37 50.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.73 147.69 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.968 0.907 . . . . 0.0 109.952 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -143.91 102.13 4.9 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.093 0.557 . . . . 0.0 110.548 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -84.11 -158.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 124.68 3.587 . . . . 0.0 107.416 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 59.6 t-105 -133.03 151.06 52.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.417 1.008 . . . . 0.0 112.313 169.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -94.85 63.23 2.74 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.448 0.699 . . . . 0.0 111.242 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -9.22 15.57 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.2 t -97.48 -2.22 42.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.3 0.24 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.44 -13.76 5.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.172 0.442 . . . . 0.0 112.059 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.8 m -59.09 -11.72 4.0 Favored 'General case' 0 C--N 1.337 0.044 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.65 120.17 39.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.286 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -103.42 157.5 16.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -155.1 144.93 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.8 ttt -140.69 -33.44 0.54 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.1 t0 56.26 174.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.149 1.38 . . . . 0.0 113.856 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.16 86.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.604 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.9 m -130.66 -27.14 2.16 Favored 'General case' 0 C--N 1.338 0.073 0 CA-C-N 118.309 1.055 . . . . 0.0 112.954 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -164.62 142.2 5.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 118.679 0.672 . . . . 0.0 111.182 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.39 176.63 9.71 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.678 2.919 . . . . 0.0 110.327 170.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.8 mp -100.84 120.25 39.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -158.29 150.79 17.85 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.167 0.587 . . . . 0.0 109.572 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.79 0.62 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.853 3.035 . . . . 0.0 113.905 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -102.43 -6.29 23.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.836 0.744 . . . . 0.0 110.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.82 22.6 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.811 0.844 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.9 m -106.91 154.68 20.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.77 154.73 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.29 149.31 29.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.37 122.77 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.0 164.6 12.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.5 13.38 57.14 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.253 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.91 125.25 85.77 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 118.359 1.079 . . . . 0.0 110.697 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.51 -176.93 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.571 3.514 . . . . 0.0 112.5 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 80.8 ttt180 -112.73 -34.24 0.11 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.457 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 87.0 Cg_endo -76.36 9.79 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.451 2.101 . . . . 0.0 114.287 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 163.86 29.38 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.555 0.616 . . . . 0.0 111.221 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -83.75 -179.61 7.34 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.566 1.146 . . . . 0.0 110.961 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.32 -3.52 8.33 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.96 0.504 . . . . 0.0 111.593 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.3 t -46.99 -36.91 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.081 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -76.57 -26.97 55.67 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.445 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.4 tt -80.19 -48.09 13.68 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.175 0.59 . . . . 0.0 109.609 -174.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.68 -28.92 62.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.869 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -28.97 43.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.008 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.7 pt -74.11 -46.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.182 0.901 . . . . 0.0 110.267 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -65.17 -21.32 66.76 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.774 -0.579 . . . . 0.0 110.305 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -95.59 -15.7 22.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -88.34 -20.65 25.06 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.595 1.088 . . . . 0.0 112.445 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.587 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -114.45 -34.13 5.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.587 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.6 m-85 -144.85 68.75 1.25 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.02 0.827 . . . . 0.0 109.532 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.9 164.49 17.21 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.65 10.55 4.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.26 159.83 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.768 0.827 . . . . 0.0 111.124 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.9 t -127.24 -42.24 1.71 Allowed 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.277 -0.264 . . . . 0.0 110.319 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -148.79 149.07 30.72 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.85 159.38 36.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.53 0.332 . . . . 0.0 110.762 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 171.37 168.57 33.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.2 143.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -68.39 142.56 55.39 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.047 0.451 . . . . 0.0 110.798 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.5 p -133.5 162.32 32.21 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.944 0.878 . . . . 0.0 112.746 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -90.92 122.44 66.72 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 125.491 1.516 . . . . 0.0 109.097 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.79 -4.8 14.78 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.872 2.381 . . . . 0.0 111.303 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.7 -45.96 60.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.798 0.439 . . . . 0.0 111.174 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.0 pt? -138.89 13.12 2.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 80.8 tttt 58.05 52.06 8.12 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.662 0.744 . . . . 0.0 110.263 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -132.0 145.46 57.51 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.467 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.41 147.0 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.117 2.544 . . . . 0.0 113.899 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -120.19 6.26 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.133 0.573 . . . . 0.0 110.055 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.13 167.56 35.85 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.61 167.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.402 1.081 . . . . 0.0 112.807 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.33 -177.63 29.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -149.15 162.11 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.126 0.488 . . . . 0.0 111.815 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.8 p -150.88 148.91 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.79 108.55 9.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.278 -0.264 . . . . 0.0 110.435 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -163.25 29.13 0.09 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.155 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 25.0 m -70.15 60.31 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.36 1.064 . . . . 0.0 111.993 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.2 -6.19 1.82 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -143.99 171.75 13.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.587 0.708 . . . . 0.0 111.453 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.01 -10.16 27.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.165 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.5 p -68.45 -38.32 81.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.728 -0.607 . . . . 0.0 109.717 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -75.19 -33.21 61.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.51 -34.62 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.01 -21.29 37.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.26 -4.82 34.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.446 0.566 . . . . 0.0 112.188 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -113.44 -13.72 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 118.127 0.421 . . . . 0.0 111.438 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 62.1 m -106.36 -0.52 24.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.487 0.315 . . . . 0.0 110.922 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -133.57 65.33 1.59 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -62.78 -26.42 68.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.774 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -119.76 139.18 52.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 238' ' ' GLN . 4.9 p -162.09 -179.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.536 ' H ' HG22 ' A' ' 237' ' ' VAL . 10.7 tm0? -58.99 120.0 8.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -159.52 136.74 9.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -146.55 130.39 17.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -159.07 140.74 13.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.765 0.426 . . . . 0.0 110.838 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.25 68.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.667 -0.519 . . . . 0.0 112.701 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.42 18.97 10.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.071 0.949 . . . . 0.0 112.836 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.77 156.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -132.18 152.13 51.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.172 -0.33 . . . . 0.0 110.565 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.04 -160.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.828 1.651 . . . . 0.0 112.746 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 51.6 82.29 0.06 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.0 1.32 . . . . 0.0 113.446 170.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 25.2 m -134.73 167.62 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.466 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -126.9 136.36 52.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.482 -0.136 . . . . 0.0 110.677 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.1 t -145.59 126.25 7.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -165.06 162.95 14.09 Favored Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.13 155.42 19.28 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.622 2.882 . . . . 0.0 113.184 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -79.81 -6.6 57.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.782 0.833 . . . . 0.0 111.771 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.605 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.137 0.018 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 57.82 176.26 0.05 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.61 1.164 . . . . 0.0 112.898 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -140.6 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.396 0.679 . . . . 0.0 110.213 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.03 -2.69 58.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.605 0.362 . . . . 0.0 111.183 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.11 169.24 38.74 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.22 -19.57 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.814 0.307 . . . . 0.0 111.366 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -152.55 154.98 36.52 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 122.761 0.424 . . . . 0.0 110.913 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.12 136.4 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.01 31.09 1.6 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.997 0.519 . . . . 0.0 110.67 -176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.72 -11.77 59.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.346 1.058 . . . . 0.0 113.361 -177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -105.72 152.6 22.97 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' HD12 ' A' ' 156' ' ' LEU . 39.1 t -75.85 134.77 40.25 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -75.81 -3.75 36.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 125.184 1.552 . . . . 0.0 113.708 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -80.51 135.14 36.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.3 t -135.32 145.64 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.2 -172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -106.33 148.98 27.4 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -128.03 142.88 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -135.3 -6.66 2.09 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.874 -0.403 . . . . 0.0 113.197 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -102.58 7.08 53.2 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.591 0.695 . . . . 0.0 112.379 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.13 136.31 67.81 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 117.505 0.652 . . . . 0.0 109.804 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.9 Cg_endo -64.82 162.49 31.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.492 2.794 . . . . 0.0 113.094 -170.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.3 Cg_exo -60.72 -8.02 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 124.788 3.659 . . . . 0.0 114.689 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -140.64 118.11 11.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.97 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 122.654 0.381 . . . . 0.0 110.922 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -130.84 -83.11 0.53 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.266 0.626 . . . . 0.0 110.237 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -155.34 -36.11 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -81.63 -20.5 39.58 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.63 -41.58 79.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.024 0.53 . . . . 0.0 109.765 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.405 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -80.31 -27.74 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.8 m -69.97 -21.92 63.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.37 -22.23 18.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.843 0.457 . . . . 0.0 111.026 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -70.54 -32.54 70.02 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 122.134 -0.354 . . . . 0.0 110.433 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -103.98 40.98 1.35 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -61.32 -20.02 62.47 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.823 -0.548 . . . . 0.0 111.426 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -87.32 -9.52 54.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.136 0.574 . . . . 0.0 111.137 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.16 -33.08 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.378 0.671 . . . . 0.0 110.461 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.08 -179.94 34.02 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.92 140.65 86.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.575 3.517 . . . . 0.0 113.234 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -153.86 168.56 25.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.804 0.842 . . . . 0.0 110.351 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.25 154.52 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.04 153.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.785 0.434 . . . . 0.0 111.472 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.13 142.73 36.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -118.34 148.19 43.36 Favored Pre-proline 0 CA--C 1.529 0.147 0 O-C-N 122.408 -0.183 . . . . 0.0 110.679 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.65 136.8 73.24 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.004 2.469 . . . . 0.0 111.39 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.0 t60 45.81 40.53 6.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.99 0.916 . . . . 0.0 112.937 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -67.03 -2.15 5.06 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.08 -4.53 44.78 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.007 0.367 . . . . 0.0 111.363 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.6 145.52 27.83 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.485 0.714 . . . . 0.0 109.25 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.2 m -147.0 154.74 41.6 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.542 0.337 . . . . 0.0 111.072 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -0.88 0.98 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.631 0.772 . . . . 0.0 111.491 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.2 m -146.75 164.26 33.33 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.319 1.047 . . . . 0.0 109.304 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -84.44 154.02 23.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.272 0.229 . . . . 0.0 110.999 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 6.8 p90 55.91 157.24 0.07 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 127.113 2.165 . . . . 0.0 113.7 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 105' ' ' PHE . 92.2 Cg_endo -75.07 171.43 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.575 2.85 . . . . 0.0 112.66 -173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.16 161.85 3.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.136 3.224 . . . . 0.0 112.829 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -109.27 157.31 18.96 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.241 0.616 . . . . 0.0 111.37 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.35 -21.16 2.98 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.073 0.844 . . . . 0.0 113.721 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -154.63 155.23 34.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.643 1.222 . . . . 0.0 111.072 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.77 174.1 12.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.189 0.596 . . . . 0.0 110.145 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.23 151.24 38.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.0 mt -143.19 163.86 31.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 133.14 14.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -87.45 163.42 16.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.894 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -75.52 -15.14 60.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.01 161.74 36.89 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 122.645 0.378 . . . . 0.0 110.193 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.64 -10.35 29.65 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.26 0.224 . . . . 0.0 111.473 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -90.95 -28.83 17.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.8 t -77.09 -26.96 53.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.85 -30.12 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 122.792 0.437 . . . . 0.0 110.562 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -33.81 16.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.81 -40.13 63.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.368 -0.207 . . . . 0.0 111.342 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.06 -37.39 23.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.741 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.76 -19.74 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.263 0.483 . . . . 0.0 110.04 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -88.35 -18.61 28.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.786 -0.571 . . . . 0.0 111.193 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -91.86 3.24 55.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 21.5 p -110.91 -176.42 2.96 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.873 0.469 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.25 155.03 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.853 0.461 . . . . 0.0 109.873 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -143.53 162.43 35.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.34 0.591 . . . . 0.0 111.871 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -144.79 156.63 44.14 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.923 1.289 . . . . 0.0 108.296 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.77 -10.99 22.85 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 122.222 -0.299 . . . . 0.0 111.196 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.73 -23.96 6.01 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.673 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.71 178.8 5.11 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.633 1.217 . . . . 0.0 111.101 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.74 163.41 13.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -138.42 122.29 17.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 135.52 33.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.33 0.652 . . . . 0.0 109.75 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 63.5 m -78.25 120.23 22.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.351 0.26 . . . . 0.0 111.459 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.32 147.45 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.7 p -166.96 34.49 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.523 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 46.5 t -141.44 -61.14 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 141' ' ' SER . 83.0 Cg_endo -72.06 108.31 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.399 2.066 . . . . 0.0 111.722 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m 49.4 19.96 0.41 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.017 1.327 . . . . 0.0 112.677 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -151.12 147.16 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.587 ' H ' HD13 ' A' ' 144' ' ' ILE . 45.3 mmtm -145.24 142.39 29.47 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.644 0.656 . . . . 0.0 112.531 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.28 12.52 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 170.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -147.32 143.14 17.67 Favored Pre-proline 0 CA--C 1.529 0.137 0 CA-C-N 119.496 1.044 . . . . 0.0 111.753 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.5 178.0 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.162 3.242 . . . . 0.0 110.952 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.26 142.01 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.375 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.57 138.96 58.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 tt -154.27 154.04 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.962 0.164 . . . . 0.0 110.751 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -160.41 129.53 3.16 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -88.82 -154.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.586 1 C-N-CA 125.978 4.452 . . . . 0.0 106.945 169.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -136.12 152.28 50.67 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 120.585 1.539 . . . . 0.0 113.174 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -110.11 73.21 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.61 0.719 . . . . 0.0 110.099 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.96 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.11 10.88 0.65 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.24 1.016 . . . . 0.0 112.37 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.9 m -108.77 -1.3 19.42 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.491 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -128.68 -28.6 2.46 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.722 0.692 . . . . 0.0 111.004 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.7 m -54.24 -15.37 1.53 Allowed 'General case' 0 C--N 1.338 0.073 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -95.43 120.84 36.37 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.564 0.62 . . . . 0.0 111.025 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.92 158.86 16.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.075 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.9 t -152.52 133.63 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.8 ttt -144.64 -6.76 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 58.15 171.33 0.05 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.459 1.104 . . . . 0.0 112.421 -174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.07 -169.48 42.11 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 121.997 -0.439 . . . . 0.0 112.08 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 40.2 m -79.47 -0.51 33.43 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.226 1.01 . . . . 0.0 112.753 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -148.25 113.25 3.83 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 118.073 0.397 . . . . 0.0 110.353 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.6 174.5 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 124.82 3.68 . . . . 0.0 113.351 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.86 130.75 39.04 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.972 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -151.48 153.91 32.81 Favored Pre-proline 0 CA--C 1.529 0.142 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.33 -3.48 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.692 2.928 . . . . 0.0 112.039 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -117.69 8.36 12.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 123.634 0.773 . . . . 0.0 110.779 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -128.15 12.97 6.67 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.561 1.145 . . . . 0.0 109.952 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.5 m -104.39 155.02 19.13 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.2 mt -132.1 152.66 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -107.13 148.31 28.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 19.4 t -133.16 122.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.55 150.51 19.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.68 86.83 0.76 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.81 0.719 . . . . 0.0 112.129 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.422 ' N ' ' CD ' ' A' ' 181' ' ' PRO . 21.4 m -141.82 46.48 0.82 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.061 0.944 . . . . 0.0 111.318 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 180' ' ' VAL . 87.5 Cg_endo -69.1 171.54 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.655 2.903 . . . . 0.0 112.094 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 60.5 159.43 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.911 1.684 . . . . 0.0 112.965 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.82 135.47 69.29 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.378 2.719 . . . . 0.0 111.379 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pp -161.24 177.81 9.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.214 0.606 . . . . 0.0 110.025 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.408 ' HG3' HG23 ' A' ' 187' ' ' VAL . 37.7 ptt85 -145.79 48.93 1.23 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 59.34 4.45 0.49 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.559 1.944 . . . . 0.0 115.471 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 185' ' ' ARG . 53.4 t -63.27 -37.98 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 118.588 0.631 . . . . 0.0 111.593 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 5.2 pt-20 -75.42 -29.42 59.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.652 -0.213 . . . . 0.0 111.039 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.8 tt -76.06 -51.21 12.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.614 0.766 . . . . 0.0 109.462 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.36 64.63 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 119.511 -0.28 . . . . 0.0 111.189 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -28.93 34.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.499 0.59 . . . . 0.0 111.948 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.3 pt -78.13 -44.22 27.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.094 0 CA-C-N 119.265 0.938 . . . . 0.0 110.571 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -66.87 -21.47 66.01 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.86 -0.525 . . . . 0.0 110.213 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 37.4 t70 -94.3 -17.77 22.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -88.06 -12.66 43.59 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.063 0.847 . . . . 0.0 112.418 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.492 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -121.54 -29.64 4.36 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 174.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.492 ' H ' HD12 ' A' ' 196' ' ' LEU . 29.0 m-85 -143.96 57.51 1.34 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.454 1.024 . . . . 0.0 110.376 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -61.48 160.24 28.69 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.249 0.452 . . . . 0.0 113.002 -176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 133.83 14.53 1.29 Allowed Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.105 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.28 157.89 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.86 0.864 . . . . 0.0 111.709 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 40.9 t -125.61 -39.34 2.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.566 0.347 . . . . 0.0 110.205 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -155.65 151.1 27.04 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.22 160.08 36.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.575 0.226 . . . . 0.0 111.282 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -168.69 170.41 42.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 205' ' ' ILE . 2.7 pp -135.37 146.35 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 45.28 -16.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 119.488 3.144 . . . . 0.0 119.488 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 205' ' ' ILE . 2.5 p -69.86 162.07 28.66 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 121.272 1.851 . . . . 0.0 114.222 -169.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -141.8 141.75 23.24 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.245 -171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.58 -3.38 13.73 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 124.083 3.189 . . . . 0.0 112.457 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -45.51 82.4 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.131 0.423 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.39 14.12 1.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.288 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 65.86 47.34 2.07 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 121.596 0.712 . . . . 0.0 109.551 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.429 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.6 t80 -139.85 146.72 48.3 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.624 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 92.7 Cg_exo -48.81 143.59 16.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.895 3.063 . . . . 0.0 114.442 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -134.23 -32.35 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.383 1.473 . . . . 0.0 109.801 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.7 156.9 7.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 122.737 0.208 . . . . 0.0 112.918 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 66.1 169.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.053 1.741 . . . . 0.0 114.178 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -118.83 167.66 13.15 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -153.2 157.6 40.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.153 0.501 . . . . 0.0 111.339 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.88 153.47 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.75 115.3 11.94 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.842 -0.536 . . . . 0.0 110.162 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.95 30.43 0.08 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.824 0.45 . . . . 0.0 111.14 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 46.7 m -69.34 75.19 0.37 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.333 0.653 . . . . 0.0 111.147 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.13 -5.23 0.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.37 165.66 30.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 110.527 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -63.41 -11.22 21.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.143 -0.348 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.2 p -68.87 -36.97 78.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -73.58 -32.75 64.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.44 -33.29 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.28 -23.94 37.59 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -176.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.01 -17.15 22.17 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.668 0.667 . . . . 0.0 111.779 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -95.85 -17.01 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 118.255 0.479 . . . . 0.0 110.602 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.9 m -97.18 3.01 51.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -120.9 52.75 1.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 250' ' ' VAL . 43.5 ttm180 -56.4 -28.71 60.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.122 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -124.97 141.72 51.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.5 p -158.16 171.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.0 OUTLIER -67.3 126.05 28.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 122.797 0.439 . . . . 0.0 110.514 -178.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 64.7 tp -156.4 141.85 17.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -146.5 114.53 6.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -159.08 106.29 1.79 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.5 -130.81 48.97 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -83.09 5.67 21.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.89 0.345 . . . . 0.0 111.826 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 42.6 mt -93.99 141.33 15.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.19 -157.26 0.77 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -51.5 -19.57 1.49 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.001 1.32 . . . . 0.0 113.178 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -87.87 80.88 7.7 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.348 0.659 . . . . 0.0 111.201 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.68 173.09 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.696 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -135.71 147.52 48.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.553 ' H ' ' HG3' ' A' ' 235' ' ' ARG . 12.7 t -142.2 127.43 17.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -163.78 157.12 16.03 Favored Pre-proline 0 CA--C 1.528 0.097 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.271 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.74 152.84 79.78 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.959 2.439 . . . . 0.0 112.173 -173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -83.4 164.1 20.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.044 0.938 . . . . 0.0 110.587 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.869 -179.671 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.337 0.113 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.4 m80 54.95 25.83 7.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.089 0.956 . . . . 0.0 113.364 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.0 167.84 23.02 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.9 0.48 . . . . 0.0 110.577 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -143.92 162.11 36.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.084 0.554 . . . . 0.0 110.534 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.57 167.88 50.82 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.53 10.95 8.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.238 0.615 . . . . 0.0 110.873 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -137.08 165.98 24.77 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.938 0.895 . . . . 0.0 109.946 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.51 141.86 43.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.297 0.639 . . . . 0.0 110.067 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -85.09 156.93 20.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.404 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -146.61 152.91 39.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.068 0.547 . . . . 0.0 110.258 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -134.31 164.46 27.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.042 -169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.6 t -70.39 123.47 21.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -71.73 -3.8 23.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.825 1.953 . . . . 0.0 113.255 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -83.9 127.52 33.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.68 123.72 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.83 149.91 24.5 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.92 152.17 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.24 -8.25 0.1 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.935 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.58 10.5 37.3 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 117.882 0.841 . . . . 0.0 113.469 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.61 152.66 73.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 117.989 0.895 . . . . 0.0 111.042 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 165.74 28.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.329 3.352 . . . . 0.0 111.924 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -58.27 -13.81 17.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.37 3.38 . . . . 0.0 113.807 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.27 113.84 8.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.17 149.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 121.538 0.685 . . . . 0.0 112.464 -173.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.64 164.04 29.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.943 1.697 . . . . 0.0 107.052 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.24 -22.26 64.64 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.438 -0.789 . . . . 0.0 111.392 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -82.02 -20.88 37.47 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.81 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -76.37 -47.2 24.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -29.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.8 m -70.76 -25.78 63.06 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 175.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.72 -17.76 35.01 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.593 0.357 . . . . 0.0 111.238 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -76.65 -29.73 56.52 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -100.66 46.49 0.95 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.57 -21.98 42.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -104.06 15.8 27.68 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.272 0.487 . . . . 0.0 112.115 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -105.19 154.82 19.7 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.48 -164.71 11.65 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 122.173 -0.33 . . . . 0.0 112.911 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.02 144.45 52.68 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.606 2.87 . . . . 0.0 110.327 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.15 168.76 24.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.507 0.323 . . . . 0.0 111.656 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.2 150.42 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.58 151.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 120.751 0.31 . . . . 0.0 111.697 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -149.53 155.37 40.23 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.247 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -102.57 156.36 35.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.541 0.736 . . . . 0.0 110.523 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -67.94 -15.21 43.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.95 2.433 . . . . 0.0 110.916 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -154.32 140.14 18.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.682 0.793 . . . . 0.0 109.192 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -154.17 169.76 22.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.842 0.457 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.52 170.32 11.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.604 0.762 . . . . 0.0 110.828 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -83.56 2.78 35.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.244 0.618 . . . . 0.0 111.374 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.7 p -69.68 166.84 18.3 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.041 0.537 . . . . 0.0 111.266 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.16 -20.85 63.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.931 0.493 . . . . 0.0 111.549 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.0 t -152.39 137.41 17.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.729 0.412 . . . . 0.0 109.973 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -154.02 161.47 41.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.881 0.472 . . . . 0.0 109.919 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -129.42 151.03 77.21 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.941 0.496 . . . . 0.0 110.259 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.13 150.4 82.12 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.952 2.434 . . . . 0.0 110.644 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.06 -11.13 19.64 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.989 3.126 . . . . 0.0 112.048 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -141.18 170.35 15.88 Favored 'General case' 0 C--N 1.337 0.047 0 C-N-CA 123.937 0.895 . . . . 0.0 109.972 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -73.03 -1.75 56.84 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -84.58 151.03 24.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.485 0.643 . . . . 0.0 111.049 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.15 154.28 40.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.162 0.585 . . . . 0.0 109.979 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -129.58 120.1 24.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.15 165.39 27.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.65 0.262 . . . . 0.0 110.458 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -146.7 160.14 42.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -108.71 162.16 14.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -172.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.55 -30.65 37.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -143.48 153.34 42.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.829 0.286 . . . . 0.0 111.147 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -87.51 -11.86 47.61 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.4 t -82.06 -30.9 31.13 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.936 0.789 . . . . 0.0 110.101 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 t -73.79 -30.8 62.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.93 -33.85 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.048 0.539 . . . . 0.0 109.61 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -74.91 -34.13 62.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.993 0.36 . . . . 0.0 110.587 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.03 -37.35 66.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.113 -0.367 . . . . 0.0 111.799 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 88' ' ' PHE . 2.8 tm? -82.99 -37.96 23.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.184 -0.322 . . . . 0.0 110.594 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.1 mt -64.06 -25.92 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.48 -20.64 29.43 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.899 -0.501 . . . . 0.0 110.811 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.03 25.26 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.351 0.66 . . . . 0.0 111.846 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.23 -179.27 6.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.51 154.93 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.304 0.642 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -145.77 162.84 36.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.191 0.52 . . . . 0.0 112.214 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -143.89 157.13 44.56 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.839 1.256 . . . . 0.0 108.465 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -62.17 -15.97 49.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.053 -0.404 . . . . 0.0 111.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -108.79 -22.56 6.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.716 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -164.22 -179.01 5.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 117.92 0.86 . . . . 0.0 111.091 -172.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 134' ' ' LYS . 3.9 mm? -117.51 164.45 14.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.223 0.609 . . . . 0.0 109.57 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -144.48 143.76 31.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -110.51 144.65 39.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.72 118.37 28.36 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.2 t -146.71 133.02 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.433 ' C ' ' CD ' ' A' ' 142' ' ' PRO . 14.6 m -159.26 154.54 25.44 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.607 0.763 . . . . 0.0 110.057 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m 82.67 -11.77 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.433 ' CD ' ' C ' ' A' ' 140' ' ' SER . 47.8 Cg_endo -81.48 69.57 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 123.446 2.267 . . . . 0.0 110.39 172.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m 61.97 22.38 13.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.46 0.704 . . . . 0.0 112.317 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -149.53 157.15 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.464 ' N ' HD13 ' A' ' 144' ' ' ILE . 24.5 tptm -140.8 141.83 34.72 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t0 49.82 42.6 24.17 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.315 1.846 . . . . 0.0 114.96 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -146.59 127.92 7.35 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.88 174.03 11.83 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.335 2.69 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.7 146.17 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -74.31 146.24 43.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.419 HG13 HD23 ' A' ' 137' ' ' LEU . 26.3 mm -140.64 132.37 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -143.06 91.09 7.2 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -84.8 -166.72 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 1 C-N-CA 125.521 4.147 . . . . 0.0 107.175 169.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -127.14 148.29 50.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.925 1.239 . . . . 0.0 113.186 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -107.83 62.97 0.62 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.171 0.989 . . . . 0.0 110.901 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.841 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.42 -0.69 2.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.951 177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 78.5 p -93.5 -5.03 50.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.527 0.331 . . . . 0.0 111.698 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -132.41 -15.26 2.84 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.163 0.438 . . . . 0.0 112.101 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.2 m -61.66 -3.65 1.15 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 175.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.73 122.14 38.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.226 0.536 . . . . 0.0 110.422 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 11.5 m-85 -99.77 159.16 15.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.22 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 78.3 t -154.31 131.5 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.5 ttp -157.58 17.83 0.27 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.588 0.176 . . . . 0.0 111.348 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.35 159.97 32.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 111.781 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.66 -2.42 0.03 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.642 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 74.7 m -132.7 -12.27 3.01 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.658 0.729 . . . . 0.0 112.205 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -156.84 132.03 5.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.19 166.31 26.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.894 3.062 . . . . 0.0 111.276 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -75.14 133.06 41.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -155.29 142.99 14.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.86 -21.44 26.08 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.558 2.839 . . . . 0.0 114.04 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -80.16 -10.9 59.78 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 122.778 0.431 . . . . 0.0 111.606 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 9.21 10.95 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.663 0.785 . . . . 0.0 110.943 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.4 m -81.96 146.63 29.66 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.11 153.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -111.51 148.94 32.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.35 121.56 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.55 149.76 18.98 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.43 93.84 0.56 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.895 0.76 . . . . 0.0 112.625 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.11 53.16 6.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.053 0.941 . . . . 0.0 109.575 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.39 156.46 65.56 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.638 2.892 . . . . 0.0 112.327 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 61.1 160.96 0.11 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.928 1.691 . . . . 0.0 112.619 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.93 104.42 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.682 2.921 . . . . 0.0 113.469 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -159.09 147.98 18.38 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 169.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -71.87 175.47 5.79 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.397 0.679 . . . . 0.0 110.594 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.41 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . -67.08 7.67 0.37 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.525 0.33 . . . . 0.0 111.784 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 55.6 t -52.45 -39.55 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 C-N-CA 122.932 0.493 . . . . 0.0 110.447 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.99 -30.11 67.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.545 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -79.08 -47.71 15.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.286 0.635 . . . . 0.0 110.051 -174.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.32 68.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.782 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.78 -29.68 45.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.096 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.8 pt -75.14 -44.84 43.2 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 CA-C-N 118.924 0.783 . . . . 0.0 110.407 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.0 mmt -70.4 -16.0 62.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.23 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.45 -11.9 21.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -14.86 24.13 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.615 1.098 . . . . 0.0 112.207 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.77 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.5 OUTLIER -115.47 -88.14 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.958 0.344 . . . . 0.0 110.718 173.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.77 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 5.6 p90 -140.74 133.23 28.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.457 1.103 . . . . 0.0 108.988 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 152.66 -150.06 21.79 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.39 -176.16 46.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.3 p -160.55 146.37 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.885 0.374 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 83.7 m -133.85 -32.41 1.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -152.29 137.07 17.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 220' ' ' VAL . . . -154.67 164.82 38.18 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.907 0.384 . . . . 0.0 111.224 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 173.97 173.7 40.29 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.39 141.61 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -72.49 142.42 48.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.4 p -133.22 155.21 49.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.039 0.923 . . . . 0.0 112.934 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.18 122.78 85.76 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.105 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.93 -4.78 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.911 2.407 . . . . 0.0 111.334 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.8 -44.99 68.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.153 0.581 . . . . 0.0 111.417 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 211' ' ' LEU . 0.6 OUTLIER -144.61 14.48 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 57.78 48.89 13.05 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 124.29 1.036 . . . . 0.0 110.639 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.411 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 63.2 t80 -122.63 146.99 49.29 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.887 -174.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 85.0 Cg_exo -48.03 145.57 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.609 2.873 . . . . 0.0 113.624 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -120.73 11.22 11.15 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.89 16.73 62.79 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 118.218 0.463 . . . . 0.0 113.758 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.48 172.54 13.06 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.592 0.696 . . . . 0.0 110.09 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.32 176.2 33.78 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.71 153.87 36.35 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 111.27 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 203' ' ' ALA . 7.8 p -146.28 157.86 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.068 0.947 . . . . 0.0 108.781 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.53 119.18 15.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.012 -0.43 . . . . 0.0 109.843 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -167.56 167.28 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.757 0.823 . . . . 0.0 109.584 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.5 m -146.29 46.14 1.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.204 0.602 . . . . 0.0 109.598 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -70.54 73.87 0.54 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.005 0.922 . . . . 0.0 112.711 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 226' ' ' GLN . 11.8 tp60 47.08 -146.22 0.22 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.993 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 4.6 tt0 -66.52 -14.34 62.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.889 -0.507 . . . . 0.0 111.682 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.3 m -72.77 -31.87 65.2 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.586 -0.696 . . . . 0.0 109.487 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -31.94 65.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 173.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.51 -33.7 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.01 -25.03 52.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.144 -0.455 . . . . 0.0 112.126 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.33 -24.09 16.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.682 0.674 . . . . 0.0 111.971 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.3 tt -85.91 -13.02 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.523 0.601 . . . . 0.0 110.113 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m -96.97 -3.94 40.76 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -93.99 54.55 1.95 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -14.0 62.69 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.383 -175.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -154.47 119.32 4.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.75 160.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -57.59 148.28 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 111.265 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -158.87 132.21 7.31 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -134.66 131.25 37.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.117 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 19.8 t60 -158.79 -176.49 5.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.429 1.092 . . . . 0.0 108.126 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -61.7 133.25 47.18 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 56.42 11.41 0.83 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.1 mt -139.24 135.9 41.48 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.866 0.757 . . . . 0.0 109.772 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -140.45 -9.33 1.1 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.62 ' H ' ' HE2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -163.07 175.43 11.09 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.514 0.597 . . . . 0.0 112.27 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 54.57 94.95 0.02 OUTLIER 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.019 1.727 . . . . 0.0 113.797 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.86 156.76 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.978 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -138.3 144.8 40.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.04 116.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.91 163.42 28.87 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 119.528 -0.273 . . . . 0.0 110.662 -177.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.52 155.96 33.88 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.407 2.738 . . . . 0.0 111.928 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -91.36 -10.05 42.62 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.806 0.443 . . . . 0.0 111.589 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.698 -178.164 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.53 0.205 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -149.23 164.84 33.64 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.149 0.58 . . . . 0.0 110.855 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -146.92 149.92 34.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.433 0.693 . . . . 0.0 109.42 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -139.27 5.07 2.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.492 0.317 . . . . 0.0 111.847 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.03 7.88 82.3 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.0 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -135.63 13.15 3.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.661 0.73 . . . . 0.0 111.485 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -111.58 6.8 20.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.747 . . . . 0.0 111.176 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 t -84.56 50.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.526 0.73 . . . . 0.0 109.863 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.47 28.35 0.2 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.25 1.02 . . . . 0.0 111.825 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.5 28.65 0.54 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.069 0.948 . . . . 0.0 113.349 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -114.72 156.96 23.85 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 36.1 t -90.85 139.96 30.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -70.42 -13.04 61.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 124.763 1.289 . . . . 0.0 112.471 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.84 122.82 23.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.66 130.43 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 110.161 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -83.1 144.75 29.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.653 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.48 151.55 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -151.26 -12.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.769 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.47 14.03 25.42 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 117.317 0.558 . . . . 0.0 112.814 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.53 148.99 52.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.048 0.924 . . . . 0.0 111.512 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 163.73 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.81 3.007 . . . . 0.0 111.868 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.12 -9.01 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.599 2.866 . . . . 0.0 111.775 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.51 115.61 9.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 146.73 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.728 0.775 . . . . 0.0 112.128 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.52 163.77 31.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.822 1.649 . . . . 0.0 107.166 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -52.43 -34.76 49.98 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.421 0.555 . . . . 0.0 111.307 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.59 -20.94 59.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.303 0.241 . . . . 0.0 111.504 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -80.53 -46.14 16.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -28.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 m -74.23 -29.18 61.59 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.54 -22.66 32.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.185 -0.322 . . . . 0.0 110.895 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.3 m -75.26 -40.64 58.63 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 87' ' ' ARG . 14.4 m-30 -86.64 57.81 4.71 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 121.021 0.438 . . . . 0.0 110.094 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.6 14.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.76 0.824 . . . . 0.0 112.201 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 85' ' ' PHE . 89.1 mmt-85 -129.55 2.05 5.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.986 0.915 . . . . 0.0 111.259 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.4 159.63 15.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.706 0.402 . . . . 0.0 110.506 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.79 -163.78 11.04 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.4 151.6 82.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.174 2.583 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.73 164.06 28.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.11 140.43 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 m -134.95 157.56 40.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.11 138.51 18.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.196 0.522 . . . . 0.0 110.896 173.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -163.39 155.91 15.68 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.081 0.952 . . . . 0.0 109.283 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.83 179.34 5.77 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.805 3.003 . . . . 0.0 111.436 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 57.77 24.12 10.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -105.85 8.55 32.76 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.57 20.15 3.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.128 0.571 . . . . 0.0 111.464 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -73.27 161.03 30.98 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.517 0.327 . . . . 0.0 111.04 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.8 m -112.51 6.64 18.62 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.204 0.602 . . . . 0.0 111.754 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -137.05 -3.55 1.99 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.272 0.629 . . . . 0.0 110.85 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -141.61 165.82 26.45 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.566 0.746 . . . . 0.0 110.153 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -143.37 147.29 34.44 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.878 0.471 . . . . 0.0 110.248 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 58.6 148.98 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.893 1.677 . . . . 0.0 112.671 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.8 159.77 41.58 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.937 2.424 . . . . 0.0 110.773 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 32.5 Cg_exo -61.04 177.74 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.073 3.182 . . . . 0.0 112.02 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -75.29 19.0 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.43 0.692 . . . . 0.0 110.953 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -75.38 -162.57 10.98 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.727 0.68 . . . . 0.0 112.525 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -82.7 165.47 19.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.115 0.483 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.26 158.45 43.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.65 0.78 . . . . 0.0 110.206 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.75 138.65 52.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -161.93 167.59 24.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -149.28 171.27 16.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.565 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.19 150.44 39.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.026 0.93 . . . . 0.0 108.529 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.72 -11.12 29.72 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.9 91.71 8.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.433 0.56 . . . . 0.0 110.017 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -64.13 -20.31 65.89 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.5 t -73.83 -25.04 59.88 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -86.01 -25.01 26.2 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.03 -41.89 93.91 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -34.87 46.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 122.272 -0.268 . . . . 0.0 110.69 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.75 72.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.46 -42.64 22.25 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.337 -0.227 . . . . 0.0 110.564 -174.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.49 -22.19 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.12 -19.57 22.16 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.752 -0.592 . . . . 0.0 111.758 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.69 18.78 10.97 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.1 176.9 7.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -69.15 148.49 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.45 160.66 39.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.422 0.629 . . . . 0.0 112.61 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.5 156.63 43.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.437 1.495 . . . . 0.0 107.867 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -64.04 -7.82 9.84 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.925 -0.484 . . . . 0.0 111.467 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.87 -24.07 4.73 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.771 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -168.21 -176.22 2.86 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.327 1.063 . . . . 0.0 110.242 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.05 169.66 15.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 110.305 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -141.26 138.65 33.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.903 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 149' ' ' VAL . 19.0 mt -100.19 143.51 30.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 27.4 p -91.7 30.92 1.26 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.144 0.977 . . . . 0.0 111.513 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -8.15 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.613 0.765 . . . . 0.0 112.623 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.9 p -83.14 75.33 9.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.956 0.503 . . . . 0.0 110.018 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.652 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 33.1 t -155.95 -37.23 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 141' ' ' SER . 34.7 Cg_exo -64.56 -152.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.132 3.221 . . . . 0.0 111.869 172.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -60.13 -6.27 1.35 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.891 0.476 . . . . 0.0 111.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.01 130.47 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.809 0.843 . . . . 0.0 109.462 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -154.67 118.21 4.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -157.69 60.33 0.48 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 63.47 156.89 0.12 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.865 1.266 . . . . 0.0 111.204 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.93 164.0 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.9 2.4 . . . . 0.0 111.048 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 137' ' ' LEU . 22.0 m -105.56 135.61 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.966 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -74.33 137.42 42.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.59 146.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 123.167 0.292 . . . . 0.0 110.826 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -159.0 134.79 6.08 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -83.99 -156.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 125.174 3.916 . . . . 0.0 107.797 171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 72.2 t-105 -123.09 151.9 41.58 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.947 0.794 . . . . 0.0 110.489 168.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -104.66 106.94 17.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.044 0.449 . . . . 0.0 110.151 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mp -65.62 -20.96 66.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.779 0.831 . . . . 0.0 110.402 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 t -88.59 -30.84 18.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.181 -174.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.34 -16.81 57.32 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.147 0.885 . . . . 0.0 110.823 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 70.4 m -62.59 -7.43 4.7 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -131.9 109.39 10.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.2 m-85 -96.21 155.06 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.524 173.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.85 155.53 4.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 tpp -126.89 -55.61 1.38 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.321 0.509 . . . . 0.0 111.389 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -158.8 -5.76 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.46 65.16 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.4 m -68.31 -11.02 58.82 Favored 'General case' 0 C--O 1.23 0.049 0 C-N-CA 123.62 0.768 . . . . 0.0 111.847 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -148.88 130.88 7.55 Favored Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.27 158.91 44.52 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.718 2.945 . . . . 0.0 110.845 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.53 129.43 34.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.398 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -151.1 153.53 32.97 Favored Pre-proline 0 C--O 1.231 0.129 0 C-N-CA 124.741 1.216 . . . . 0.0 108.055 176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.76 -14.93 47.05 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 111.321 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -81.72 -12.3 58.67 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.553 0.741 . . . . 0.0 111.748 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 173' ' ' LYS . 44.5 mtmt -131.77 8.03 4.47 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.346 0.658 . . . . 0.0 111.559 -175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 94.2 m -90.49 154.1 19.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.74 154.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -114.93 146.4 41.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.6 t -135.29 125.09 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -121.92 179.98 16.11 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.49 9.52 72.22 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.647 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.7 128.35 93.75 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.92 -33.53 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.315 2.676 . . . . 0.0 112.763 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -152.14 166.4 15.37 Favored Pre-proline 0 C--O 1.23 0.077 0 C-N-CA 124.603 1.161 . . . . 0.0 108.226 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.04 124.95 16.81 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.244 1.963 . . . . 0.0 109.183 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.5 HD12 ' H ' ' A' ' 186' ' ' ALA . 4.1 pp -142.83 152.06 41.77 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.952 0.406 . . . . 0.0 110.783 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -82.16 37.15 0.48 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.834 0.854 . . . . 0.0 111.597 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.5 ' H ' HD12 ' A' ' 184' ' ' LEU . . . 52.63 18.32 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.92 1.288 . . . . 0.0 112.647 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.38 -52.81 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 122.681 0.393 . . . . 0.0 111.783 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -73.77 -19.71 60.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.693 -0.194 . . . . 0.0 111.131 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 189' ' ' LEU . 5.7 tt -77.58 -56.05 4.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.317 1.047 . . . . 0.0 110.372 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -72.92 -28.24 62.34 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.963 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -37.56 57.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.478 -174.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.2 pt -73.26 -39.78 56.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 119.135 0.88 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.405 ' HA ' HD11 ' A' ' 196' ' ' LEU . 26.5 mmt -67.04 -24.86 66.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.922 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.47 -21.56 26.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 195' ' ' ARG . 45.5 mtt85 -80.25 -30.08 38.43 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.14 -23.45 12.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -176.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 196' ' ' LEU . 41.5 m-85 -140.86 -123.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 111.807 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.72 177.58 54.31 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.311 0.481 . . . . 0.0 112.865 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.96 -139.87 2.6 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.6 p -161.86 148.93 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.4 t -117.61 -35.7 3.89 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -150.17 144.1 25.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -162.36 168.69 21.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.11 172.59 33.63 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.6 pp -91.21 149.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.069 0.461 . . . . 0.0 110.18 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -72.98 135.07 44.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 p -123.23 161.5 24.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 122.24 1.019 . . . . 0.0 112.763 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -90.44 121.67 68.17 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.672 -1.604 . . . . 0.0 108.987 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.58 -5.76 17.78 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.019 2.48 . . . . 0.0 111.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.31 -44.99 42.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.739 0.416 . . . . 0.0 111.224 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 211' ' ' LEU . 1.9 pt? -135.4 12.46 3.51 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 58.32 49.68 10.67 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.924 0.49 . . . . 0.0 110.786 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -133.17 147.68 66.15 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.185 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.91 139.86 24.6 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.112 2.541 . . . . 0.0 113.199 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.09 8.27 11.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.765 0.826 . . . . 0.0 110.923 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.49 158.9 32.74 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.55 175.37 0.08 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.437 1.095 . . . . 0.0 113.146 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -156.81 -171.13 22.59 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -156.73 164.71 37.81 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.502 0.668 . . . . 0.0 112.333 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.58 157.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.822 1.249 . . . . 0.0 108.446 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -148.4 106.97 3.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.14 34.84 0.14 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.837 0.455 . . . . 0.0 110.994 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 m -71.16 81.25 0.7 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.775 0.43 . . . . 0.0 110.12 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.5 -2.19 0.77 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -150.01 155.68 40.35 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.181 0.9 . . . . 0.0 111.74 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 229' ' ' ILE . 71.4 tp60 -60.49 -14.98 22.63 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 122.113 -0.367 . . . . 0.0 110.702 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.3 m -81.15 -20.84 40.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.508 -0.745 . . . . 0.0 110.431 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -32.84 66.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 226' ' ' GLN . 4.1 mm -62.62 -39.01 83.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.82 61.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.41 26.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.31 0.505 . . . . 0.0 112.223 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -85.77 -15.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 118.555 0.616 . . . . 0.0 109.365 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -92.0 -9.31 43.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -85.91 56.75 4.11 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.14 -13.42 60.46 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.27 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -140.39 152.36 45.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.04 161.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -60.03 -32.11 70.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.34 0.656 . . . . 0.0 110.985 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 24.2 tp 6.58 117.06 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.84 2.856 . . . . 0.0 116.374 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -113.91 122.29 46.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -154.87 128.97 8.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.575 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.29 -136.52 50.52 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.29 16.58 11.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.473 0.709 . . . . 0.0 111.921 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.39 152.95 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -139.19 148.95 43.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.2 pttt 46.87 9.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 117.095 2.257 . . . . 0.0 117.095 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -141.06 112.28 7.32 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.744 1.156 . . . . 0.0 112.399 -173.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.69 -178.65 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.719 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -141.45 142.83 33.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.52 0.328 . . . . 0.0 110.836 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.89 126.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -150.87 160.1 32.84 Favored Pre-proline 0 C--N 1.338 0.068 0 CA-C-O 119.475 -0.297 . . . . 0.0 110.418 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.18 155.98 67.09 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.695 2.264 . . . . 0.0 110.229 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -80.69 -4.04 52.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.001 0.52 . . . . 0.0 111.767 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.738 -1.125 . . . . 0.0 110.516 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.52 0.2 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -148.01 167.28 25.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.015 0.526 . . . . 0.0 110.435 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -138.67 161.55 36.86 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.425 0.69 . . . . 0.0 110.113 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -148.27 162.63 39.12 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.932 0.493 . . . . 0.0 110.014 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.12 6.41 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.03 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -142.07 153.26 44.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.921 0.861 . . . . 0.0 110.85 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.82 160.71 40.46 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.03 0.532 . . . . 0.0 111.106 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.53 141.22 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 124.051 0.94 . . . . 0.0 108.618 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.4 -46.24 7.77 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.24 176.3 12.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.395 0.678 . . . . 0.0 109.633 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -151.12 -162.8 1.62 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.676 -176.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.3 t -77.71 117.72 19.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -67.99 -8.35 36.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 126.342 2.276 . . . . 0.0 113.356 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -76.5 134.17 39.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.99 126.01 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.836 0.351 . . . . 0.0 110.125 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -89.7 145.92 24.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.07 120.61 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.17 -21.78 29.15 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.697 -0.502 . . . . 0.0 112.599 -174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.44 127.32 7.82 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.1 tp -150.41 143.86 16.89 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 53.6 Cg_exo -55.23 156.89 15.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.993 3.129 . . . . 0.0 114.0 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.5 Cg_exo -60.36 -14.8 31.73 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 124.585 3.523 . . . . 0.0 113.503 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.3 115.09 9.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.07 145.29 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.883 0.849 . . . . 0.0 112.518 -174.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 20.5 t70 -143.36 168.06 20.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.294 1.837 . . . . 0.0 106.604 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.63 -33.44 55.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.591 0.632 . . . . 0.0 111.225 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.31 -19.01 58.67 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.513 0.325 . . . . 0.0 111.778 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 6.3 tp10 -81.55 -44.1 17.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -25.01 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.4 m -76.48 -26.6 55.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.55 -21.06 28.74 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.142 0.177 . . . . 0.0 110.542 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -77.22 -33.72 56.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -99.22 45.22 1.0 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -63.29 -18.23 63.37 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.99 -0.444 . . . . 0.0 111.612 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.88 8.86 30.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.619 0.767 . . . . 0.0 110.742 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -121.11 160.91 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.184 0.993 . . . . 0.0 110.358 -173.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.33 -170.37 33.87 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.036 0.351 . . . . 0.0 112.313 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.6 142.34 39.91 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.8 3.0 . . . . 0.0 110.556 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -153.85 176.17 12.47 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.091 0.556 . . . . 0.0 110.576 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -128.65 154.51 39.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -120.01 159.47 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 140.09 21.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -100.0 154.75 37.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 O-C-N 122.241 -0.287 . . . . 0.0 110.9 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.85 -31.4 93.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.297 2.665 . . . . 0.0 113.449 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -158.47 -16.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -73.09 155.81 39.34 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.157 0.583 . . . . 0.0 110.509 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.69 166.08 25.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.335 0.654 . . . . 0.0 110.509 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.99 10.59 11.45 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.233 0.613 . . . . 0.0 111.471 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.7 t -78.57 5.97 9.73 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.366 0.667 . . . . 0.0 111.952 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -138.5 155.08 48.74 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.238 0.615 . . . . 0.0 110.048 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.8 m -87.63 14.42 8.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.602 0.761 . . . . 0.0 112.799 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -121.35 153.33 37.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.601 0.36 . . . . 0.0 110.91 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.87 152.89 38.54 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.811 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.1 156.58 47.06 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.604 2.869 . . . . 0.0 110.906 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -76.18 -176.35 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.541 3.494 . . . . 0.0 110.734 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -58.5 151.45 20.26 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.33 -139.64 6.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -129.63 166.08 20.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.948 0.499 . . . . 0.0 110.122 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.46 173.31 14.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.608 0.363 . . . . 0.0 110.728 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.46 141.37 51.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.2 mt -138.14 161.02 37.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.18 158.5 42.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -116.85 159.5 22.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -169.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -88.35 -17.5 30.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.526 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -126.02 155.12 41.97 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.14 -12.22 16.84 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.9 m -91.92 -26.83 18.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.132 0.424 . . . . 0.0 110.696 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.8 t -73.14 -32.66 65.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 63' ' ' TYR . 90.2 t -64.11 -34.05 66.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -31.31 23.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.57 -37.08 60.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 137' ' ' LEU . 3.1 tm? -85.44 -40.4 16.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.881 0.309 . . . . 0.0 110.701 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.0 mt -69.33 -22.76 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.607 0.64 . . . . 0.0 109.98 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -87.48 -20.95 25.84 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.058 -0.401 . . . . 0.0 111.347 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.54 -6.57 58.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.944 0.338 . . . . 0.0 110.639 175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 83.8 m -105.77 -171.17 1.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.99 0.916 . . . . 0.0 109.007 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 136' ' ' TYR . 15.8 tt -92.74 154.2 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 O-C-N 121.594 -0.691 . . . . 0.0 110.288 -173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -140.74 165.49 27.34 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -147.17 153.49 39.94 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.606 1.562 . . . . 0.0 107.588 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.53 -11.84 47.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.688 -0.633 . . . . 0.0 111.071 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.85 -27.58 7.39 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.061 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.423 ' C ' HD22 ' A' ' 135' ' ' LEU . 3.7 ptpt -166.88 171.72 11.01 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.385 1.093 . . . . 0.0 111.178 -176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 134' ' ' LYS . 2.8 mm? -112.67 164.41 13.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB2' HG23 ' A' ' 129' ' ' ILE . 38.1 m-85 -144.11 136.27 26.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 110.66 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -94.06 140.46 29.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.508 0.723 . . . . 0.0 109.611 -179.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 50.4 t -92.99 117.64 30.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -151.51 146.98 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-O 120.629 0.252 . . . . 0.0 110.538 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.7 t -160.34 98.98 1.3 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD3' ' A' ' 142' ' ' PRO . 31.4 t -159.18 -48.41 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.518 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 141' ' ' SER . 34.2 Cg_exo -60.98 -173.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.555 2.17 . . . . 0.0 111.163 169.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.7 p -70.94 4.13 2.83 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -31.46 23.67 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.143 0.883 . . . . 0.0 111.249 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 42.62 106.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 127.118 2.167 . . . . 0.0 115.036 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.35 32.42 21.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.678 1.191 . . . . 0.0 113.394 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -123.85 134.22 25.2 Favored Pre-proline 0 CA--C 1.529 0.154 0 O-C-N 122.21 -0.306 . . . . 0.0 110.63 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.46 174.77 11.88 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.145 3.23 . . . . 0.0 111.265 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.14 146.58 32.93 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.94 144.57 50.52 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.2 mm -137.57 142.09 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.972 0.909 . . . . 0.0 109.271 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -149.58 92.2 4.25 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.43 -173.37 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.994 3.13 . . . . 0.0 106.039 167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -141.11 119.94 12.62 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 121.314 1.87 . . . . 0.0 115.8 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.95 77.95 0.22 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.364 1.865 . . . . 0.0 112.498 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.728 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -65.5 1.73 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.067 0.547 . . . . 0.0 112.211 174.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.9 m -110.59 1.04 17.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.689 0.396 . . . . 0.0 111.057 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.76 -18.33 11.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.904 0.32 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 32.1 m -62.61 37.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -142.01 119.3 11.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.651 0.66 . . . . 0.0 110.335 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 186' ' ' ALA . 68.9 m-85 -129.33 112.41 13.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.272 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.58 150.83 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-O 121.384 0.612 . . . . 0.0 112.109 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.55 15.37 2.55 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.306 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -65.32 158.34 26.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.749 0.785 . . . . 0.0 112.721 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.42 9.16 0.03 OUTLIER Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.735 1.159 . . . . 0.0 110.757 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.9 t -153.31 -22.93 0.15 Allowed 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.984 0.892 . . . . 0.0 113.228 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.02 89.41 14.74 Favored Pre-proline 0 N--CA 1.455 -0.225 0 CA-C-N 118.186 0.448 . . . . 0.0 110.729 -170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.21 162.24 5.92 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.328 3.352 . . . . 0.0 112.912 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.3 136.04 54.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -156.13 139.19 10.81 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.02 -24.16 47.4 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.347 2.698 . . . . 0.0 114.08 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.58 -15.87 58.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.698 0.399 . . . . 0.0 111.285 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -108.38 6.25 26.19 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.91 0.884 . . . . 0.0 110.593 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.4 m -86.6 146.09 26.48 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.68 153.57 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -108.3 147.31 31.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.7 t -138.87 114.97 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 122.766 0.427 . . . . 0.0 109.956 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 129.32 9.86 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 154.61 10.68 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.889 -0.95 . . . . 0.0 114.528 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.07 64.71 7.0 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 119.152 1.476 . . . . 0.0 110.666 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.26 -0.37 7.98 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.233 3.289 . . . . 0.0 113.294 -174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -138.5 157.19 72.72 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 118.221 0.464 . . . . 0.0 110.906 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.62 129.3 17.5 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.188 2.592 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 pp -165.77 157.23 14.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.036 1.334 . . . . 0.0 108.073 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -79.44 44.57 0.61 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.508 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . . . 49.03 21.62 0.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.178 1.391 . . . . 0.0 112.595 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.07 -41.47 92.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 C-N-CA 122.25 0.22 . . . . 0.0 111.271 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.11 -23.64 43.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.313 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 189' ' ' LEU . 4.6 tt -78.24 -51.46 10.14 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.945 0.898 . . . . 0.0 109.366 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.18 -40.11 90.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.09 56.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 17.8 pt -74.62 -45.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.773 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -64.75 -19.92 66.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.98 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.25 -7.48 29.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 -12.37 16.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.042 1.292 . . . . 0.0 113.847 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -107.05 -84.37 0.52 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.147 0.885 . . . . 0.0 113.116 177.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.674 ' H ' ' CD1' ' A' ' 196' ' ' LEU . 0.3 OUTLIER -146.18 0.52 0.82 Allowed 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -80.63 -165.52 33.24 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -160.23 174.11 36.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.16 144.81 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 117.578 0.689 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 77.9 m -130.82 -29.99 1.86 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -145.27 139.08 26.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.24 150.73 30.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.61 173.0 45.97 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -97.62 135.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.498 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 38.8 t70 -74.44 144.99 44.0 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.861 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -128.81 150.94 50.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 111.921 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.25 122.73 81.48 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.483 1.513 . . . . 0.0 108.606 177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.29 -4.85 15.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.211 2.607 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.51 -42.71 58.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.867 0.303 . . . . 0.0 111.17 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 211' ' ' LEU . 2.2 pt? -143.5 13.53 1.76 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? 59.17 52.15 6.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.715 0.806 . . . . 0.0 110.594 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 70.5 t80 -125.81 147.56 59.19 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 109.462 -177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 96.7 Cg_exo -47.82 132.56 21.78 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.995 2.464 . . . . 0.0 112.833 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -109.87 9.54 24.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.419 0.688 . . . . 0.0 111.811 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 85.83 15.36 65.58 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.708 -0.496 . . . . 0.0 113.726 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -139.54 168.69 19.25 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.823 0.812 . . . . 0.0 110.311 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -149.44 178.31 27.05 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -154.53 159.49 40.97 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.47 0.652 . . . . 0.0 111.941 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.23 153.68 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 114.623 -1.171 . . . . 0.0 107.937 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.31 122.62 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -161.35 -51.78 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 119.439 -0.315 . . . . 0.0 111.17 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 50.0 m 42.5 41.22 2.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.416 0.686 . . . . 0.0 111.617 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -65.12 -68.55 0.35 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.4 0.68 . . . . 0.0 112.808 -172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.522 ' HG2' ' H ' ' A' ' 226' ' ' GLN . 14.0 tt0 -154.38 -149.07 0.26 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -174.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.522 ' H ' ' HG2' ' A' ' 225' ' ' GLN . 3.9 tt0 -60.18 -10.79 4.89 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.483 -0.761 . . . . 0.0 110.838 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.4 p -68.51 -41.48 79.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.706 -0.621 . . . . 0.0 110.266 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.5 OUTLIER -74.91 -27.94 60.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 176.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.4 -32.04 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.3 -32.26 55.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.882 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.34 -5.88 42.41 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.73 0.695 . . . . 0.0 112.61 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.6 tt -105.66 -12.94 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 118.295 0.498 . . . . 0.0 110.735 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 m -105.21 -5.06 21.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.436 0.294 . . . . 0.0 110.326 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.44 8.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.412 ' HD2' ' H ' ' A' ' 235' ' ' ARG . 0.0 OUTLIER -134.25 16.39 3.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.857 -177.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -135.53 36.77 2.92 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.867 -0.52 . . . . 0.0 110.394 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 164.99 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -50.2 136.59 19.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.379 0.609 . . . . 0.0 111.626 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 54.5 tp -169.85 153.47 4.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.406 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -145.72 107.24 4.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.73 155.17 32.63 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.606 0.362 . . . . 0.0 110.47 -177.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 54.82 -119.23 11.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.28 22.51 7.8 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.591 0.756 . . . . 0.0 110.154 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 65.3 mt -129.39 153.49 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.713 0.805 . . . . 0.0 110.04 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -137.68 151.9 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.612 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 47.07 6.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.582 2.353 . . . . 0.0 117.015 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -147.86 140.1 24.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.675 1.125 . . . . 0.0 112.091 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 178.57 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.67 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.27 123.49 34.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.5 t -140.35 123.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -162.9 162.62 18.26 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.021 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.65 152.96 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.447 2.765 . . . . 0.0 112.536 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -81.04 163.13 23.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.328 0.651 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.253 1.243 0 CA-C-O 116.111 -1.899 . . . . 0.0 112.231 179.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -140.08 161.79 36.79 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.321 0.649 . . . . 0.0 110.463 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -87.9 161.39 17.51 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.621 0.368 . . . . 0.0 110.843 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.0 t30 60.27 167.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.927 1.291 . . . . 0.0 112.674 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.03 176.32 40.82 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -146.92 165.15 30.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.57 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -150.72 150.44 31.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.039 0.535 . . . . 0.0 109.906 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.74 158.15 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.133 0.573 . . . . 0.0 110.366 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 155.81 39.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.102 -0.374 . . . . 0.0 110.264 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -137.65 137.85 38.85 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.411 0.624 . . . . 0.0 110.818 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 4.3 p90 -162.91 -161.58 0.71 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.167 -169.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 t -76.6 102.24 6.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 109.833 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -67.48 -5.2 13.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 125.725 1.891 . . . . 0.0 112.595 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.23 136.8 35.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.8 t -134.37 136.15 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.339 0.59 . . . . 0.0 111.501 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -87.44 140.25 29.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.68 116.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.47 -21.01 45.99 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.101 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.0 134.37 9.82 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -148.01 151.74 38.62 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.774 1.23 . . . . 0.0 107.994 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.21 155.29 71.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.755 2.303 . . . . 0.0 110.915 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.58 -7.24 8.52 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.202 3.268 . . . . 0.0 114.427 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -127.3 26.62 5.99 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.313 0.645 . . . . 0.0 110.988 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.74 129.87 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.24 0.543 . . . . 0.0 111.801 -176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -157.6 108.14 2.22 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 42.08 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.9 -23.08 64.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.106 0.562 . . . . 0.0 111.809 -176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -66.99 -47.8 70.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.774 0.261 . . . . 0.0 110.34 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -29.04 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -69.08 -20.17 64.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.87 -19.74 14.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.275 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.9 m -68.66 -33.48 74.06 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -89.6 146.82 24.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -114.68 134.77 54.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.524 0.147 . . . . 0.0 110.606 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 48.21 29.48 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.48 1.112 . . . . 0.0 113.067 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.25 3.85 33.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.019 0.372 . . . . 0.0 111.674 -177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.79 173.92 32.24 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.612 0.625 . . . . 0.0 112.327 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.5 141.11 97.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.977 3.118 . . . . 0.0 110.961 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -147.9 164.18 34.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -122.26 145.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.0 m -133.38 154.34 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.729 0.299 . . . . 0.0 111.543 -173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.54 145.5 27.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -100.1 152.15 37.73 Favored Pre-proline 0 N--CA 1.456 -0.165 0 C-N-CA 122.414 0.285 . . . . 0.0 110.868 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.95 -17.42 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.111 2.541 . . . . 0.0 111.108 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -156.61 145.23 19.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.866 0.466 . . . . 0.0 110.452 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -155.43 160.76 40.89 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 123.999 0.92 . . . . 0.0 109.064 176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.69 0.51 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.22 168.65 24.68 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.198 0.454 . . . . 0.0 111.015 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.9 m -89.97 15.42 10.04 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.437 0.695 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.55 -171.96 2.59 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.02 0.928 . . . . 0.0 109.577 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -53.29 137.92 33.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.792 0.33 . . . . 0.0 110.665 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -153.69 161.13 42.41 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.678 0.791 . . . . 0.0 109.545 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -125.35 121.29 24.97 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.35 159.13 40.41 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.261 2.64 . . . . 0.0 110.674 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 109' ' ' GLY . 72.1 Cg_endo -70.31 157.52 59.07 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.282 2.655 . . . . 0.0 109.987 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt 54.48 -5.7 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.673 1.589 . . . . 0.0 114.78 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . 62.53 61.39 6.59 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.15 0.881 . . . . 0.0 114.007 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -136.73 161.16 36.71 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.16 175.07 14.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 112.105 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -128.45 141.84 51.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 pp -158.21 166.99 31.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.0 111.386 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -152.33 160.33 43.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.159 0.583 . . . . 0.0 109.856 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.1 159.42 41.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.075 0.55 . . . . 0.0 110.513 -174.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -92.0 -18.13 24.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -84.69 90.46 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.06 -12.11 59.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -85.71 -21.68 28.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 109.906 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -82.73 -18.29 41.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.85 -45.61 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -33.66 25.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.88 84.13 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.83 -41.88 18.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.117 -0.364 . . . . 0.0 110.779 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.49 -16.09 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 117.878 0.308 . . . . 0.0 110.61 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.27 -20.65 17.1 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.81 -0.556 . . . . 0.0 111.838 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.66 18.9 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.708 0.403 . . . . 0.0 112.046 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.63 -176.13 4.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.066 0.546 . . . . 0.0 111.776 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -68.31 147.67 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.362 0.665 . . . . 0.0 109.6 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -133.98 148.72 51.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.124 0.57 . . . . 0.0 111.815 -174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.46 153.72 42.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.78 1.232 . . . . 0.0 107.832 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.16 -13.1 46.02 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.046 -0.409 . . . . 0.0 111.242 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -103.73 -26.6 6.71 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.363 -0.687 . . . . 0.0 113.687 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.04 176.9 5.13 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.296 1.048 . . . . 0.0 110.986 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.92 162.2 16.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -139.16 140.37 37.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.735 0.302 . . . . 0.0 110.439 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.8 133.08 52.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.313 0.645 . . . . 0.0 109.615 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.74 129.49 34.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.0 p -153.18 3.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.55 0.214 . . . . 0.0 111.535 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.0 p -87.81 58.48 4.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.503 0.721 . . . . 0.0 112.196 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 28.0 m -146.28 -42.65 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 141' ' ' SER . 15.4 Cg_exo -69.73 -169.25 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.874 2.382 . . . . 0.0 110.599 173.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 60.8 p -63.41 -9.74 13.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -73.22 -38.62 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.122 0.569 . . . . 0.0 109.742 176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 56.85 -30.52 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' H ' HD13 ' A' ' 144' ' ' ILE . 27.3 t0 -56.46 142.15 39.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 120.356 1.435 . . . . 0.0 112.151 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -45.53 159.27 0.3 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.477 1.911 . . . . 0.0 113.028 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.98 159.01 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.866 3.711 . . . . 0.0 113.485 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.33 145.1 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -172.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -85.01 132.08 34.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.223 0.609 . . . . 0.0 110.602 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.76 142.15 40.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.025 0.93 . . . . 0.0 109.311 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -147.49 104.7 3.74 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.608 0.363 . . . . 0.0 111.643 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -83.43 -163.88 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.507 3.471 . . . . 0.0 107.348 168.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -144.57 140.29 28.69 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.716 1.144 . . . . 0.0 111.121 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 36.3 p-10 -105.07 72.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.454 1.102 . . . . 0.0 111.726 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.848 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.0 -0.42 0.5 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.155 0.982 . . . . 0.0 112.343 176.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.5 p -93.95 -7.04 44.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -121.14 -19.67 7.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.616 0.189 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.0 m -54.7 -7.14 0.15 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -88.64 124.87 34.49 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.067 0.849 . . . . 0.0 110.968 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 186' ' ' ALA . 7.8 m-85 -107.87 159.9 16.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.524 176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -166.55 145.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.3 mmt -139.55 -11.93 1.18 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -150.32 156.82 42.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.763 0.425 . . . . 0.0 110.158 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.65 4.93 4.05 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.6 t -71.62 -14.76 62.16 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.326 0.65 . . . . 0.0 111.535 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 44.4 mt-30 -126.57 130.72 23.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 122.618 0.367 . . . . 0.0 110.668 -170.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.5 Cg_exo -60.59 172.96 2.37 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.005 3.137 . . . . 0.0 113.604 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 66.6 mt -128.24 126.5 41.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.574 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -146.63 153.41 46.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.999 0.919 . . . . 0.0 109.212 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.14 -20.91 63.16 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.063 2.509 . . . . 0.0 111.45 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -76.01 -16.16 60.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.175 0.59 . . . . 0.0 110.66 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 8.7 mmmm -114.91 20.46 15.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.325 0.65 . . . . 0.0 110.684 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 61.7 m -110.4 154.05 24.11 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.198 0.523 . . . . 0.0 109.871 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 83.2 mt -131.57 156.52 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.96 148.08 37.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.58 121.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -95.34 141.49 15.59 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.48 95.94 1.4 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.844 0.735 . . . . 0.0 113.02 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.2 m -137.08 60.01 25.8 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.296 1.038 . . . . 0.0 108.934 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.53 162.0 43.69 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.27 3.313 . . . . 0.0 112.086 -173.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 51.43 167.26 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.416 2.286 . . . . 0.0 113.602 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.24 138.37 83.1 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.546 2.164 . . . . 0.0 111.413 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -154.85 -179.1 7.71 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.084 0.554 . . . . 0.0 110.671 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -133.12 35.35 3.51 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.967 0.907 . . . . 0.0 109.788 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 161' ' ' PHE . . . 57.77 5.67 0.37 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.621 1.568 . . . . 0.0 113.351 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 80.8 t -56.96 -33.71 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 C-N-CA 122.567 0.347 . . . . 0.0 111.439 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.88 -28.46 44.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.961 0.346 . . . . 0.0 111.09 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.05 -47.6 43.33 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.155 0.982 . . . . 0.0 110.211 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.41 61.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.037 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -24.95 51.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.003 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.5 pt -82.6 -43.82 19.05 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 119.136 0.88 . . . . 0.0 111.132 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.8 mmm -67.12 -18.83 65.47 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.999 0.818 . . . . 0.0 110.451 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -104.56 -10.53 17.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -86.27 -13.72 45.9 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.643 1.11 . . . . 0.0 108.475 170.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.74 -82.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.236 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -122.08 -19.99 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -170.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.2 -150.81 46.23 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 118.072 0.396 . . . . 0.0 112.399 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.76 87.49 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.08 147.47 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.222 0.609 . . . . 0.0 110.749 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 14.9 t -121.31 -41.06 2.53 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -149.99 148.3 28.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -158.79 166.54 31.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.527 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.18 172.86 41.31 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 94.6 mt -85.86 135.92 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 37.7 t70 -73.04 141.77 47.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.4 p -133.06 159.08 41.12 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 122.279 1.037 . . . . 0.0 113.282 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -75.25 118.67 72.44 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.402 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.73 -10.72 15.01 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.308 2.672 . . . . 0.0 112.607 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.13 -42.38 69.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.137 0.575 . . . . 0.0 111.658 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.14 13.38 1.63 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.62 0.248 . . . . 0.0 111.361 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 59.62 47.77 10.28 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.902 0.881 . . . . 0.0 110.691 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 82.0 t80 -120.04 145.58 40.22 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.361 -176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 93.4 Cg_exo -47.87 138.78 20.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.259 2.639 . . . . 0.0 113.268 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -111.07 10.46 22.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 0.0 111.775 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.14 16.35 61.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.146 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.83 175.44 10.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.623 0.711 . . . . 0.0 110.568 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -144.33 177.75 22.73 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -152.26 157.36 41.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.418 0.628 . . . . 0.0 111.414 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.24 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.591 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.82 105.52 8.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -157.57 22.81 0.28 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.718 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 30.9 p -71.25 83.58 0.75 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.515 0.326 . . . . 0.0 111.27 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -144.47 -12.46 0.6 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 227' ' ' SER . 16.4 pt20 -151.6 -177.44 6.1 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.453 0.644 . . . . 0.0 111.958 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -64.17 -11.08 27.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 225' ' ' GLN . 83.6 p -70.32 -41.07 73.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -71.92 -30.63 65.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.3 mm -65.8 -33.61 64.73 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.05 -20.81 44.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.24 1.59 22.15 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.601 0.637 . . . . 0.0 112.348 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 tt -113.57 -19.08 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.58 0.627 . . . . 0.0 110.793 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -88.31 -5.35 58.38 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -121.68 76.73 1.29 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -2.95 9.99 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.935 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -126.88 141.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.5 t -132.45 21.77 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.603 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 53.06 -98.52 0.08 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.104 0.562 . . . . 0.0 111.616 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.77 160.79 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.106 1.362 . . . . 0.0 113.22 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.3 90.73 1.76 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -151.55 145.51 25.2 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.57 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.3 -137.88 48.85 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.2 0.95 38.74 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.715 0.406 . . . . 0.0 111.525 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.26 142.16 15.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.545 0.738 . . . . 0.0 109.01 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -128.46 -13.44 4.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -173.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 -6.3 0.12 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -152.94 136.3 15.82 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 120.182 1.355 . . . . 0.0 113.193 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.47 160.91 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.39 144.61 47.81 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -147.05 125.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 122.894 0.478 . . . . 0.0 109.932 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 167.62 11.49 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.171 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.31 151.32 13.26 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.666 2.911 . . . . 0.0 113.5 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.88 -9.52 58.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.828 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.055 -1.45 . . . . 0.0 110.272 -179.638 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.81 161.95 36.76 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.387 0.675 . . . . 0.0 110.417 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -136.24 161.4 35.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.195 0.598 . . . . 0.0 110.214 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -99.39 164.92 11.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.101 0.56 . . . . 0.0 110.489 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.38 -165.61 54.77 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.04 163.42 25.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.529 0.732 . . . . 0.0 110.607 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -118.83 -1.15 11.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.434 0.694 . . . . 0.0 111.164 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.56 151.82 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 122.96 0.504 . . . . 0.0 109.979 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.85 164.84 17.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.506 0.723 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -138.47 156.86 47.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.205 0.526 . . . . 0.0 110.942 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 5.9 p90 -156.89 -158.46 0.78 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.977 -169.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 t -88.16 117.37 27.0 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 120.941 0.4 . . . . 0.0 110.568 -170.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -69.72 -1.78 10.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 126.049 2.093 . . . . 0.0 111.932 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -78.61 123.27 26.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.42 117.57 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-O 121.1 0.476 . . . . 0.0 110.623 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -82.24 141.86 32.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.578 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.43 151.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -147.76 -2.91 0.43 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.728 -0.484 . . . . 0.0 113.131 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.13 57.82 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 117.832 0.816 . . . . 0.0 112.021 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.5 mt -63.78 151.79 88.13 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 124.0 0.92 . . . . 0.0 111.43 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 54.3 Cg_exo -53.79 156.98 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.947 3.098 . . . . 0.0 112.855 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.7 Cg_exo -60.65 -19.26 59.67 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.93 3.087 . . . . 0.0 113.244 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -135.39 110.62 8.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -150.83 147.97 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -171.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -129.48 -96.4 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.613 0.765 . . . . 0.0 109.593 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.66 -24.48 0.64 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.36 0.982 . . . . 0.0 112.876 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.33 -32.94 20.74 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.777 0.717 . . . . 0.0 110.204 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 2.1 pm0 -72.51 -34.59 67.73 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.591 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -75.64 -32.53 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -67.46 -24.67 65.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 -22.56 17.6 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -65.32 -49.12 70.67 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.88 0.309 . . . . 0.0 110.81 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.56 154.44 28.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.256 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.16 147.97 35.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.078 0.551 . . . . 0.0 109.761 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 51.53 27.57 3.97 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 112.449 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.63 116.46 19.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.53 -168.97 31.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.348 0.499 . . . . 0.0 112.077 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.08 142.64 53.72 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.11 3.207 . . . . 0.0 111.812 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -150.09 168.91 22.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.312 0.645 . . . . 0.0 111.114 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.5 mm -113.62 151.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 123.407 0.683 . . . . 0.0 109.359 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.57 157.35 4.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -134.51 162.03 33.41 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.287 173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -113.12 157.55 40.55 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.457 0.703 . . . . 0.0 110.859 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.84 -13.68 37.35 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.07 2.514 . . . . 0.0 111.221 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -150.56 142.67 24.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.538 0.735 . . . . 0.0 109.521 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -158.02 176.36 12.63 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.999 0.52 . . . . 0.0 110.509 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.94 18.22 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.461 0.704 . . . . 0.0 110.159 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -124.45 6.71 8.32 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -130.57 -2.02 4.31 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.866 0.466 . . . . 0.0 111.417 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -157.18 166.99 31.7 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.687 0.795 . . . . 0.0 109.814 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -79.0 151.21 31.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -156.64 153.75 29.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.834 0.454 . . . . 0.0 110.649 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.58 145.06 19.25 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.78 117.83 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.383 2.722 . . . . 0.0 110.41 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.08 127.68 11.57 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.853 2.369 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.0 pttt 43.32 22.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.404 1.482 . . . . 0.0 113.568 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.53 -176.17 48.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.338 0.41 . . . . 0.0 112.518 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -85.72 172.84 10.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.766 0.427 . . . . 0.0 110.143 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 151.66 51.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.473 0.309 . . . . 0.0 111.09 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.41 70.08 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.468 HD22 HD11 ' A' ' 81' ' ' ILE . 4.3 pp -95.13 161.15 14.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.9 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 114' ' ' LEU . 1.8 pp -147.38 157.82 43.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -99.64 151.01 21.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.625 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -73.54 -19.06 61.0 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -134.34 143.29 47.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -84.95 -5.34 59.35 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -74.82 -28.38 60.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.945 -0.472 . . . . 0.0 109.806 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.2 t -83.92 -25.45 30.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.07 -46.74 95.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.93 -31.13 40.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.991 -0.443 . . . . 0.0 111.42 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.44 -39.94 64.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -91.38 -25.06 19.55 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.912 0.323 . . . . 0.0 111.168 -174.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 81.8 mt -75.35 -21.7 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.08 -21.89 24.46 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.634 -0.666 . . . . 0.0 110.651 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.04 15.97 19.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.987 0.515 . . . . 0.0 112.194 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 15.5 p -115.01 177.17 4.75 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.717 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 1.9 mp -76.92 154.36 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.838 0.855 . . . . 0.0 109.502 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.37 160.74 39.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 111.772 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.41 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.0 tt0 -141.59 154.69 45.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.698 1.199 . . . . 0.0 108.343 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -63.56 -9.76 14.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.169 -0.332 . . . . 0.0 111.022 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -111.8 -24.48 5.22 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.858 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.3 ptpt -166.75 -176.92 3.67 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.734 1.267 . . . . 0.0 111.266 -174.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -115.56 163.46 15.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -143.72 143.15 31.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.194 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 124' ' ' LEU . 1.7 mp -112.73 162.56 15.6 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.9 t -104.47 130.53 52.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.32 163.03 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.2 p -149.69 119.19 6.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.22 0.533 . . . . 0.0 112.09 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.3 m -157.1 169.18 11.04 Favored Pre-proline 0 CA--C 1.53 0.178 0 C-N-CA 126.545 1.938 . . . . 0.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.84 147.03 14.95 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.733 2.289 . . . . 0.0 113.213 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 m 62.69 -11.25 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.013 1.725 . . . . 0.0 114.671 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 144' ' ' ILE . 2.3 pp -133.67 18.3 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.483 1.038 . . . . 0.0 111.449 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.02 130.69 44.96 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 59.1 29.35 18.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.612 1.165 . . . . 0.0 113.416 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -117.42 146.31 38.12 Favored Pre-proline 0 CA--C 1.532 0.276 0 O-C-N 122.015 -0.428 . . . . 0.0 109.978 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.06 167.52 25.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.692 2.928 . . . . 0.0 111.649 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.37 148.48 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.045 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.872 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.81 141.75 51.34 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.41 HG13 HD13 ' A' ' 137' ' ' LEU . 26.6 mm -139.83 139.32 37.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.028 0.531 . . . . 0.0 111.136 -174.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -145.77 94.97 4.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.81 0.844 . . . . 0.0 112.001 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.06 -166.62 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.159 3.24 . . . . 0.0 106.94 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -154.1 122.81 6.26 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 56.1 t-20 -79.98 87.82 5.37 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.876 0.87 . . . . 0.0 111.887 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -68.52 -0.29 4.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.967 0.907 . . . . 0.0 112.664 177.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.8 m -96.17 -2.95 45.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.629 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.91 -21.57 4.34 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.673 0.67 . . . . 0.0 111.116 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.3 m -43.01 -31.86 0.58 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -88.0 111.86 21.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 27.4 p90 -99.86 88.83 3.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.038 0.923 . . . . 0.0 109.113 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.03 158.72 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.401 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 tpt -136.15 -31.23 0.91 Allowed 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.608 -0.234 . . . . 0.0 111.253 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -160.33 168.01 26.21 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.133 0.424 . . . . 0.0 110.868 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.49 22.84 38.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.124 0.869 . . . . 0.0 111.532 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 t -64.11 -18.6 64.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -133.49 151.42 77.3 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -170.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.67 4.46 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.599 1 C-N-CA 125.465 4.11 . . . . 0.0 114.536 -174.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp 57.57 33.99 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.085 0.554 . . . . 0.0 110.993 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.83 143.18 94.46 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.194 0.598 . . . . 0.0 110.098 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.34 -3.69 8.0 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.722 2.948 . . . . 0.0 113.548 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.3 mmt-85 -111.24 7.51 21.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.257 0.623 . . . . 0.0 110.614 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.19 12.86 7.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.394 1.478 . . . . 0.0 109.37 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 85.6 m -108.41 157.4 18.44 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 35.1 mt -133.76 152.01 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.02 149.9 24.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.75 119.34 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -102.1 160.83 17.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.77 35.22 8.51 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.816 -0.436 . . . . 0.0 112.431 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.9 m -123.33 47.18 1.58 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.549 0.74 . . . . 0.0 111.641 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 162.8 36.13 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.109 2.54 . . . . 0.0 111.08 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 62.43 162.09 0.11 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.15 1.38 . . . . 0.0 111.801 -173.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.38 112.07 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.38 2.72 . . . . 0.0 112.496 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.08 136.81 51.72 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -87.19 45.37 1.26 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.39 0.614 . . . . 0.0 110.886 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 60.48 12.25 3.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.624 1.569 . . . . 0.0 114.584 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.77 -48.62 87.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 118.21 0.459 . . . . 0.0 111.566 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -78.87 -26.53 43.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.313 -175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -52.57 10.3 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.538 1.135 . . . . 0.0 109.538 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 161' ' ' PHE . . . -72.37 -30.96 65.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.171 -175.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -37.86 57.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.667 -175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.0 pt -71.22 -40.18 74.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 119.605 1.093 . . . . 0.0 110.518 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -24.27 65.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.509 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -87.81 -15.11 37.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -85.25 -21.83 28.9 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 118.995 -0.526 . . . . 0.0 112.241 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -124.83 -27.63 3.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.517 ' CD2' HD13 ' A' ' 196' ' ' LEU . 27.8 m-85 -143.13 47.7 1.51 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.569 1.077 . . . . 0.0 110.719 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.88 156.38 36.64 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 139.97 14.47 0.57 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.231 -175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.19 154.94 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.0 0.92 . . . . 0.0 111.639 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.0 t -129.03 -48.32 1.22 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 122.278 0.231 . . . . 0.0 110.979 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.41 137.51 18.29 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.425 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -156.31 171.17 20.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -147.65 -178.22 22.71 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.56 122.9 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 118.123 0.961 . . . . 0.0 110.961 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 42.9 2.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 161.06 24.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 120.623 1.556 . . . . 0.0 114.665 -169.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 215' ' ' LYS . 15.0 t70 -143.13 139.27 16.52 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.348 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.29 -9.86 17.62 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.879 3.053 . . . . 0.0 112.2 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -61.54 -48.82 79.27 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.031 0.378 . . . . 0.0 110.741 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.35 14.76 1.45 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.383 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 66.43 50.26 1.3 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 72.0 t80 -140.34 146.64 46.44 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.955 -175.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 213' ' ' TYR . 71.2 Cg_exo -53.0 136.87 61.73 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.249 2.633 . . . . 0.0 113.422 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HG3' ' CG ' ' A' ' 208' ' ' ASP . 42.4 mmtm -126.64 -29.23 2.91 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.417 1.087 . . . . 0.0 109.916 173.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.95 157.39 7.27 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 112.701 -0.16 . . . . 0.0 112.701 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.06 124.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.927 2.091 . . . . 0.0 115.881 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -72.66 163.82 54.76 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.161 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.68 142.88 20.36 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.736 -0.273 . . . . 0.0 110.376 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.22 150.88 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.71 111.54 11.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.0 110.673 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 138.67 13.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.482 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 14.2 m -147.41 17.49 1.18 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.013 0.525 . . . . 0.0 110.91 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.53 -8.92 46.15 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -149.41 164.54 34.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.693 0.679 . . . . 0.0 112.082 -171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.47 -11.37 15.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -71.58 -33.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.2 -37.36 78.07 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.83 -35.34 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 197' ' ' TYR . . . -81.41 -26.27 35.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.62 -21.18 20.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.936 0.789 . . . . 0.0 111.486 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 4.9 tt -88.6 -15.71 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.347 0.522 . . . . 0.0 109.893 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -91.34 -9.5 44.69 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.87 55.77 3.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -58.62 -19.07 35.6 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.806 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -139.8 140.93 36.76 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.6 158.49 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -104.73 151.3 23.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -147.94 131.13 16.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -136.85 74.67 1.5 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.57 145.27 31.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.657 0.783 . . . . 0.0 109.552 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.75 -140.35 48.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -87.59 14.98 7.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.019 0.528 . . . . 0.0 111.573 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.3 mt -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 123.006 0.523 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -140.48 24.72 2.26 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.825 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 247' ' ' ARG . 7.2 tppt? -130.87 172.48 11.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.575 -172.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.477 ' H ' ' HG3' ' A' ' 246' ' ' LYS . 37.0 ptt180 -63.35 160.83 15.17 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.735 0.814 . . . . 0.0 112.382 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.06 167.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.068 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -131.46 145.54 51.83 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.949 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -143.35 108.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -144.67 164.01 30.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.761 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.97 151.16 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.594 2.863 . . . . 0.0 113.112 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -83.7 162.43 20.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.581 0.752 . . . . 0.0 110.217 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.056 -178.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -142.69 161.92 36.82 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.306 0.642 . . . . 0.0 110.382 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -139.61 163.93 31.25 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.282 0.633 . . . . 0.0 110.138 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -138.44 9.72 2.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.882 0.473 . . . . 0.0 111.058 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.74 41.57 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.43 11.86 4.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.481 0.712 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -148.57 167.94 24.09 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.691 0.797 . . . . 0.0 110.279 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.71 140.6 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -145.56 35.44 1.06 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.095 0.474 . . . . 0.0 109.939 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.588 ' HG2' ' H ' ' A' ' 63' ' ' TYR . 14.0 ttm180 -127.97 179.39 5.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.53 0.732 . . . . 0.0 110.239 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' H ' ' HG2' ' A' ' 62' ' ' ARG . 88.0 m-85 58.46 144.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 116.166 1.914 . . . . 0.0 116.166 -175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 41.6 t -91.41 131.24 37.02 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -79.97 -4.91 54.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 125.156 1.535 . . . . 0.0 112.959 -169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.28 127.21 31.83 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -134.28 127.36 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.214 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -86.5 146.37 26.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.802 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.87 167.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.01 -9.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.028 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -90.13 12.27 68.32 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 117.819 0.81 . . . . 0.0 112.713 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.26 151.54 86.77 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 117.55 0.675 . . . . 0.0 110.295 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.48 160.99 8.08 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.682 2.922 . . . . 0.0 111.726 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.95 164.78 32.36 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.27 2.647 . . . . 0.0 110.727 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.3 t70 54.35 29.55 11.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 112.272 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HA ' ' CG ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -73.52 137.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.981 0.419 . . . . 0.0 111.918 -177.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -140.59 -10.41 1.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.93 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 157.08 -38.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.16 0.984 . . . . 0.0 110.507 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.48 -34.4 31.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 4.0 mm-40 -67.55 -36.07 80.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -38.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.686 -175.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 42.1 m -69.15 -19.13 64.01 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.73 -25.79 14.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.841 0.457 . . . . 0.0 111.258 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -55.99 -63.33 1.21 Allowed 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.374 0.27 . . . . 0.0 110.509 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -66.14 134.47 52.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -113.29 1.32 15.13 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -139.19 2.14 2.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.006 0.366 . . . . 0.0 111.769 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -85.52 -54.13 4.75 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.983 -0.448 . . . . 0.0 110.486 -175.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.86 -170.36 22.83 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.09 134.66 65.81 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.139 3.226 . . . . 0.0 112.398 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.01 173.53 13.26 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.335 0.654 . . . . 0.0 110.767 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.04 149.76 17.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.1 m -127.92 162.3 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 122.576 0.35 . . . . 0.0 111.603 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.41 133.74 17.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -101.24 151.65 37.76 Favored Pre-proline 0 N--CA 1.454 -0.256 0 O-C-N 122.317 -0.239 . . . . 0.0 110.563 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -59.65 -8.78 7.89 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.527 2.818 . . . . 0.0 113.563 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -129.93 13.49 5.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 111.62 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -72.67 126.17 29.25 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.13 -4.87 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.271 0.628 . . . . 0.0 111.341 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.58 162.28 41.25 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.011 0.525 . . . . 0.0 110.399 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -83.04 6.99 17.03 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.61 1.09 13.47 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -94.46 150.65 20.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.109 0.413 . . . . 0.0 110.957 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -156.86 172.95 17.73 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.184 0.594 . . . . 0.0 110.499 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.2 t80 49.68 83.88 0.21 Allowed Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 124.947 1.299 . . . . 0.0 112.95 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 49.7 Cg_exo -58.35 151.15 62.69 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.819 3.012 . . . . 0.0 111.565 176.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 32.4 Cg_exo -63.19 -13.66 37.02 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.861 3.041 . . . . 0.0 114.117 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -141.31 164.74 29.41 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 118.296 0.498 . . . . 0.0 111.421 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.99 8.88 48.88 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.978 0.799 . . . . 0.0 112.822 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -101.52 144.98 29.61 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 117.627 0.713 . . . . 0.0 109.425 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.11 170.54 22.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.0 112.624 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -117.52 148.03 42.24 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.521 171.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.13 159.65 34.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.94 163.84 37.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.8 158.4 17.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.898 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -77.71 -21.19 52.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -174.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -138.86 150.6 46.18 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.907 0.321 . . . . 0.0 111.667 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.93 -22.21 53.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.7 m -73.65 -26.01 60.55 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.578 0.626 . . . . 0.0 110.948 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.6 t -82.43 -24.79 34.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.46 -43.55 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -71.38 -33.19 69.3 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.37 76.62 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 88' ' ' PHE . 3.2 tm? -84.78 -39.26 18.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.296 -0.252 . . . . 0.0 110.873 -176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.3 mt -69.42 -20.94 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.79 -20.73 18.0 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.894 -0.503 . . . . 0.0 111.968 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.35 17.93 4.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.74 0.416 . . . . 0.0 112.052 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 19.7 p -132.15 175.16 9.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 112.11 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 72.3 mt -75.78 153.77 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.459 0.703 . . . . 0.0 109.232 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.28 161.08 36.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.401 0.62 . . . . 0.0 112.128 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.8 159.81 41.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.991 1.316 . . . . 0.0 108.703 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.29 -13.96 9.69 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.682 0.393 . . . . 0.0 111.843 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -119.27 -19.48 4.25 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.548 -0.585 . . . . 0.0 114.301 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -165.5 -173.77 2.9 Favored 'General case' 0 C--O 1.228 -0.05 0 CA-C-N 118.132 0.966 . . . . 0.0 110.711 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.92 164.24 27.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.867 0.467 . . . . 0.0 109.771 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.01 126.69 25.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.905 0.383 . . . . 0.0 110.717 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.19 135.71 33.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.943 0.897 . . . . 0.0 109.51 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 34.9 t -92.99 67.1 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.62 4.29 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.0 m -76.19 91.64 3.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.11 0.564 . . . . 0.0 110.099 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.3 t -158.47 -41.02 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.761 ' HD2' ' H ' ' A' ' 141' ' ' SER . 42.9 Cg_endo -81.23 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.603 2.202 . . . . 0.0 109.871 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -61.46 -9.33 5.41 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.555 0.742 . . . . 0.0 112.195 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.441 HD12 ' C ' ' A' ' 144' ' ' ILE . 1.7 pp -114.2 159.8 13.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 122.94 0.496 . . . . 0.0 110.324 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -153.41 162.05 41.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.352 0.261 . . . . 0.0 110.396 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 56.22 32.22 19.88 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.535 1.134 . . . . 0.0 113.114 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -138.98 75.16 35.89 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.297 0.639 . . . . 0.0 110.317 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.61 165.66 30.05 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.639 2.893 . . . . 0.0 109.844 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 9.8 t -119.04 122.92 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 117.655 0.207 . . . . 0.0 111.18 -175.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.03 124.17 26.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.28 143.12 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.13 0.572 . . . . 0.0 110.556 -174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -140.58 96.35 7.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.19 0.596 . . . . 0.0 110.289 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -86.45 -156.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 1 C-N-CA 125.582 4.188 . . . . 0.0 109.143 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 66.9 t-105 -148.55 151.66 35.48 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.798 -0.564 . . . . 0.0 112.122 169.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -118.66 118.09 30.7 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.638 0.775 . . . . 0.0 110.475 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.55 -15.26 61.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.969 -173.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -74.24 -28.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.432 -0.318 . . . . 0.0 110.518 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -86.16 -18.97 30.82 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.347 0.521 . . . . 0.0 111.707 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.5 m -52.72 -23.03 5.92 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -131.71 118.83 20.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.895 0.855 . . . . 0.0 110.15 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 204' ' ' GLY . 2.9 p90 -125.42 99.58 6.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.589 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 202' ' ' TYR . 21.8 t -103.09 141.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.69 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 96.5 mmm -103.32 -25.52 13.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.252 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 30.8 t0 54.09 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.711 1.204 . . . . 0.0 112.717 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.56 14.36 80.11 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.872 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.7 t -127.84 -74.09 0.59 Allowed 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.477 1.139 . . . . 0.0 112.004 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 41.9 mt-30 -150.06 158.32 36.84 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 31.9 Cg_exo -61.2 174.53 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 124.565 3.51 . . . . 0.0 113.143 173.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.6 mt -111.5 136.97 49.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.757 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.9 143.96 16.01 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.272 0.629 . . . . 0.0 109.804 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.83 -23.63 59.84 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.604 2.869 . . . . 0.0 114.285 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -1.62 58.18 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.164 0.438 . . . . 0.0 110.498 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.92 15.69 12.54 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.171 0.988 . . . . 0.0 110.411 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 60.1 m -107.14 156.87 18.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.577 0.351 . . . . 0.0 110.088 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -129.64 155.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -114.98 146.78 40.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 t -136.31 115.01 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -110.38 161.74 12.81 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.86 26.91 52.34 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.377 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.9 140.82 97.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.773 1.287 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.17 80.62 2.83 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 124.049 3.166 . . . . 0.0 111.829 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 62.19 169.88 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.443 1.097 . . . . 0.0 112.076 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.08 129.86 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.122 2.548 . . . . 0.0 112.056 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 pp -154.12 153.05 31.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.556 0.742 . . . . 0.0 109.48 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -80.87 55.44 2.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 54.81 21.34 3.53 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.88 -58.91 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.72 -47.97 42.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.466 -0.302 . . . . 0.0 110.588 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.16 -48.02 68.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.235 0.614 . . . . 0.0 110.702 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.8 -37.57 55.54 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.542 -177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -77.33 -25.95 51.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.209 0.458 . . . . 0.0 112.176 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.6 pt -84.63 -45.56 17.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.519 0.6 . . . . 0.0 110.667 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.24 -19.5 65.53 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 33.4 t70 -92.51 -30.89 15.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -75.76 -36.78 59.74 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.516 1.053 . . . . 0.0 113.105 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -89.09 -33.33 17.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.448 ' CD2' HD13 ' A' ' 196' ' ' LEU . 34.0 m-85 -139.38 -29.56 0.74 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.084 1.311 . . . . 0.0 113.082 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . 67.47 -164.38 45.14 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 118.634 0.652 . . . . 0.0 113.563 173.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.59 82.12 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.589 0.614 . . . . 0.0 113.313 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.86 136.06 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 118.116 0.958 . . . . 0.0 111.465 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 49.2 t -117.87 -36.56 3.61 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.435 ' CD2' HG22 ' A' ' 162' ' ' VAL . 19.7 t80 -143.75 137.92 28.44 Favored 'General case' 0 CA--C 1.523 -0.091 0 O-C-N 122.141 -0.349 . . . . 0.0 110.376 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.29 158.12 41.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 161' ' ' PHE . . . -170.41 179.93 42.24 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 176.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.433 HD11 ' CZ2' ' A' ' 154' ' ' TRP . 34.3 pt -113.27 156.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 117.583 0.692 . . . . 0.0 110.07 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -79.38 130.7 35.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.9 p -127.85 160.21 32.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.042 0.925 . . . . 0.0 112.334 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -90.23 115.46 64.09 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.025 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.06 -9.93 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.522 2.815 . . . . 0.0 112.63 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.14 -40.64 74.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.7 0.4 . . . . 0.0 111.365 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 211' ' ' LEU . 1.2 pt? -144.0 11.17 1.57 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.557 0.218 . . . . 0.0 111.558 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? 58.8 53.09 6.06 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.482 1.113 . . . . 0.0 109.89 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -124.49 145.95 50.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.765 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -54.11 147.11 45.48 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.433 2.755 . . . . 0.0 112.493 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -115.01 7.97 15.66 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.3 20.8 31.49 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.247 0.476 . . . . 0.0 113.622 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -149.45 173.98 12.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.061 0.93 . . . . 0.0 110.475 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -160.46 179.5 35.92 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 112.394 -0.282 . . . . 0.0 112.394 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 148.85 26.42 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 111.474 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.26 148.14 18.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 123.868 0.867 . . . . 0.0 108.856 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -128.41 119.01 24.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.976 0.417 . . . . 0.0 111.05 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -164.19 33.01 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.907 0.883 . . . . 0.0 110.285 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.506 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 38.3 m -74.24 64.24 1.07 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.479 0.712 . . . . 0.0 111.347 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.76 0.56 2.23 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.372 0.669 . . . . 0.0 112.598 -176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -153.03 164.65 37.6 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.144 0.497 . . . . 0.0 110.8 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -59.62 -11.31 4.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.937 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 61.3 p -68.02 -40.74 82.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.753 -0.592 . . . . 0.0 109.508 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -69.73 -35.44 75.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 mm -62.38 -35.83 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.412 ' HB1' ' CZ ' ' A' ' 197' ' ' TYR . . . -80.75 -24.29 38.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.26 -12.97 31.16 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.545 0.611 . . . . 0.0 112.263 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 tt -108.79 -17.95 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.18 0.446 . . . . 0.0 112.15 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.5 m -92.26 -7.9 46.81 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -86.94 -23.23 25.19 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.804 0.274 . . . . 0.0 111.082 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . 0.308 0.0 OUTLIER 51.81 -6.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 234' ' ' ALA . 42.3 m-85 -150.12 157.39 43.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 169.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.51 149.1 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.61 142.7 29.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.84 169.89 17.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 111.383 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -141.52 32.26 1.67 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.066 0.946 . . . . 0.0 109.317 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 242' ' ' GLY . 20.9 t60 -115.78 173.85 6.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -171.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 241' ' ' HIS . . . -58.67 140.12 47.72 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 59.29 -9.24 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.987 1.715 . . . . 0.0 115.4 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 47.5 mt -144.04 133.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 120.085 1.311 . . . . 0.0 111.365 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.63 -3.33 2.1 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -150.9 -12.51 0.23 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -154.49 126.55 7.74 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.62 149.91 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 113.507 -1.678 . . . . 0.0 108.538 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.93 134.4 33.98 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.355 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.73 119.42 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -150.33 166.39 15.25 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.37 151.47 36.71 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.035 2.49 . . . . 0.0 111.952 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -76.03 151.97 37.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.902 0.481 . . . . 0.0 110.773 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.026 -1.464 . . . . 0.0 110.74 -178.292 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -139.01 6.45 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.879 0.472 . . . . 0.0 111.734 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -75.13 155.06 37.43 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.821 0.448 . . . . 0.0 110.432 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.22 155.62 38.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.916 0.486 . . . . 0.0 110.381 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.0 46.0 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -132.24 11.29 4.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.325 0.65 . . . . 0.0 110.984 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -146.06 165.82 27.94 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 123.449 0.7 . . . . 0.0 110.344 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.38 139.19 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -145.58 22.8 1.46 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.355 0.662 . . . . 0.0 110.723 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -130.11 -4.77 4.44 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -172.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -101.02 156.49 17.37 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 119.234 0.924 . . . . 0.0 111.144 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.606 ' HB2' HD12 ' A' ' 156' ' ' LEU . 47.4 t -85.0 132.08 34.39 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -76.65 -11.98 59.94 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 125.369 1.668 . . . . 0.0 111.494 -172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -68.17 130.24 42.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.84 107.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -74.96 144.71 43.06 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 HG13 ' CG1' ' A' ' 149' ' ' VAL . 30.9 t -131.26 137.25 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 O-C-N 123.824 0.703 . . . . 0.0 109.157 176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.66 -13.28 2.82 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -91.82 17.65 55.83 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 117.254 0.527 . . . . 0.0 112.297 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -65.73 140.13 97.24 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 117.745 0.772 . . . . 0.0 110.005 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.2 158.7 33.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.275 2.65 . . . . 0.0 111.862 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -70.61 -10.5 28.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.338 3.359 . . . . 0.0 112.597 -176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -127.56 118.12 23.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.51 145.6 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.026 0.917 . . . . 0.0 113.286 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 33.8 t70 -145.72 166.48 25.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.89 2.076 . . . . 0.0 106.489 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -52.09 -31.78 32.12 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.04 0.837 . . . . 0.0 111.976 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.6 -21.49 48.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.381 0.134 . . . . 0.0 111.09 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 11.6 tp10 -79.75 -42.99 23.39 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.508 0.323 . . . . 0.0 110.217 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -27.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.6 m -76.3 -24.1 54.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.85 -17.42 22.1 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.207 -0.308 . . . . 0.0 111.433 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.1 m -67.17 -64.58 0.82 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -61.9 143.68 56.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -114.32 151.27 33.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.974 0.509 . . . . 0.0 109.632 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.97 29.07 4.19 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.195 0.598 . . . . 0.0 111.491 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.38 123.68 39.85 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.06 -173.94 29.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.2 0.428 . . . . 0.0 112.483 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.79 146.59 65.97 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.152 3.235 . . . . 0.0 112.348 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.27 160.95 42.04 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.576 0.75 . . . . 0.0 109.779 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.2 mp -91.85 151.95 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.08 154.52 40.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-O 120.72 0.295 . . . . 0.0 111.759 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.36 139.42 17.37 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -100.9 153.65 37.61 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.36 -29.82 86.36 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.93 2.42 . . . . 0.0 111.965 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -161.58 157.54 24.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.634 0.773 . . . . 0.0 109.481 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -154.46 143.98 21.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.348 0.659 . . . . 0.0 109.314 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.2 164.22 38.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.995 0.518 . . . . 0.0 110.206 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.69 124.04 28.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.4 p -163.47 -172.31 2.89 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.281 0.632 . . . . 0.0 109.9 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.16 8.55 3.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.707 0.403 . . . . 0.0 111.138 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.0 t -140.24 169.41 17.74 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.043 0.937 . . . . 0.0 109.909 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.13 4.59 2.49 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.026 0.53 . . . . 0.0 111.623 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.71 154.17 80.96 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.241 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 52.3 Cg_exo -55.17 115.62 2.57 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.251 2.634 . . . . 0.0 110.95 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 36.9 Cg_exo -61.03 -5.46 4.89 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 124.388 3.392 . . . . 0.0 114.857 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -129.87 3.71 4.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.28 0.491 . . . . 0.0 112.282 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 -172.8 45.43 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 52.7 p90 48.18 177.65 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.45 169.34 22.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.732 -0.605 . . . . 0.0 111.363 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -120.21 144.61 47.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -141.82 162.28 35.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.42 149.37 29.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 167.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -108.19 159.82 16.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.535 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -64.42 -32.0 73.44 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.757 0.423 . . . . 0.0 111.777 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.5 156.98 43.67 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.99 -21.85 43.19 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.2 m -72.55 -23.3 60.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.009 0.368 . . . . 0.0 110.119 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.1 m -84.22 -29.91 26.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.16 -41.29 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.38 -32.57 37.62 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.025 -0.422 . . . . 0.0 110.636 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.73 -41.21 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -84.81 -34.42 22.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.14 0.427 . . . . 0.0 110.794 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.0 mt -68.78 -27.09 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.753 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.83 -21.93 29.66 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.099 -0.376 . . . . 0.0 111.213 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.52 23.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.738 0.415 . . . . 0.0 111.482 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 95.8 m -122.84 -176.03 3.3 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.66 0.784 . . . . 0.0 110.604 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.2 154.24 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.124 0.57 . . . . 0.0 111.011 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -134.24 157.02 47.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.947 0.499 . . . . 0.0 110.843 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -144.73 151.95 39.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.36 -9.14 22.31 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.036 -0.415 . . . . 0.0 111.361 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.26 -28.12 5.32 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.275 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -169.57 -178.74 3.15 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.352 1.076 . . . . 0.0 110.962 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.8 mm? -106.21 155.36 19.55 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' C ' HD12 ' A' ' 137' ' ' LEU . 46.4 m-85 -138.23 136.62 36.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 136' ' ' TYR . 9.9 mp -120.25 153.69 35.99 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.76 124.34 48.72 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.35 -0.219 . . . . 0.0 110.87 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.36 0.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.66 0.384 . . . . 0.0 111.141 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 146' ' ' ASP . 39.1 p -72.97 142.62 47.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 110.72 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.5 m -158.64 167.59 14.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 123.827 0.851 . . . . 0.0 109.198 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.6 -5.03 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 124.046 3.164 . . . . 0.0 114.395 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.7 p -120.68 12.23 11.39 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.469 0.707 . . . . 0.0 111.973 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' H ' ' A' ' 145' ' ' LYS . 13.1 tt -149.97 176.73 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.68 169.88 7.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.514 0.673 . . . . 0.0 111.231 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 7.5 p-10 -101.76 178.21 4.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.941 1.296 . . . . 0.0 112.324 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm 63.58 150.83 0.11 Allowed Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 125.491 1.516 . . . . 0.0 113.113 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.37 178.25 5.77 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.367 3.378 . . . . 0.0 112.372 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG1' HG13 ' A' ' 69' ' ' VAL . 18.8 t -107.13 134.64 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.793 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -78.73 124.03 27.77 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.1 145.66 33.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.657 0.783 . . . . 0.0 110.022 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -151.98 111.27 2.89 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -84.53 -160.13 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.926 3.751 . . . . 0.0 106.584 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -144.03 159.91 41.78 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 121.197 1.817 . . . . 0.0 114.428 169.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -119.54 56.52 0.93 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.194 1.397 . . . . 0.0 109.969 -177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.854 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.26 -0.81 0.26 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.549 1.54 . . . . 0.0 113.954 -179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.0 p -87.47 -9.16 55.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.68 -14.27 0.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.9 m -53.44 -16.04 1.29 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.03 122.17 27.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 203' ' ' ALA . 18.8 p90 -93.48 151.82 19.48 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.0 t -155.02 153.45 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -167.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 49.0 ttp -126.96 -15.56 5.32 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.506 0.323 . . . . 0.0 110.629 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t0 48.83 57.54 6.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.244 1.018 . . . . 0.0 112.615 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -161.14 -178.83 35.45 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m 59.47 -74.82 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -137.51 149.19 64.4 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 122.728 0.411 . . . . 0.0 111.458 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.93 169.44 21.65 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.362 3.375 . . . . 0.0 111.544 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.75 133.93 40.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.471 ' HB3' ' HE3' ' A' ' 173' ' ' LYS . 14.5 t70 -158.31 139.26 9.42 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.66 -13.59 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.351 2.7 . . . . 0.0 112.967 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -92.4 -2.07 56.58 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.517 0.599 . . . . 0.0 111.27 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 43.0 mtmt -131.46 27.51 4.72 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.284 1.034 . . . . 0.0 110.237 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 88.8 m -104.2 154.33 19.89 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -130.43 157.84 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.66 147.31 38.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.73 130.17 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -105.36 163.03 14.21 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.89 28.29 8.88 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.197 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.07 59.2 21.77 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 110.662 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.38 12.54 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.571 3.514 . . . . 0.0 113.305 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -136.09 130.74 18.52 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 118.408 0.549 . . . . 0.0 110.631 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.8 129.32 25.79 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.399 2.733 . . . . 0.0 110.92 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.42 166.32 20.7 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.826 0.451 . . . . 0.0 111.006 -177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -75.24 39.04 0.14 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.439 1.496 . . . . 0.0 112.524 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 55.22 14.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.942 1.297 . . . . 0.0 113.237 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.28 -52.06 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -80.49 -25.09 39.0 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.857 0.299 . . . . 0.0 111.516 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 189' ' ' LEU . 3.2 tm? -82.63 -46.07 13.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 110.29 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.32 -34.76 65.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -73.8 -28.84 61.84 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.915 -0.564 . . . . 0.0 112.126 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 13.4 pt -76.09 -44.68 37.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 119.374 0.988 . . . . 0.0 110.666 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.21 -11.17 60.79 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.748 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.54 -13.93 16.38 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -90.31 -20.43 22.92 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.166 0.894 . . . . 0.0 111.876 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.624 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -109.2 -40.32 4.99 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.624 ' H ' HD12 ' A' ' 196' ' ' LEU . 35.0 m-85 -147.38 61.04 1.16 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.975 0.807 . . . . 0.0 110.814 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.14 38.67 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 121.128 0.294 . . . . 0.0 112.67 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.67 4.01 0.25 Allowed Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.861 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.51 146.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.071 0.949 . . . . 0.0 111.94 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.6 t -119.73 -40.23 2.78 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.029 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.98 144.94 25.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.61 165.31 18.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 112.292 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -143.49 159.05 27.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.99 124.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 216' ' ' GLY . 17.2 p30 31.25 7.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 121.519 3.896 . . . . 0.0 121.519 -177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 140.02 41.8 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 121.652 2.024 . . . . 0.0 113.315 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -78.71 120.67 81.78 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.805 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.08 -10.91 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.254 2.636 . . . . 0.0 112.64 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.59 -46.24 48.36 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.121 0.568 . . . . 0.0 111.949 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.23 17.89 2.59 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-O 120.627 0.251 . . . . 0.0 111.345 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 56.18 50.0 14.34 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.817 0.847 . . . . 0.0 111.084 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.453 ' CD1' ' HD2' ' A' ' 214' ' ' PRO . 76.6 t80 -137.94 139.92 27.68 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.618 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 213' ' ' TYR . 33.4 Cg_exo -44.84 131.33 10.35 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.021 3.148 . . . . 0.0 114.051 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 215' ' ' LYS . 0.1 OUTLIER -141.58 -0.1 1.41 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.331 1.053 . . . . 0.0 112.301 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 206' ' ' ASP . . . 112.32 169.41 18.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.774 0.702 . . . . 0.0 113.279 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 58.34 178.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.449 1.5 . . . . 0.0 113.54 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -144.66 170.61 26.2 Favored Glycine 0 CA--C 1.525 0.671 0 O-C-N 121.636 -0.665 . . . . 0.0 111.655 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.2 ptt-85 -149.14 152.89 36.89 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.689 0.28 . . . . 0.0 110.734 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.4 p -152.91 152.08 10.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.71 116.33 12.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.59 0.632 . . . . 0.0 112.51 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -167.24 150.17 6.27 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.151 1.38 . . . . 0.0 108.333 171.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 88.6 p -155.46 15.39 0.38 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.33 0.252 . . . . 0.0 111.22 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.76 -3.73 58.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -169.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -152.54 166.75 31.03 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.19 0.905 . . . . 0.0 111.888 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.62 -10.61 12.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.31 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.6 p -69.24 -39.29 78.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.492 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 1.0 OUTLIER -65.31 -37.77 88.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mm -67.34 -29.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.74 -20.45 26.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.68 -15.34 22.75 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.712 0.687 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -109.37 -13.86 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.6 m -104.88 12.91 31.98 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.328 0.251 . . . . 0.0 110.979 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -114.74 -34.43 5.16 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 63.38 -26.68 0.07 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 171.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -143.52 137.21 28.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.717 0.69 . . . . 0.0 109.149 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.22 157.19 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.517 ' C ' HD22 ' A' ' 239' ' ' LEU . 53.1 tt0 -96.67 128.26 43.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.537 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.4 mm? -139.21 160.45 39.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -128.64 103.27 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -161.0 145.0 13.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.579 0.752 . . . . 0.0 109.252 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 55.08 -131.9 48.47 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -88.29 -3.27 58.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.065 0.546 . . . . 0.0 111.159 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.91 135.02 26.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.86 -1.11 0.6 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.901 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -32.1 1.11 Allowed 'General case' 0 C--N 1.34 0.162 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -162.44 156.64 21.39 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.762 1.165 . . . . 0.0 113.436 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.38 173.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.502 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.86 136.95 51.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.85 128.03 11.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.064 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 164.96 15.43 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-O 119.563 -0.256 . . . . 0.0 110.33 176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.05 152.54 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.716 2.944 . . . . 0.0 113.013 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -76.52 154.57 34.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.381 0.672 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.251 1.184 0 CA-C-O 116.926 -1.511 . . . . 0.0 110.83 -178.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -76.55 161.58 28.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.8 0.44 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -77.75 163.11 26.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.893 0.477 . . . . 0.0 110.748 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -99.88 19.5 16.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.438 0.695 . . . . 0.0 111.003 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.31 -1.49 86.2 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.43 156.3 46.42 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.93 0.892 . . . . 0.0 109.442 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -151.98 138.82 18.92 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.555 0.342 . . . . 0.0 110.235 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t 45.1 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 125.886 1.674 . . . . 0.0 112.972 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -64.91 130.48 43.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -98.63 -166.85 1.41 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -157.15 -167.0 2.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.273 -169.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 213' ' ' TYR . 47.3 t -76.29 114.48 15.02 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.81 0.338 . . . . 0.0 111.666 -170.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -74.24 -0.49 17.08 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 125.619 1.825 . . . . 0.0 112.368 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -76.14 132.92 40.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 t -126.72 127.06 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.04 0.448 . . . . 0.0 110.41 -174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -88.91 145.93 25.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.5 t -140.19 149.47 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.04 -10.89 0.14 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.068 -0.296 . . . . 0.0 112.717 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.24 10.41 49.17 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 117.467 0.633 . . . . 0.0 112.747 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.8 mt -55.51 149.64 28.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.596 0.698 . . . . 0.0 111.513 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.77 156.04 20.33 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.722 2.948 . . . . 0.0 111.959 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.36 1.28 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.976 3.117 . . . . 0.0 112.092 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.67 23.71 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.747 0.819 . . . . 0.0 110.792 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.32 134.81 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 122.784 0.434 . . . . 0.0 111.469 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -157.34 89.59 1.06 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 47.82 -77.17 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.1 -21.54 65.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.484 0.314 . . . . 0.0 111.25 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.46 -49.87 56.65 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -26.94 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.2 m -67.29 -25.6 66.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -17.78 22.78 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.659 0.383 . . . . 0.0 111.354 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.6 m -75.29 -34.64 61.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.869 0.304 . . . . 0.0 111.099 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -98.11 52.38 1.05 Allowed 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.225 -0.297 . . . . 0.0 110.727 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -66.59 6.9 0.4 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.42 0.688 . . . . 0.0 112.517 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -117.46 -0.31 11.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.029 0.932 . . . . 0.0 111.67 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' CE1' ' CZ ' ' A' ' 115' ' ' PHE . 1.2 m-85 -102.47 3.61 37.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.738 0.415 . . . . 0.0 111.631 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -157.98 53.51 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.39 148.94 49.69 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.112 2.541 . . . . 0.0 110.576 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.09 171.4 14.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.104 0.478 . . . . 0.0 111.635 -172.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 tt -138.56 144.27 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.18 155.62 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.47 141.32 21.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.999 0.428 . . . . 0.0 111.309 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -161.62 158.9 22.85 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.713 0.805 . . . . 0.0 109.539 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.22 168.62 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.184 3.256 . . . . 0.0 113.772 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 59.19 9.11 1.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.202 1.401 . . . . 0.0 114.061 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -83.7 142.77 30.49 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 121.804 -0.56 . . . . 0.0 109.97 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.8 169.53 23.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.177 0.591 . . . . 0.0 109.86 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.11 -2.87 33.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.731 0.412 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.4 p -129.08 14.55 6.26 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.455 0.702 . . . . 0.0 111.862 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -134.35 158.03 44.87 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.279 0.632 . . . . 0.0 110.734 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -146.17 14.85 1.31 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.459 0.704 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -74.16 165.18 25.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.992 0.425 . . . . 0.0 111.345 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.54 155.54 92.45 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.645 0.778 . . . . 0.0 111.042 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.14 151.14 84.43 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.852 2.368 . . . . 0.0 110.066 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.74 -6.34 18.84 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.105 3.204 . . . . 0.0 113.217 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -124.22 -3.54 7.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.369 0.531 . . . . 0.0 112.173 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.33 3.55 53.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.458 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -102.86 167.5 9.82 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 117.506 0.653 . . . . 0.0 110.769 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 156.7 43.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.671 0.388 . . . . 0.0 111.441 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.03 128.51 38.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 pp -156.69 168.43 27.44 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.835 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 pp -152.68 171.63 17.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.056 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.453 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 4.3 p90 -142.44 165.21 28.03 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.846 0.458 . . . . 0.0 110.454 -175.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -75.23 -23.17 57.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -90.73 87.84 6.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.397 0.544 . . . . 0.0 110.233 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -67.47 -15.82 63.88 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -84.0 -18.69 36.31 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.881 -0.512 . . . . 0.0 110.469 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.2 t -79.48 -17.36 54.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.15 -47.94 79.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -86.84 -30.35 21.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.02 -39.47 72.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 122.109 -0.369 . . . . 0.0 111.811 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.0 tm? -83.16 -40.92 19.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.308 -0.245 . . . . 0.0 110.347 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.58 -27.84 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.77 -19.33 26.17 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.099 -0.376 . . . . 0.0 111.736 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -86.9 11.48 13.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 4.0 t -136.72 -160.26 1.04 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.529 0.332 . . . . 0.0 111.084 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -78.89 158.11 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.025 0.53 . . . . 0.0 111.243 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.59 164.26 35.6 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.204 0.526 . . . . 0.0 111.301 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.401 ' OE2' ' HE3' ' A' ' 134' ' ' LYS . 33.7 tt0 -142.12 155.07 45.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.471 1.108 . . . . 0.0 108.472 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -65.24 -4.22 4.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.145 -0.347 . . . . 0.0 111.317 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.97 -22.64 3.84 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.6 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.401 ' HE3' ' OE2' ' A' ' 131' ' ' GLU . 8.8 ptpt -165.7 179.4 6.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.687 1.243 . . . . 0.0 111.388 -175.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.71 159.35 16.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.842 0.457 . . . . 0.0 109.882 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -142.88 134.29 26.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.8 mt -110.19 162.95 14.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.23 141.47 50.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.68 154.55 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.637 0.256 . . . . 0.0 110.983 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.8 p -155.75 162.39 40.53 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.078 0.951 . . . . 0.0 109.862 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 142' ' ' PRO . 8.3 p -157.37 171.26 7.68 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.335 0.654 . . . . 0.0 109.538 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 141' ' ' SER . 96.1 Cg_endo -71.92 0.33 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 112.386 177.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -120.76 -15.68 8.34 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.445 0.566 . . . . 0.0 111.793 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.45 125.36 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.45 -175.36 2.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.736 0.815 . . . . 0.0 112.295 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -49.85 129.75 20.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.088 0.555 . . . . 0.0 111.7 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -146.66 118.92 4.88 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.663 0.785 . . . . 0.0 109.446 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.67 149.04 37.77 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.61 2.207 . . . . 0.0 109.197 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.94 135.72 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.053 0 CA-C-O 120.68 0.276 . . . . 0.0 110.575 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.42 128.43 34.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.12 152.19 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.741 0.305 . . . . 0.0 111.077 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -147.71 123.26 5.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 122.653 0.381 . . . . 0.0 111.595 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -84.66 -161.07 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.745 3.63 . . . . 0.0 106.928 168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 56.6 t-105 -145.83 154.57 42.14 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.846 1.203 . . . . 0.0 110.471 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 32.4 p-10 -117.52 94.45 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.91 1.338 . . . . 0.0 111.531 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -64.74 2.06 0.75 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.163 174.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.3 p -82.89 -29.29 29.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -86.7 -20.85 27.12 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.019 0.372 . . . . 0.0 110.185 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 58.5 m -61.1 -12.25 11.48 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -131.23 112.37 12.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 19.3 p90 -133.35 114.89 14.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 112.103 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.32 156.48 3.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.483 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 55.8 ttm -129.82 -25.83 2.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.604 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -158.79 168.82 25.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.322 0.51 . . . . 0.0 110.841 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -103.14 20.17 43.87 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.128 0.87 . . . . 0.0 111.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 t -63.2 -20.61 65.58 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.08 156.14 78.67 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.83 2.41 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.658 3.572 . . . . 0.0 112.45 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp 57.82 35.53 25.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.87 0.868 . . . . 0.0 110.854 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.11 146.48 45.45 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.475 0.71 . . . . 0.0 110.0 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 -23.35 30.04 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.402 2.735 . . . . 0.0 114.627 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -83.31 -5.86 59.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.893 0.769 . . . . 0.0 111.074 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 173' ' ' LYS . 9.8 mmpt? -117.89 10.94 13.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.393 1.077 . . . . 0.0 110.078 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -110.7 155.49 22.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.669 0.387 . . . . 0.0 110.172 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.33 153.39 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -105.5 150.66 25.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.64 123.66 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.72 149.85 16.8 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 93.53 99.14 1.52 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.9 m -142.48 57.06 5.85 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.728 1.211 . . . . 0.0 109.441 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.27 166.87 28.5 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.954 3.102 . . . . 0.0 112.221 -175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 183' ' ' PRO . 4.8 ptm180 56.42 169.69 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.804 2.042 . . . . 0.0 113.194 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 182' ' ' ARG . 56.3 Cg_endo -65.59 136.19 45.2 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.029 1.819 . . . . 0.0 109.592 177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 184' ' ' LEU . 1.7 pp -158.9 -171.18 3.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -169.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 29.2 mmt85 -140.51 175.6 9.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.618 1.967 . . . . 0.0 106.495 171.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.63 -5.56 16.22 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.457 -0.777 . . . . 0.0 111.066 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.07 -43.08 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -71.26 -28.5 64.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 190' ' ' ALA . 3.4 pp -88.15 -24.07 23.46 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 -177.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 189' ' ' LEU . . . -84.35 -37.36 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -36.99 72.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.389 -176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 196' ' ' LEU . 19.9 pt -71.24 -46.64 64.59 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.839 1.2 . . . . 0.0 109.722 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -66.22 -4.08 6.98 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 119.272 0.942 . . . . 0.0 110.986 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -112.92 -2.93 14.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.397 0.279 . . . . 0.0 111.74 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -76.31 -24.48 54.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 121.807 -0.558 . . . . 0.0 110.106 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -151.15 -7.23 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -176.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.93 30.52 3.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.119 0.872 . . . . 0.0 111.146 -176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -55.23 152.61 14.1 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.018 0.342 . . . . 0.0 113.556 -172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.88 10.49 1.03 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.561 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 p -58.19 150.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.909 0.855 . . . . 0.0 112.117 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -124.47 -41.74 2.14 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.295 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -146.82 145.79 30.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -167.96 166.73 13.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.041 0.448 . . . . 0.0 111.594 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.58 168.02 36.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 82.7 mt -85.49 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.23 140.6 44.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.244 0.217 . . . . 0.0 110.97 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.8 p -138.2 158.91 43.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.87 0.843 . . . . 0.0 112.307 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -90.11 118.89 69.22 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.111 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.52 -11.54 17.31 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.452 2.768 . . . . 0.0 112.425 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -43.23 80.06 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.663 0.385 . . . . 0.0 111.348 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 211' ' ' LEU . 1.9 pt? -138.75 10.03 2.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.611 0.243 . . . . 0.0 111.124 177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 62.25 33.86 16.36 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.141 1.377 . . . . 0.0 112.098 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 64' ' ' SER . 17.1 m-30 -116.9 157.03 47.39 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -54.36 152.4 26.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.081 3.187 . . . . 0.0 114.481 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.07 5.27 2.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.009 0.924 . . . . 0.0 111.387 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.2 156.34 31.84 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 64.25 173.37 0.19 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.993 1.317 . . . . 0.0 111.796 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.99 -171.92 22.89 Favored Glycine 0 CA--C 1.524 0.601 0 O-C-N 122.073 -0.392 . . . . 0.0 112.189 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -152.93 158.69 42.47 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.113 0.482 . . . . 0.0 111.397 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 13.3 p -145.43 152.5 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.16 117.93 11.68 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.514 -0.741 . . . . 0.0 111.895 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -166.49 151.51 7.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.274 1.03 . . . . 0.0 109.607 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.3 m -138.46 27.5 2.53 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.888 0.875 . . . . 0.0 109.438 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -58.44 -69.8 0.17 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.302 1.041 . . . . 0.0 113.5 -170.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -148.95 -160.04 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.084 0.554 . . . . 0.0 110.367 -174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -57.85 -12.64 3.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.019 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 p -67.96 -34.98 77.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.728 -0.607 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -29.24 38.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -66.42 -36.96 78.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -76.92 -27.8 55.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.699 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.47 -32.67 23.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.452 0.569 . . . . 0.0 111.254 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.8 tt -76.62 -11.02 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.807 0.731 . . . . 0.0 109.564 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -106.34 17.24 23.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.518 169.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -90.51 40.39 1.01 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -81.42 92.45 6.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 66.45 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.125 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 238' ' ' GLN . 1.1 p -155.32 174.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.411 ' H ' HG22 ' A' ' 237' ' ' VAL . 0.6 OUTLIER -71.76 121.91 19.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 122.68 0.392 . . . . 0.0 110.887 -178.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -157.23 126.11 5.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -126.39 105.79 9.03 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.89 134.15 5.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.626 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 57.84 -129.58 49.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.6 -4.23 58.88 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.901 0.48 . . . . 0.0 111.27 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.74 141.27 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.782 -0.574 . . . . 0.0 109.937 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -146.15 -26.53 0.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 2.15 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -136.27 107.81 6.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.196 0.522 . . . . 0.0 111.903 -171.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -141.28 148.15 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.698 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.82 130.77 56.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 8.9 t -147.03 117.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -150.17 168.65 10.58 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.395 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.87 147.03 43.49 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.774 2.316 . . . . 0.0 111.493 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -82.56 159.35 22.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.784 0.433 . . . . 0.0 110.878 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.002 -1.475 . . . . 0.0 110.348 -179.625 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -148.53 148.92 30.76 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.199 0.6 . . . . 0.0 109.773 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -152.79 -24.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 161.01 43.54 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.17 -0.331 . . . . 0.0 111.116 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 176.42 47.98 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.56 165.68 34.39 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.004 0.522 . . . . 0.0 110.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -87.54 166.96 14.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.927 0.491 . . . . 0.0 111.026 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.68 137.17 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.505 0.722 . . . . 0.0 109.193 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.51 28.06 0.99 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.01 0.524 . . . . 0.0 111.023 -177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 7.16 3.9 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -114.57 167.64 10.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 154' ' ' TRP . 29.7 t -94.88 137.93 33.31 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -78.11 1.11 22.23 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 124.502 1.126 . . . . 0.0 112.398 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.79 69.52 7.36 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.86 129.33 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.245 0.618 . . . . 0.0 110.476 -174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -89.31 139.39 30.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 113' ' ' LEU . 46.9 t -139.26 156.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.34 -8.11 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.827 -0.43 . . . . 0.0 112.699 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 149' ' ' VAL . . . -83.71 11.27 57.13 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.71 0.755 . . . . 0.0 112.131 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.7 mt -53.69 149.35 16.32 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.398 0.679 . . . . 0.0 111.251 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.33 166.2 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.291 2.66 . . . . 0.0 110.348 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.61 165.26 31.41 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.493 2.795 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 52.18 32.22 10.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.744 0.818 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.2 139.78 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.564 0.697 . . . . 0.0 112.64 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 p30 -138.42 172.13 13.34 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -58.87 -23.46 60.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.41 -26.48 26.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.948 0.795 . . . . 0.0 110.157 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.3 tp10 -68.96 -46.03 69.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.29 -32.67 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.5 m -67.03 -24.02 65.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.999 0.363 . . . . 0.0 110.097 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.07 -22.39 15.72 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -62.75 -42.9 99.89 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 118.059 0.391 . . . . 0.0 111.081 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 5.3 m-30 -71.89 128.27 35.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -104.54 -7.25 19.87 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.45 15.56 4.49 Favored 'General case' 0 N--CA 1.46 0.029 0 C-N-CA 122.967 0.507 . . . . 0.0 111.079 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD2' ' HD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -111.68 140.82 45.99 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.404 0.682 . . . . 0.0 109.267 -176.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.66 -167.87 32.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.55 140.2 67.79 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.396 2.73 . . . . 0.0 110.355 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.4 pt? -148.04 178.81 8.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.937 0.895 . . . . 0.0 110.68 -173.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.74 146.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.59 151.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.546 0.338 . . . . 0.0 110.56 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.93 157.33 43.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -99.59 152.11 37.69 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 123.023 0.529 . . . . 0.0 110.2 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.32 -20.15 32.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.892 2.395 . . . . 0.0 111.159 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -160.63 157.71 27.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.571 0.748 . . . . 0.0 109.513 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 100' ' ' GLU . 18.2 ptmt -155.1 151.31 28.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.295 0.638 . . . . 0.0 109.582 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.12 -18.43 39.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 98' ' ' LYS . 40.9 tt0 -155.47 152.24 28.71 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.8 p -70.85 -3.21 17.86 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -109.26 -2.82 17.65 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.241 0.617 . . . . 0.0 110.966 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 60.8 m -77.67 155.21 31.5 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.089 -0.382 . . . . 0.0 110.749 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.27 10.13 4.47 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.285 0.634 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.19 130.14 24.21 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.506 0.723 . . . . 0.0 109.959 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.75 146.72 26.9 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.464 2.776 . . . . 0.0 110.793 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.17 -10.95 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.752 2.968 . . . . 0.0 111.952 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -140.5 166.97 23.26 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.59 0.756 . . . . 0.0 110.135 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.37 -6.8 81.46 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.119 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -94.27 153.95 17.77 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-N 118.04 0.92 . . . . 0.0 110.195 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.06 32.35 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -127.18 124.53 39.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 69' ' ' VAL . 4.1 pp -134.49 156.5 48.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.12 157.82 43.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.11 0.481 . . . . 0.0 109.898 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -107.49 156.35 19.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -71.69 -16.99 62.26 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.55 139.88 45.73 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.9 -11.86 56.31 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.3 p -87.33 -20.02 27.36 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.77 -0.581 . . . . 0.0 110.37 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.0 m -77.16 -21.66 53.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.26 -37.19 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -82.96 -32.95 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.999 -0.438 . . . . 0.0 110.561 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.93 -38.64 86.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.046 0.384 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 137' ' ' LEU . 0.8 OUTLIER -91.77 -24.15 19.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.458 -176.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 72.2 mt -78.05 -16.94 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 121.882 -0.511 . . . . 0.0 109.657 173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -90.67 -24.58 20.42 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.641 -0.662 . . . . 0.0 110.601 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.0 20.14 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.096 0.558 . . . . 0.0 111.987 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.3 p -128.66 -177.61 4.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.003 0.521 . . . . 0.0 111.329 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -66.38 148.86 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.639 0.776 . . . . 0.0 110.422 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.7 149.33 52.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.967 0.507 . . . . 0.0 111.357 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -139.59 153.15 47.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -65.37 -7.94 16.12 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.89 -0.506 . . . . 0.0 111.411 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -110.75 -25.78 5.02 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.465 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -168.73 -179.48 3.79 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.445 1.122 . . . . 0.0 111.307 -174.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.6 162.99 15.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -147.04 138.8 24.31 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.54 0.336 . . . . 0.0 110.445 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 124' ' ' LEU . 5.4 mp -98.09 144.36 27.67 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.3 p -89.15 44.25 1.2 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.094 0.958 . . . . 0.0 112.556 -173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 m -68.85 -4.43 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 p -92.84 79.18 4.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.29 0.636 . . . . 0.0 110.229 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.77 ' H ' ' HD2' ' A' ' 142' ' ' PRO . 37.1 t -159.1 -42.73 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.77 ' HD2' ' H ' ' A' ' 141' ' ' SER . 30.0 Cg_endo -82.68 -123.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.35 2.7 . . . . 0.0 111.079 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 p -64.81 -3.14 3.03 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.055 0.942 . . . . 0.0 112.675 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.51 136.47 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -153.88 95.62 1.89 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -154.03 -41.08 0.09 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -156.84 138.65 10.01 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.71 -177.45 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.743 2.962 . . . . 0.0 110.282 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.441 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 31.5 m -112.11 135.69 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 O-C-N 122.239 -0.288 . . . . 0.0 110.357 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -75.31 142.55 43.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 17.6 mm -139.06 134.37 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 122.69 0.396 . . . . 0.0 110.755 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -150.24 95.12 3.62 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.637 0.375 . . . . 0.0 111.88 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.36 158.32 22.74 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.466 2.777 . . . . 0.0 106.382 167.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 50.1 t-105 -86.05 155.5 20.8 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 120.572 1.533 . . . . 0.0 112.417 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' CD1' ' A' ' 154' ' ' TRP . 1.8 m120 -110.97 61.89 0.61 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.349 -174.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.81 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -72.81 7.98 1.72 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -112.46 -6.91 13.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.217 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.25 -20.64 6.65 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 118.378 0.535 . . . . 0.0 111.229 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.9 m -57.01 -8.13 0.59 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.98 121.81 27.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.23 162.0 17.67 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.5 p -162.02 136.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -173.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 62.5 mtt -149.16 11.16 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.399 0.28 . . . . 0.0 111.301 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -73.98 162.13 29.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.29 0.567 . . . . 0.0 112.151 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -169.64 7.57 0.04 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.504 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.1 t -145.93 -14.71 0.47 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.544 0.672 . . . . 0.0 112.521 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -137.2 141.38 34.05 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.02 0.373 . . . . 0.0 111.257 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.11 158.64 26.81 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.96 3.107 . . . . 0.0 110.899 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.25 133.12 34.18 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.92 140.75 12.12 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.77 -8.06 16.64 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.374 2.716 . . . . 0.0 113.832 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.18 -0.61 32.62 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.474 0.579 . . . . 0.0 111.128 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -133.62 23.33 3.99 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.776 0.831 . . . . 0.0 111.27 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -103.07 152.49 21.32 Favored 'General case' 0 C--O 1.23 0.045 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 59.7 mt -130.63 160.37 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 219' ' ' ARG . 1.7 t80 -131.22 146.39 52.3 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.326 1.016 . . . . 0.0 111.367 -174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 219' ' ' ARG . 38.8 t -139.32 135.96 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 C-N-CA 124.613 1.165 . . . . 0.0 109.184 170.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.75 121.26 6.96 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 173.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.26 35.25 0.05 OUTLIER Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.089 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.44 44.08 0.73 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 118.975 1.388 . . . . 0.0 113.308 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.52 175.78 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.868 2.378 . . . . 0.0 111.253 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 61.84 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.043 1.337 . . . . 0.0 112.286 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.72 125.82 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.509 2.806 . . . . 0.0 113.384 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -159.47 -176.08 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.493 1.517 . . . . 0.0 107.814 169.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 187' ' ' VAL . 20.4 ttp-105 -128.29 41.65 3.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.904 0.775 . . . . 0.0 112.521 -174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.557 ' H ' ' CD2' ' A' ' 184' ' ' LEU . . . 59.97 -5.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.748 1.619 . . . . 0.0 113.849 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 185' ' ' ARG . 70.5 t -51.21 -39.67 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -72.77 -32.88 65.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.4 ' C ' HD12 ' A' ' 189' ' ' LEU . 1.2 pp -81.86 -34.29 30.17 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 119.129 0.877 . . . . 0.0 110.796 -171.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.41 29.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 119.668 -0.206 . . . . 0.0 110.455 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -26.84 37.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.108 0.413 . . . . 0.0 111.629 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.4 pt -79.41 -46.14 23.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 118.436 0.562 . . . . 0.0 110.688 175.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.32 -18.33 63.09 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.002 -0.436 . . . . 0.0 110.676 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 198' ' ' GLY . 35.1 t70 -96.8 -20.13 18.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -80.5 -26.97 37.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.643 1.111 . . . . 0.0 112.058 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 197' ' ' TYR . 0.3 OUTLIER -106.09 -26.98 11.39 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 176.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.558 ' CD2' HD13 ' A' ' 196' ' ' LEU . 28.2 m-85 -143.16 53.89 1.36 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.199 0.909 . . . . 0.0 110.283 -177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 194' ' ' ASP . . . -65.63 169.81 28.95 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.566 0.603 . . . . 0.0 113.643 -175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.23 12.28 4.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.553 0.597 . . . . 0.0 111.611 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.92 149.1 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 123.432 0.693 . . . . 0.0 111.752 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -117.9 -27.03 6.29 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.348 0.259 . . . . 0.0 111.647 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -146.87 146.45 30.19 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 220' ' ' VAL . . . -153.03 153.77 33.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.043 0.449 . . . . 0.0 111.765 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.87 -177.3 47.6 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.1 mt -110.4 138.66 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -73.97 123.23 23.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -113.79 157.56 22.12 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 122.263 1.03 . . . . 0.0 113.456 -174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . 0.466 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 38.3 t0 -90.46 120.06 69.04 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.076 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 -13.67 30.65 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.016 2.477 . . . . 0.0 112.605 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -87.52 -47.12 8.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.842 0.457 . . . . 0.0 111.769 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 211' ' ' LEU . 3.9 mm? -98.87 -5.3 31.19 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 177.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 53.8 29.62 9.97 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 54.2 t80 -129.11 147.79 66.37 Favored Pre-proline 0 CA--C 1.528 0.1 0 C-N-CA 123.442 0.697 . . . . 0.0 109.963 -170.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 88.2 Cg_exo -50.47 140.22 35.91 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 208' ' ' ASP . 53.1 mttm -91.13 9.04 32.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.593 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 93.89 17.86 39.51 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.578 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.29 157.92 45.57 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.377 0.671 . . . . 0.0 111.095 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 177.6 -178.11 48.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 220' ' ' VAL . 1.6 mmm-85 161.08 -128.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.967 0.907 . . . . 0.0 110.838 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.515 ' H ' ' HB3' ' A' ' 219' ' ' ARG . 28.7 m -158.64 177.92 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 117.806 0.275 . . . . 0.0 111.541 -166.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -138.25 110.68 7.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.39 32.38 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.553 0.741 . . . . 0.0 110.827 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 228' ' ' TYR . 36.2 m -71.54 71.52 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.405 0.682 . . . . 0.0 111.399 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.541 HD22 ' HG3' ' A' ' 225' ' ' GLN . 0.8 OUTLIER -143.85 -7.4 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 224' ' ' ASN . 37.8 mt-30 -145.39 171.65 14.31 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.689 0.677 . . . . 0.0 111.141 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -63.22 -10.75 16.87 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.693 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.4 p -66.92 -42.67 84.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 223' ' ' SER . 0.1 OUTLIER -72.7 -33.16 66.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.211 -0.306 . . . . 0.0 110.568 175.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.2 mm -62.03 -34.58 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.75 -23.99 36.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.826 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.29 3.41 46.13 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.519 0.599 . . . . 0.0 112.555 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tt -123.91 -25.64 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 118.713 0.688 . . . . 0.0 112.328 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.8 m -88.19 -1.29 57.93 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.97 0.35 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 236' ' ' PHE . . . -77.84 -20.87 52.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 49.85 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 234' ' ' ALA . 77.3 m-85 -152.94 157.4 40.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.0 t -147.58 147.63 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -71.43 -67.46 0.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 117.61 0.187 . . . . 0.0 110.883 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 61.9 mt 56.23 169.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -160.8 84.31 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -147.96 143.2 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.261 0.224 . . . . 0.0 110.625 -175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 56.55 -140.23 43.7 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.44 10.06 29.2 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.584 0.354 . . . . 0.0 110.924 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.8 136.1 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.296 0.638 . . . . 0.0 109.717 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -146.27 151.84 38.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.037 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 pttt 50.06 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.085 2.554 . . . . 0.0 117.766 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -159.54 147.27 17.17 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 120.577 1.535 . . . . 0.0 113.256 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.22 155.86 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.439 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -88.62 139.73 30.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.97 121.56 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.667 0.667 . . . . 0.0 111.232 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -167.78 169.84 5.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 122.685 0.394 . . . . 0.0 110.022 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.23 157.38 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.5 2.8 . . . . 0.0 113.009 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -80.45 -9.83 59.75 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.652 0.781 . . . . 0.0 111.81 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.203 -1.379 . . . . 0.0 109.793 -178.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.329 0.109 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 54.52 22.22 3.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.181 0.992 . . . . 0.0 113.373 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -139.77 156.49 46.74 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.416 0.687 . . . . 0.0 109.969 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.64 10.66 2.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.176 0.59 . . . . 0.0 111.327 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.4 156.15 53.15 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -152.75 170.32 20.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -109.91 160.56 16.28 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.388 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.25 137.87 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 109.688 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.32 20.57 2.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.697 0.799 . . . . 0.0 110.511 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -78.1 -14.13 59.6 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -89.2 153.46 20.91 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 119.005 0.82 . . . . 0.0 111.705 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 156' ' ' LEU . 37.4 t -82.35 135.53 35.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -82.17 8.71 10.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.667 1.23 . . . . 0.0 112.36 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -74.08 70.21 1.54 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.5 t -91.22 114.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.567 0.699 . . . . 0.0 109.954 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -84.18 145.6 28.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.595 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 t -123.86 136.94 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 15.97 60.39 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.234 0.445 . . . . 0.0 112.897 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.59 151.07 8.91 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 117.203 0.502 . . . . 0.0 112.428 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.0 mt -146.97 154.19 46.57 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.7 1.2 . . . . 0.0 108.29 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -58.29 153.84 44.39 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.963 2.442 . . . . 0.0 111.383 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.15 -0.69 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.601 3.534 . . . . 0.0 113.399 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -133.39 35.92 3.42 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.347 0.659 . . . . 0.0 109.526 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.0 137.44 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.834 0.826 . . . . 0.0 112.677 -172.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.517 ' H ' ' HB3' ' A' ' 80' ' ' GLU . 36.4 t70 -151.17 167.37 27.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.257 2.223 . . . . 0.0 105.773 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.86 -32.07 13.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.4 -26.27 38.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.31 0.504 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.7 tp10 -75.47 -44.21 45.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.565 0.346 . . . . 0.0 110.204 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -35.13 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.1 m -71.62 -22.53 61.69 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.65 -16.62 20.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.516 0.326 . . . . 0.0 111.818 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.7 m -65.39 -54.14 33.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.75 159.79 32.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -121.49 9.22 10.23 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -169.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -146.04 -19.49 0.45 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CZ ' HD12 ' A' ' 124' ' ' LEU . 22.6 m-85 -71.86 148.33 46.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.959 0.345 . . . . 0.0 111.462 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.99 -160.13 35.85 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.88 155.86 21.42 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.176 3.25 . . . . 0.0 111.666 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.33 164.55 32.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -170.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.4 mt -72.27 147.61 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.1 m -94.63 109.37 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -165.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.567 ' CB ' ' H ' ' A' ' 112' ' ' PHE . 5.4 p-10 -50.15 -6.76 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 168.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -123.47 151.98 64.01 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 119.504 1.047 . . . . 0.0 111.196 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.96 172.0 15.52 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.904 3.07 . . . . 0.0 110.72 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -61.57 150.94 34.58 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.626 0.251 . . . . 0.0 111.006 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -90.74 167.44 12.49 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.339 0.656 . . . . 0.0 111.295 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.38 178.04 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.996 0.519 . . . . 0.0 111.034 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.11 15.01 0.77 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.472 0.709 . . . . 0.0 112.74 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.3 t -132.31 150.19 52.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.963 0.505 . . . . 0.0 110.727 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -79.1 -13.55 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.081 0.552 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.0 m -82.65 1.71 37.09 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.881 0.472 . . . . 0.0 111.604 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -91.62 150.62 21.08 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.905 0.482 . . . . 0.0 110.748 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -138.85 143.95 39.56 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.265 0.626 . . . . 0.0 109.897 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.85 168.55 21.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.906 3.071 . . . . 0.0 111.255 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.29 159.98 11.84 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.219 3.279 . . . . 0.0 112.874 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -112.23 14.69 20.58 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.848 0.859 . . . . 0.0 111.605 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.75 -121.02 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.242 0.925 . . . . 0.0 111.665 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -96.35 179.67 4.95 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . . . -144.29 150.81 38.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -170.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.567 ' H ' ' CB ' ' A' ' 94' ' ' ASP . 94.5 m-85 -126.99 97.09 4.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.406 0.622 . . . . 0.0 110.309 169.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -129.88 143.24 50.71 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 120.343 -1.473 . . . . 0.0 110.978 -172.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.61 100.65 3.81 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.742 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.503 ' CE1' HG22 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -62.82 157.51 21.13 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.93 1.292 . . . . 0.0 110.641 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -88.86 0.46 56.54 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.86 134.18 55.19 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -99.02 -9.74 23.54 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.2 m -86.13 -31.15 22.0 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.703 0.683 . . . . 0.0 110.561 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -71.14 -18.39 62.51 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 115' ' ' PHE . 38.5 t -62.61 -37.69 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -89.53 -28.78 19.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.44 58.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 118.374 0.534 . . . . 0.0 111.787 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.443 HD12 ' CZ ' ' A' ' 88' ' ' PHE . 3.3 tm? -79.61 -44.15 21.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.61 -29.69 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 121.136 -0.225 . . . . 0.0 110.494 177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.96 -16.55 33.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.286 0.494 . . . . 0.0 111.816 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.54 4.04 26.13 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.131 -0.356 . . . . 0.0 111.893 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.52 -162.52 1.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.398 0.279 . . . . 0.0 111.036 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.93 151.07 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.388 0.614 . . . . 0.0 112.016 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.49 145.66 31.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.259 1.024 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.21 166.99 27.21 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.533 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.75 -7.52 34.63 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.95 7.7 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 118.72 0.691 . . . . 0.0 112.618 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -171.46 177.53 3.47 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 117.758 0.779 . . . . 0.0 111.125 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.2 mt -104.16 153.67 20.66 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 148' ' ' PRO . 0.9 OUTLIER -142.13 129.51 21.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.924 0.392 . . . . 0.0 111.282 -173.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.0 153.41 28.11 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.742 0.417 . . . . 0.0 110.336 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.8 m -119.13 51.98 1.1 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.194 0.598 . . . . 0.0 110.611 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.23 -6.99 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.3 p -94.6 120.69 35.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.802 0.441 . . . . 0.0 110.736 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 142' ' ' PRO . 35.3 t -160.48 -43.4 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 118.653 -0.689 . . . . 0.0 112.18 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' CD ' ' H ' ' A' ' 141' ' ' SER . 16.9 Cg_exo -69.2 -168.32 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.966 2.444 . . . . 0.0 110.96 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.3 p -65.03 -1.45 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.574 0.349 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.477 HD12 ' C ' ' A' ' 144' ' ' ILE . 2.0 pp -91.52 5.47 6.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 123.673 0.789 . . . . 0.0 111.235 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -47.1 132.84 12.04 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.836 0.854 . . . . 0.0 112.247 -172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -144.38 24.98 1.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.26 1.024 . . . . 0.0 110.849 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 63.23 162.7 0.12 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.203 1.401 . . . . 0.0 111.68 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 88.2 Cg_exo -51.96 165.37 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.334 3.356 . . . . 0.0 113.197 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.66 147.27 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.028 0.442 . . . . 0.0 111.785 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -76.28 145.54 39.57 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.559 1.144 . . . . 0.0 108.696 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.53 137.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 118.914 0.779 . . . . 0.0 111.077 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -146.6 92.83 5.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -85.8 -174.88 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.858 3.705 . . . . 0.0 107.639 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.43 ' HZ2' ' HG ' ' A' ' 159' ' ' SER . 73.0 t-105 -130.86 156.33 45.22 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.529 1.513 . . . . 0.0 113.644 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.4 59.08 0.6 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.358 1.463 . . . . 0.0 111.639 -175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.811 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -62.59 5.87 0.11 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.399 1.479 . . . . 0.0 114.211 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.4 p -117.2 -6.52 11.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.615 0.366 . . . . 0.0 110.757 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.9 14.95 3.94 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.43 ' HG ' ' HZ2' ' A' ' 154' ' ' TRP . 21.5 m -71.45 -7.54 48.06 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.818 -0.551 . . . . 0.0 111.416 174.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.05 130.75 35.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 203' ' ' ALA . 35.2 p90 -120.08 116.36 25.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.933 176.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.59 138.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.955 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt -89.21 -44.24 10.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.538 0.153 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -163.22 162.26 25.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.437 0.295 . . . . 0.0 110.348 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.07 22.8 4.13 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.003 0.811 . . . . 0.0 112.304 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.7 m -54.79 -32.39 60.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -142.55 150.02 52.82 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 117.844 0.293 . . . . 0.0 111.026 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.46 160.98 43.5 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.654 2.903 . . . . 0.0 110.462 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.406 HD21 ' CE2' ' A' ' 202' ' ' TYR . 7.5 mp -94.55 124.32 38.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.878 0.471 . . . . 0.0 110.015 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -151.92 145.72 17.96 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.6 -14.56 26.59 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.063 2.509 . . . . 0.0 112.124 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -69.47 -8.04 43.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.458 1.103 . . . . 0.0 113.003 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -135.15 14.04 3.55 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -88.77 151.66 22.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.43 156.16 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -109.36 140.16 43.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.65 115.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 122.413 0.285 . . . . 0.0 110.346 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -97.56 120.56 6.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.44 20.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.911 -0.938 . . . . 0.0 114.463 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.22 46.46 1.71 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.077 1.438 . . . . 0.0 112.064 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.64 -9.4 25.73 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.222 2.615 . . . . 0.0 112.302 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -97.39 141.63 23.32 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.57 135.88 40.98 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.125 2.55 . . . . 0.0 111.74 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -156.6 175.84 13.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.313 0.645 . . . . 0.0 110.463 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -128.49 58.41 1.56 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.41 0.684 . . . . 0.0 109.244 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 61.24 13.51 4.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.562 1.545 . . . . 0.0 113.482 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.3 t -74.56 -45.63 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 O-C-N 122.259 -0.276 . . . . 0.0 111.457 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -69.17 -34.83 75.56 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 111.41 0.152 . . . . 0.0 111.41 -172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.482 HD13 ' C ' ' A' ' 189' ' ' LEU . 2.4 tm? -75.84 -44.37 41.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.878 0.871 . . . . 0.0 109.581 -176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -73.56 -36.69 65.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.163 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -76.42 -29.52 57.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.249 0.477 . . . . 0.0 111.722 -173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.18 -47.31 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.971 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.7 mmt -70.96 -10.65 60.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.78 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -106.48 -4.51 19.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -101.37 -14.41 17.61 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.067 0.848 . . . . 0.0 112.012 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.647 HD12 ' H ' ' A' ' 197' ' ' TYR . 0.4 OUTLIER -118.78 -38.38 3.11 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 176.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.647 ' H ' HD12 ' A' ' 196' ' ' LEU . 41.6 m-85 -147.26 67.61 1.14 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.195 0.907 . . . . 0.0 110.094 -176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.91 156.03 37.31 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.395 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.17 7.82 0.18 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.996 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 10.1 p -58.52 146.46 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.228 1.014 . . . . 0.0 111.279 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.2 t -125.2 -45.32 1.85 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' CE2' HD21 ' A' ' 169' ' ' LEU . 51.0 t80 -141.11 138.31 33.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 161' ' ' PHE . . . -165.45 169.08 16.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.26 154.35 15.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 47.7 pt -78.48 154.64 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 118.081 0.94 . . . . 0.0 110.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.542 ' H ' ' HA2' ' A' ' 218' ' ' GLY . 28.5 t70 -80.96 155.83 26.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.253 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.9 p -138.39 159.93 40.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.981 0.896 . . . . 0.0 113.114 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -71.01 118.14 62.8 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.598 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.51 -10.02 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.175 2.583 . . . . 0.0 112.492 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -72.93 -42.25 63.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.928 0.491 . . . . 0.0 111.705 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.92 14.49 1.51 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 57.13 51.54 10.22 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 124.386 1.074 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.406 ' CG ' ' HD2' ' A' ' 214' ' ' PRO . 60.1 t80 -122.5 143.85 40.75 Favored Pre-proline 0 N--CA 1.463 0.177 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.076 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 213' ' ' TYR . 77.8 Cg_exo -44.99 136.18 10.22 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.39 2.726 . . . . 0.0 113.445 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -110.99 7.28 21.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.612 0.765 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.77 15.33 70.75 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.082 0.401 . . . . 0.0 112.146 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.34 22.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.782 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 206' ' ' ASP . . . -146.42 172.29 27.03 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 122.093 -0.379 . . . . 0.0 112.618 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 -146.59 156.38 43.18 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.0 p -151.18 149.55 14.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.57 110.52 11.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.218 0.463 . . . . 0.0 110.844 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -162.72 33.15 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.491 0.716 . . . . 0.0 111.172 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 228' ' ' TYR . 24.1 m -72.65 57.37 0.41 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.703 0.801 . . . . 0.0 111.539 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.438 HD22 ' HG2' ' A' ' 225' ' ' GLN . 1.0 OUTLIER -134.74 -5.46 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.438 ' HG2' HD22 ' A' ' 224' ' ' ASN . 23.3 mm-40 -145.8 168.92 19.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.644 0.735 . . . . 0.0 111.556 -177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.84 -13.25 31.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.689 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.5 m -68.39 -32.7 72.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.481 ' CG ' ' HA ' ' A' ' 223' ' ' SER . 0.0 OUTLIER -76.99 -35.47 57.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.3 mm -63.06 -37.19 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.22 -29.77 42.95 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.86 -13.45 44.89 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.372 0.533 . . . . 0.0 111.986 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 tt -101.45 -15.59 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 117.781 0.264 . . . . 0.0 110.686 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.2 m -101.71 -8.78 21.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.41 0.284 . . . . 0.0 111.361 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -130.89 83.19 2.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -109.6 5.21 22.86 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.838 -173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -129.21 42.78 3.25 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.15 161.48 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.365 0.266 . . . . 0.0 111.199 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 48.52 -117.31 0.9 Allowed 'General case' 0 C--N 1.338 0.106 0 C-N-CA 124.071 0.948 . . . . 0.0 111.554 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.47 -107.0 0.16 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.323 0.649 . . . . 0.0 111.05 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 49.21 47.06 22.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.314 0.646 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -118.72 130.0 55.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.84 -143.14 48.55 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.03 9.75 18.64 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.698 0.399 . . . . 0.0 111.211 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 244' ' ' ILE . 2.9 mp -102.98 136.1 37.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -143.66 150.56 38.91 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 53.4 pttt 46.68 -8.64 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 129.17 2.988 . . . . 0.0 118.775 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -147.24 124.01 11.22 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 120.461 1.482 . . . . 0.0 112.538 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.27 178.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.02 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.67 132.32 49.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 t -140.65 125.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -161.81 158.86 22.22 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -63.08 152.16 80.98 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.747 2.298 . . . . 0.0 111.399 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -78.78 157.18 28.5 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.693 0.797 . . . . 0.0 111.013 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.083 -1.437 . . . . 0.0 110.452 -179.634 . . . . . . . . 0 0 . 1 stop_ save_